{"nct_id": "NCT05350410", "official_title": "A Pilot Study for the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program (HALT-AD)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer's Disease", "Dementia Prevention"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03136679", "official_title": "Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05858996", "official_title": "Testing the Pain Clinical Practice Guideline Using the Evidence Integration Triangle", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Pain", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04931862", "official_title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)", "overall_status": "TERMINATED", "phase": "PHASE1, PHASE2", "conditions": ["ALS", "FTD"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Ireland"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "New Zealand"}, {"country": "New Zealand"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02861846", "official_title": "Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Epilepsy"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01554683", "official_title": "Seizure-like Hippocampal Activity in Alzheimer's Disease Neurodegeneration", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease", "Seizures"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03034122", "official_title": "Is Caffeine an Environmental Modifier in Huntington's Disease?", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04949529", "official_title": "Falls: A Marker of Preclinical Alzheimer Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Fall", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02126059", "official_title": "The Health Effects of Cognitive Stimulation, Reminiscence, and Aroma-massage Complementary Interventions on Different Behavior Patterns of Patients With Dementia: Comparative and Longitudinal Research", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03487380", "official_title": "Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease", "Intestinal Microbiota"], "locations": [{"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04498962", "official_title": "The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Chronic Stable Angina", "Vascular Dementia", "Idiopathic Membranous Nephropathy"], "locations": [{"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04382170", "official_title": "Dexmedetomidine Sublingual Film for the Management of Agitation in Delirium: Safety and Preliminary Efficacy", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Delirium"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06029894", "official_title": "Improving Sleep and Alzheimer's Disease (AD) Biomarkers: A Pilot Randomized Clinical Trial (RCT) of Citicoline", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03804229", "official_title": "A Multi-center, Random, Double Blind and Placebo Control Phase III Clinical Study on the Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE3", "conditions": ["Vascular Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06786676", "official_title": "A Randomized, Double-blind, Placebo-controlled, Single- and Multiple-oral Administration, Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Korean or Caucasian Adults and Korean Elderly People", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Healthy"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01362959", "official_title": "Nicotine Replacement Therapy in the Intensive Care Unit: a Randomized, Controlled Pilot Study", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Delirium", "Psychomotor Agitation", "Substance Withdrawal Syndrome", "Nicotine Replacement Therapy"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03402503", "official_title": "A Randomized Phase IIa, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety, Feasibility, Tolerability, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02660983", "official_title": "A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Dementia Associated With Cerebrovascular Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00255866", "official_title": "Improving Affect and Behavior in Assisted Living Residents", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04099823", "official_title": "MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics and Association of Intracranial CSF Flow with Brain Function", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Hydrocephalus", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03335696", "official_title": "Predicting MRI Abnormalities With Longitudinal Data of the Whitehall II Substudy", "overall_status": "COMPLETED", "phase": null, "conditions": ["Cognitive Impairment", "Dementia", "Affective Disorders"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02079246", "official_title": "An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Estonia"}, {"country": "Estonia"}, {"country": "Estonia"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Lithuania"}, {"country": "Lithuania"}, {"country": "Lithuania"}, {"country": "Lithuania"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01652222", "official_title": "Experimental Study to Validate the \"Therapeutic Game\" CONEM-BETA", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [{"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03612622", "official_title": "Investigating the Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) add-on Treatment for Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Transcranial Magnetic Stimulation", "Magnetic Resonance Imaging", "Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05225051", "official_title": "N-homocysteinylated Huntingtin in Huntington's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Huntington Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01380288", "official_title": "Changes of Cognitive Function in Patients With Mild to Moderate Alzheimer's Disease Associated With or Without White Matter Changes After Rivastigmine Patch Therapy - Multi-center, Prospective, Open-label Clinical Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05711888", "official_title": "A Sensitive Measurement Proposal in Alzheimer's Disease: Semantic Recognition Task", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05010603", "official_title": "Late Onset Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00305903", "official_title": "A Prospective, 26-Week, Open-Label, Multi-Center, Single-Arm Pilot Study to Evaluate the Safety and Tolerability of Rivastigmine Capsule With Add on Memantine HCl in Patients With Probable Alzheimer's Disease (MMSE 10-20)", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00857727", "official_title": "Use of Dexmedetomidine for Emergence Delirium in Children Undergoing General Anesthesia for Endovascular Interventional Neuroradiologic Procedures", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Agitation", "Anesthesia", "Pediatrics"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00141661", "official_title": "A Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multiple Dose, Multicenter Study in Subjects With Mild to Moderate Dementia of the Alzheimer's Type to Evaluate the Safety and Tolerability of Two 10-Week Dose Regimens of Orally-Administered PF-04494700", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05527405", "official_title": "Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes in Visual Mapping Assistive Technology", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Caregiver Burden", "Assistive Technology"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06880822", "official_title": "Effects of a Closed-Loop and Neuroplasticity-Based Mindfulness Program for Reducing Stress in Family Caregivers of People with Dementia: a Randomized Controlled Trial with a Process Evaluation", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Caregiving Stress"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04162990", "official_title": "Lifestyle Remodeling in Subjective Memory Complaint (SMC): Brain Imaging and Blood Biochemistry Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Subjective Memory Complaint"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03531710", "official_title": "An Extension Study of a Phase IIa Study in Patients With Mild Alzheimer's Disease to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311)", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00007124", "official_title": "A Trial of Ketogenic Diet in Lafora Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Lafora Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03692988", "official_title": "Dignity Therapy: a Brief Psychological and Existential Intervention for Patients With Early Dementia and Their Family. A Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Mild", "Depressive Disorder"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03709173", "official_title": "FuRST 2.0: Cognitive Pre-testing for a New Functional Rating Scale for Use in Huntington's Disease - Round 2", "overall_status": "COMPLETED", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01710969", "official_title": "Individual and Group Intervention Formats With Aggressive Children", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggressive Behavior"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00467766", "official_title": "Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Caregivers"], "locations": [{"country": "United States"}, {"country": "Australia"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02420756", "official_title": "Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study: A Coverage With Evidence Development Longitudinal Cohort Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05635968", "official_title": "The Multicenter Phase II Clinical Trial for Evaluation of Safety and Efficacy Using Low Dose Irradiation With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03218982", "official_title": "A Culturally-Relevant Approach to Reducing Dementia Caregiver Stress in an Underserved Population", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease (Incl Subtypes)", "Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02418546", "official_title": "Electronic-health Application To Measure Outcomes REmotely Clinical Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Neurodegenerative Disease", "Weight Loss", "Amyotrophic Lateral Sclerosis", "Parkinson's Disease", "Huntington's Disease", "Cachexia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06976203", "official_title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Puerto Rico"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03443973", "official_title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Croatia"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Singapore"}, {"country": "Singapore"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05267535", "official_title": "Randomized, Delayed Start, Double Blind, Parallel Group, Placebo Controlled, Multicenter Study of Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01630525", "official_title": "\" The Eyes Have it \" : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01354691", "official_title": "A 6-Month Prospective, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Adaptive-Trial-Design Study to Evaluate the Safety and Efficacy of 80mg b.i.d Ladostigil in Patients With Mild to Moderate Probable Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Dementia", "Memory Loss", "Cognitive Impairment"], "locations": [{"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04270474", "official_title": "Reducing Risk of Dementia Through Deprescribing (R2D2)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease, Late Onset"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01297218", "official_title": "Open-Label, Single-Center, Phase 1 Clinical Trial to Evaluate the Safety and the Efficacy of NEUROTSTEM®-AD in Patients With Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia of the Alzheimer's Type"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06850870", "official_title": "Onward Door-Through-Door Companion Rideshare Technology to Improve Care for Older Adults and Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease or Associated Disorder", "Dementia", "Cognitive Decline"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00495417", "official_title": "Randomized, Controlled, Parallel Group, Patient-blinded, Single-center Phase I Pilot Study to Assess Tolerability and Safety of Repeated s.c. Administration of a Single-dose of Affitope AD01 Applied With or Without Adjuvant to Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Austria"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04916210", "official_title": "Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY", "overall_status": "RECRUITING", "phase": null, "conditions": ["Ischemic Stroke", "Intracerebral Hemorrhage", "Subarachnoid Hemorrhage", "Dementia, Vascular", "Mild Cognitive Impairment", "Vascular Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00403520", "official_title": "Assessment of the Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers in Patients With Mild Cognitive Disorders", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04260724", "official_title": "Prospective, Randomized, Evaluator-blind, Single Center Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild to Moderate Alzheimer Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03916588", "official_title": "Dementia Management With Interactive Technology", "overall_status": "TERMINATED", "phase": null, "conditions": ["Dementia", "Memory Disorders in Old Age"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02578303", "official_title": "Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06140342", "official_title": "A Music-Based Mobile App to Combat Neuropsychiatric Symptoms in People Living With ADRD", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia", "Agitation", "Depressive Symptoms"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01002586", "official_title": "Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Dementia", "Falls", "Gait Impairment", "Balance Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01600170", "official_title": "Statin Modulation of Monocyte/Macrophage Activation for HAND Treatment", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["HIV Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT07061470", "official_title": "RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Sleep in Pediatric Patients With Attention Deficit/Hyperactivity Disorder, Phase II", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["ADHD", "Sleep Problems"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04396873", "official_title": "Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Parkinson's Disease", "Dementia", "Alzheimer's Disease", "ALS", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03461276", "official_title": "A Multi-center, Randomized, Double-blind, Placebo-controlled, 24 Months Study in Patients With Amnestic Mild Cognitive Impairment or Very Mild Alzheimer's Disease to Investigate the Safety, Tolerability and Immune Response of Repeated Subcutaneous Injections of ABvac40", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Italy"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03197740", "official_title": "A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01793168", "official_title": "Coordination of Rare Diseases at Sanford", "overall_status": "RECRUITING", "phase": null, "conditions": ["Rare Disorders", "Undiagnosed Disorders", "Disorders of Unknown Prevalence", "Cornelia De Lange Syndrome", "Prenatal Benign Hypophosphatasia", "Perinatal Lethal Hypophosphatasia", "Odontohypophosphatasia", "Adult Hypophosphatasia", "Childhood-onset Hypophosphatasia", "Infantile Hypophosphatasia", "Hypophosphatasia", "Kabuki Syndrome", "Bohring-Opitz Syndrome", "Narcolepsy Without Cataplexy", "Narcolepsy-cataplexy", "Hypersomnolence Disorder", "Idiopathic Hypersomnia Without Long Sleep Time", "Idiopathic Hypersomnia With Long Sleep Time", "Idiopathic Hypersomnia", "Kleine-Levin Syndrome", "Kawasaki Disease", "Leiomyosarcoma", "Leiomyosarcoma of the Corpus Uteri", "Leiomyosarcoma of the Cervix Uteri", "Leiomyosarcoma of Small Intestine", "Acquired Myasthenia Gravis", "Addison Disease", "Hyperacusis (Hyperacousis)", "Juvenile Myasthenia Gravis", "Transient Neonatal Myasthenia Gravis", "Williams Syndrome", "Lyme Disease", "Myasthenia Gravis", "Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome)", "Isolated Klippel-Feil Syndrome", "Frasier Syndrome", "Denys-Drash Syndrome", "Beckwith-Wiedemann Syndrome", "Emanuel Syndrome", "Isolated Aniridia", "Axenfeld-Rieger Syndrome", "Aniridia-intellectual Disability Syndrome", "Aniridia - Renal Agenesis - Psychomotor Retardation", "Aniridia - Ptosis - Intellectual Disability - Familial Obesity", "Aniridia - Cerebellar Ataxia - Intellectual Disability", "Aniridia - Absent Patella", "Aniridia", "Peters Anomaly - Cataract", "Peters Anomaly", "Potocki-Shaffer Syndrome", "Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11", "Silver-Russell Syndrome Due to Imprinting Defect of 11p15", "Silver-Russell Syndrome Due to 11p15 Microduplication", "Syndromic Aniridia", "WAGR Syndrome", "Wolf-Hirschhorn Syndrome", "4p16.3 Microduplication Syndrome", "4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome", "Autosomal Recessive Stickler Syndrome", "Stickler Syndrome Type 2", "Stickler Syndrome Type 1", "Stickler Syndrome", "Mucolipidosis Type 4", "X-linked Spinocerebellar Ataxia Type 4", "X-linked Spinocerebellar Ataxia Type 3", "X-linked Intellectual Disability - Ataxia - Apraxia", "X-linked Progressive Cerebellar Ataxia", "X-linked Non Progressive Cerebellar Ataxia", "X-linked Cerebellar Ataxia", "Vitamin B12 Deficiency Ataxia", "Toxic Exposure Ataxia", "Unclassified Autosomal Dominant Spinocerebellar Ataxia", "Thyroid Antibody Ataxia", "Sporadic Adult-onset Ataxia of Unknown Etiology", "Spinocerebellar Ataxia With Oculomotor Anomaly", "Spinocerebellar Ataxia With Epilepsy", "Spinocerebellar Ataxia With Axonal Neuropathy Type 2", "Spinocerebellar Ataxia Type 8", "Spinocerebellar Ataxia Type 7", "Spinocerebellar Ataxia Type 6", "Spinocerebellar Ataxia Type 5", "Spinocerebellar Ataxia Type 4", "Spinocerebellar Ataxia Type 37", "Spinocerebellar Ataxia Type 36", "Spinocerebellar Ataxia Type 35", "Spinocerebellar Ataxia Type 34", "Spinocerebellar Ataxia Type 32", "Spinocerebellar Ataxia Type 31", "Spinocerebellar Ataxia Type 30", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 29", "Spinocerebellar Ataxia Type 28", "Spinocerebellar Ataxia Type 27", "Spinocerebellar Ataxia Type 26", "Spinocerebellar Ataxia Type 25", "Spinocerebellar Ataxia Type 23", "Spinocerebellar Ataxia Type 22", "Spinocerebellar Ataxia Type 21", "Spinocerebellar Ataxia Type 20", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 19/22", "Spinocerebellar Ataxia Type 18", "Spinocerebellar Ataxia Type 17", "Spinocerebellar Ataxia Type 16", "Spinocerebellar Ataxia Type 15/16", "Spinocerebellar Ataxia Type 14", "Spinocerebellar Ataxia Type 13", "Spinocerebellar Ataxia Type 12", "Spinocerebellar Ataxia Type 11", "Spinocerebellar Ataxia Type 10", "Spinocerebellar Ataxia Type 1 With Axonal Neuropathy", "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia - Unknown", "Spinocerebellar Ataxia - Dysmorphism", "Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature", "Spasticity-ataxia-gait Anomalies Syndrome", "Spastic Ataxia With Congenital Miosis", "Spastic Ataxia - Corneal Dystrophy", "Spastic Ataxia", "Rare Hereditary Ataxia", "Rare Ataxia", "Recessive Mitochondrial Ataxia Syndrome", "Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature", "Posterior Column Ataxia - Retinitis Pigmentosa", "Post-Stroke Ataxia", "Post-Head Injury Ataxia", "Post Vaccination Ataxia", "Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract", "Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus", "Non-hereditary Degenerative Ataxia", "Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity", "Olivopontocerebellar Atrophy - Deafness", "NARP Syndrome", "Myoclonus - Cerebellar Ataxia - Deafness", "Multiple System Atrophy, Parkinsonian Type", "Multiple System Atrophy, Cerebellar Type", "Multiple System Atrophy", "Maternally-inherited Leigh Syndrome", "Machado-Joseph Disease Type 3", "Machado-Joseph Disease Type 2", "Machado-Joseph Disease Type 1", "Leigh Syndrome", "Late-onset Ataxia With Dementia", "Infection or Post Infection Ataxia", "GAD Ataxia", "Hereditary Episodic Ataxia", "Gliadin/Gluten Ataxia", "Friedreich Ataxia", "Fragile X-associated Tremor/Ataxia Syndrome", "Familial Paroxysmal Ataxia", "Exposure to Medications Ataxia", "Episodic Ataxia With Slurred Speech", "Episodic Ataxia Unknown Type", "Episodic Ataxia Type 7", "Episodic Ataxia Type 6", "Episodic Ataxia Type 5", "Episodic Ataxia Type 4", "Episodic Ataxia Type 3", "Episodic Ataxia Type 1", "Epilepsy and/or Ataxia With Myoclonus as Major Feature", "Early-onset Spastic Ataxia-neuropathy Syndrome", "Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity", "Early-onset Cerebellar Ataxia With Retained Tendon Reflexes", "Early-onset Ataxia With Dementia", "Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia", "Dilated Cardiomyopathy With Ataxia", "Cataract - Ataxia - Deafness", "Cerebellar Ataxia, Cayman Type", "Cerebellar Ataxia With Peripheral Neuropathy", "Cerebellar Ataxia - Hypogonadism", "Cerebellar Ataxia - Ectodermal Dysplasia", "Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss", "Brain Tumor Ataxia", "Brachydactyly - Nystagmus - Cerebellar Ataxia", "Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia", "Autosomal Recessive Syndromic Cerebellar Ataxia", "Autosomal Recessive Spastic Ataxia With Leukoencephalopathy", "Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay", "Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria", "Autosomal Recessive Spastic Ataxia", "Autosomal Recessive Metabolic Cerebellar Ataxia", "Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine", "Autosomal Recessive Ataxia, Beauce Type", "Autosomal Recessive Ataxia Due to Ubiquinone Deficiency", "Autosomal Recessive Ataxia Due to PEX10 Deficiency", "Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia", "Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency", "Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency", "Autosomal Recessive Congenital Cerebellar Ataxia", "Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome", "Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency", "Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency", "Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency", "Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome", "Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity", "Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency", "Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect", "Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion", "Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation", "Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness", "Autosomal Recessive Cerebellar Ataxia", "Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly", "Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation", "Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy", "Autosomal Dominant Spastic Ataxia Type 1", "Autosomal Dominant Spastic Ataxia", "Autosomal Dominant Optic Atrophy", "Ataxia-telangiectasia Variant", "Ataxia-telangiectasia", "Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy", "Autosomal Dominant Cerebellar Ataxia Type 4", "Autosomal Dominant Cerebellar Ataxia Type 3", "Autosomal Dominant Cerebellar Ataxia Type 2", "Autosomal Dominant Cerebellar Ataxia Type 1", "Autosomal Dominant Cerebellar Ataxia", "Ataxia-telangiectasia-like Disorder", "Ataxia With Vitamin E Deficiency", "Ataxia With Dementia", "Ataxia - Oculomotor Apraxia Type 1", "Ataxia - Other", "Ataxia - Genetic Diagnosis - Unknown", "Acquired Ataxia", "Adult-onset Autosomal Recessive Cerebellar Ataxia", "Alcohol Related Ataxia", "Multiple Endocrine Neoplasia", "Multiple Endocrine Neoplasia Type II", "Multiple Endocrine Neoplasia Type 1", "Multiple Endocrine Neoplasia Type 2", "Multiple Endocrine Neoplasia, Type IV", "Multiple Endocrine Neoplasia, Type 3", "Multiple Endocrine Neoplasia (MEN) Syndrome", "Multiple Endocrine Neoplasia Type 2B", "Multiple Endocrine Neoplasia Type 2A", "Atypical Hemolytic Uremic Syndrome", "Atypical HUS", "Wiedemann-Steiner Syndrome", "Breast Implant-Associated Anaplastic Large Cell Lymphoma", "Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)", "Hemophagocytic Lymphohistiocytosis", "Behcet&#39;s Disease", "Alagille Syndrome", "Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)", "Lowe Syndrome", "Pitt Hopkins Syndrome", "1p36 Deletion Syndrome", "Jansen Type Metaphyseal Chondrodysplasia", "Cockayne Syndrome", "Chronic Recurrent Multifocal Osteomyelitis", "CRMO", "Malan Syndrome", "Hereditary Sensory and Autonomic Neuropathy Type Ie", "VCP Disease", "Hypnic Jerking", "Sleep Myoclonus", "Mollaret Meningitis", "Recurrent Viral Meningitis", "CRB1", "Leber Congenital Amaurosis", "Retinitis Pigmentosa", "Rare Retinal Disorder", "KCNMA1-Channelopathy", "Primary Biliary Cirrhosis", "ZMYND11", "Transient Global Amnesia", "Glycogen Storage Disease", "Alstrom Syndrome", "White Sutton Syndrome", "DNM1", "EIEE31", "Myhre Syndrome", "Recurrent Respiratory Papillomatosis", "Laryngeal Papillomatosis", "Tracheal Papillomatosis", "Refsum Disease", "Nicolaides Baraitser Syndrome", "Leukodystrophy", "Tango2", "Cauda Equina Syndrome", "Rare Gastrointestinal Disorders", "Achalasia-Addisonian Syndrome", "Achalasia Cardia", "Achalasia Icrocephaly Syndrome", "Anal Fistula", "Congenital Sucrase-Isomaltase Deficiency", "Eosinophilic Gastroenteritis", "Idiopathic Gastroparesis", "Hirschsprung Disease", "Rare Inflammatory Bowel Disease", "Intestinal Pseudo-Obstruction", "Scleroderma", "Short Bowel Syndrome", "Sacral Agenesis", "Sacral Agenesis Syndrome", "Caudal Regression", "Scheuermann Disease", "SMC1A Truncated Mutations (Causing Loss of Gene Function)", "Cystinosis", "Juvenile Nephropathic Cystinosis", "Nephropathic Cystinosis", "Kennedy Disease", "Spinal Bulbar Muscular Atrophy", "Warburg Micro Syndrome", "Mucolipidoses", "Mitochondrial Diseases", "Mitochondrial Aminoacyl-tRNA Synthetases", "Mt-aaRS Disorders", "Hypertrophic Olivary Degeneration", "Non-Ketotic Hyperglycinemia", "Fish Odor Syndrome", "Halitosis", "Isolated Congenital Asplenia", "Lambert Eaton (LEMS)", "Biliary Atresia", "STAG1 Gene Mutation", "Coffin Lowry Syndrome", "Borjeson-Forssman-Lehman Syndrome", "Blau Syndrome", "Arginase 1 Deficiency", "HSPB8 Myopathy", "Beta-Mannosidosis", "TBX4 Syndrome", "DHDDS Gene Mutations", "MAND-MBD5-Associated Neurodevelopmental Disorder", "Constitutional Mismatch Repair Deficiency (CMMRD)", "SPATA5 Disorder", "SPATA5L1 Related Disorder", "Acrodysostosis", "Multi-systematic Smooth Muscle Dysfunction Syndrome", "CRELD1 (Cysteine Rich With EGF Like Domains 1)", "GNB1 Syndrome", "Pyruvate Dehydrogenase Complex Deficiency Disease", "Beta Mannosidosis", "Kbg Syndrome", "Labrune Syndrome", "Metachromatic Leukodystrophy (MLD)", "Moyamoya Disease", "OPHN1 Syndrome", "Oculopharyngeal Muscular Dystrophy (OPMD)", "TUBB3 Mutation", "WOREE (WWOX-related Epileptic Encephalopathy", "SCAR12", "Skraban-Deardorff Syndrome", "Hereditary Myopathy With Early Respiratory Failure"], "locations": [{"country": "United States"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05573490", "official_title": "Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04296123", "official_title": "Psychometric Properties of Four Step Tests and Effects of Step Training in Reducing Falls on Older Adults with Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03483896", "official_title": "Pilot Study to Examine the Effects of Indoor Daylight Exposure on Depression and Other Neuropsychiatric Symptoms in People Living With Dementia in Long Term Care Facilities", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Depression", "Behavior Disorders"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03890861", "official_title": "Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)\"", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia, Alzheimer Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00711204", "official_title": "A 12-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease", "overall_status": "WITHDRAWN", "phase": "PHASE4", "conditions": ["Severe Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06621758", "official_title": "Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment (MCI)", "Subjective Cognitive Decline (SCD)"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03484143", "official_title": "Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease", "overall_status": "SUSPENDED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05827276", "official_title": "Effects of the Life Story Questionnaire on Physical Therapy Participation in Patients With Dementia: A Randomized Control Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia Alzheimers"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06629740", "official_title": "A Post-market Clinical Follow-up Investigation in Healthy Volunteers Measuring Eye Parameters to Verify Performance and Safety of Previct® Drugs for Monitoring of Patients in Treatment of Substance Use Disorder", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Substance Use Disorder (SUD)"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04391218", "official_title": "Applicabilità ed Efficacia di un Approccio Multi-Disciplinare Comprendente un Sistema Informatico di Supporto Per la Decisione Della Terapia di Pazienti Anziani Polipatologici", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Polypharmacy", "Multimorbidity", "Aged"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06584110", "official_title": "Effects of Buddy-Up Dyadic Physical Activity Program on Health Outcomes and Social Dynamic of Persons With Dementia and Family Caregivers: A Mixed Method Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive Impairment, Mild", "Dementia, Mild"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06181513", "official_title": "Effect of Probiotics on Cognitive Functioning of Patients With Mild Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "EARLY_PHASE1", "conditions": ["Neurodegenerative Diseases", "Cognition Disorders in Old Age"], "locations": [{"country": "Cyprus"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00847860", "official_title": "Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Vascular Dementia", "Stroke"], "locations": [{"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02035982", "official_title": "A Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease in Long Term Care Setting", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT05265182", "official_title": "Developing an Immersive Gamification Technology System (ImGTS) for the Management of Patients With Behavioral and Psychological Symptoms of Dementia (Phase 1 Trial)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia Alzheimers"], "locations": [{"country": "Philippines"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02098824", "official_title": "Symptomatic Treatment of Vascular Cognitive Impairment", "overall_status": "UNKNOWN", "phase": "PHASE2, PHASE3", "conditions": ["Mild Cognitive Impairment (Vascular)", "Mild Cognitive Disorder (Vascular)", "Vascular Dementia"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01669876", "official_title": "3-Month, Single Site or Multi-Site, Double Blind, Randomized, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety Tolerability and Potential Effects of the Dietary Supplement Anatabloc(R) in Subjects With Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03734289", "official_title": "Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With Alzheimer Dementia and Traumatic Brain Injury (NeuroNS) Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Traumatic Brain Injury"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04440891", "official_title": "Application of Transcranial Magnetic Stimulation Coupled With Virtual Reality for Slowing the Rate of Cognitive Decline in Patients With Alzheimer's Disease", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01251718", "official_title": "Post-marketing Surveillance of Donepezil Hydrochloride- Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02016560", "official_title": "An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03790982", "official_title": "A Randomized, Double Blind, Placebo Controlled, Parallel-Group 52-week Multicenter Phase II Study to Investigate the Safety, Efficacy and Pharmacokinetics of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02396082", "official_title": "MIND: An RCT of Care Coordination for Community-living Person With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Caregiver Burden"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT01876823", "official_title": "Effects of Combined Memantine (Namenda) Plus Escitalopram (Lexapro) Treatment in Elderly Depressed Patients With Cognitive Impairment", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Mild Cognitive Impairment", "Major Depressive Disorder", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06608589", "official_title": "CONSTELLATIONS Living Lab: Development, Implementation and Evaluation of a Patient-oriented Quality Improvement Program Targeting Care Transitions of Older Adults Living with Major Neurocognitive Disorders and Their Caregivers.", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Neurocognitive Decline"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02819089", "official_title": "Recovery Profiles After c Spine Surgery: With or Without Dexmedetomidine as an Anesthetic Adjuvant", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Cervical Spondylosis"], "locations": [{"country": "Thailand"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT04439097", "official_title": "Short and Medium-term Effects of a Multicomponent Physical Exercise Program With a Mediterranean Diet on Bone Mineral Density, Gait, Balance, and Fall Risk for Patients With Alzheimer's Disease: Randomized Controlled Clinical Trial Study Protocol", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Physical Exercise", "Bone Density", "Fall"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00921297", "official_title": "Therapeutic Effects of Cataract Removal in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cataracts", "Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03599076", "official_title": "Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT03297268", "official_title": "Behavioral and Environmental Sensing and Intervention for Dementia Caregiver Empowerment", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Behavioral and Psychiatric Symptoms of Dementia", "Dementia", "Caregivers"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT00726726", "official_title": "Effect of Concomitant Administration of BMS-708163 on the Pharmacokinetics of Midazolam, Warfarin, Caffeine, Omeprazole and Dextromethorphan in Healthy Male Subjects by Administration of a Modified Cooperstown Cocktail", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT06412185", "official_title": "A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Single Dose Escalation of CM383 in Male Healthy Subjects", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02017340", "official_title": "A European Multicentre Double-blind Placebo-controlled Phase III Trial of Nilvadipine in Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Hungary"}, {"country": "Ireland"}, {"country": "Ireland"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Sweden"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02122068", "official_title": "Mentalizing Imagery Therapy for Major Depressive Disorder in Family Dementia Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mentalizing Imagery Therapy", "Relaxation Recording"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:40+00:00"}
{"nct_id": "NCT02525991", "official_title": "A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of Self-administered ADASUVE® (Staccato Loxapine for Inhalation) in Agitated Patients Outside the Hospital Setting", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Agitation"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00990613", "official_title": "A Phase 1, Fixed Sequence, Cross-Over Study To Investigate The Single Dose Pharmacokinetics Of A Dimebon (Latrepirdine) Transdermal Solution Relative To The Immediate Release Formulation In Older Adults", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease", "Huntington's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03303638", "official_title": "Investigating the Impact of Multi-sensory Environments on Behavior During Assisted Bathing for Veterans With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "BPSD"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT07064226", "official_title": "Transcultural and Multidimensional Validation of dIgital Rehabilitation Intervention of COgnitive Resources Domain-Oriented - Work Package 4", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)", "Subjective Memory Complaint", "Dementia Alzheimer Type"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05495113", "official_title": "In a Patient With Mild Dementia, Improvement of Cognitive Function Using YMS-201B, To Evaluate the Effectiveness and Safety, Randomized, Double-blinded, Sham Control Comparison, Confirmatory", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Dementia"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04141150", "official_title": "A Phase 2, Multicenter Study of [18F]APN-1607 Positron Emission Tomography in Subjects With Alzheimer's Disease Compared to Healthy Subjects", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment Due to Alzheimer's Disease", "Healthy Volunteers"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04920591", "official_title": "Efficacy of Doll thErapy Compared With Standard Treatment in the Control of Behavioral and Psychologic Symptoms and CaRegIver Burden of dEmentia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06032520", "official_title": "The Effectiveness of Forensic Outpatient Systemic Therapy: a Multiple Case Experimental Design", "overall_status": "RECRUITING", "phase": null, "conditions": ["Conduct Disorder", "Antisocial Behavior", "Aggression", "Behavioral Disorder"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05779813", "official_title": "Genetic Frontotemporal Dementia Initiative for Neurodevelopment", "overall_status": "RECRUITING", "phase": null, "conditions": ["Frontotemporal Dementia", "Family Members"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01401582", "official_title": "Dementia: Life- and Personcentered Help in Germany", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03784846", "official_title": "Mindfulness-Based Resilience Training for Aggression, Health, and Stress Among Law Enforcement Officers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Stress, Psychological", "Aggression"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02576639", "official_title": "A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of CNP520 in Healthy Elderly Subjects", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Germany"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00954369", "official_title": "A Phase 0, Open Label, Non-randomized, Multi-center, Exploratory and Safety Study of [F-18]W372", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03625622", "official_title": "A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild to Moderate Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06933212", "official_title": "Effetto Della DIETa mEdiTerranea Sull'Incidenza di Ictus e Sul Decadimento Cognitivo in Pazienti Affetti da Cadasil e Angiopatia Cerebrale Amiloide", "overall_status": "RECRUITING", "phase": null, "conditions": ["Cerebral Amyloid Angiopathy", "CAA - Cerebral Amyloid Angiopathy"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04831281", "official_title": "A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Parkinson Disease Dementia", "Dementia With Lewy Bodies"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01962753", "official_title": "Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Elderly", "Major Depression"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03041272", "official_title": "Aggressive Incidents in Medical Settings Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Aggression"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00409175", "official_title": "Safety and Efficacy of Orally Administered Fx-1006A in Patients With Familial Amyloid Polyneuropathy (FAP): A Randomized, Double-blind, Placebo-controlled Study", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Familial Amyloid Polyneuropathy"], "locations": [{"country": "United States"}, {"country": "Argentina"}, {"country": "Brazil"}, {"country": "France"}, {"country": "Germany"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01715506", "official_title": "Modeling and Evaluating Evidence Based Continuing Education in Nursing Home Dementia Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Agitation"], "locations": [{"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06781333", "official_title": "A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to the Treatment of Patients Suffering Agitation/Aggression or Other Behavioral Abnormalities From Alzheimer's Disease.", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Agitation in Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03053908", "official_title": "Orexin and Tau Pathology in Cognitively Normal Elderly (A New Prevention Strategy for Alzheimer's Disease)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Elderly", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00753662", "official_title": "Phase 2 (Feasibility) Study of Transcranial Magnetic Stimulation as Additional Therapy to Drug Treatment in Patients With Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06995573", "official_title": "A Phase 2a, Multi-Center, Randomized, Parallel Group, Double Blind and Placebo-controlled Clinical Trial to Assess Safety and Tolerability as Well as Explorative Efficacy of the Orthosteric Selective Muscarinic M1 Agonist NSC001 in Mild to Moderate Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Austria"}, {"country": "Austria"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT07202494", "official_title": "Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging", "overall_status": "RECRUITING", "phase": null, "conditions": ["Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorders", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "Alzheimer Disease", "Parkinson Disease", "Amyotrophic Lateral Sclerosis (ALS)", "Temporal Lobe Epilepsy", "Epilepsy", "Mild Traumatic Brain Injury", "Healthy Aging"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02484794", "official_title": "Efficacy and Acceptability of Augmenting Specialty Eating Disorder Clinical Treatment With a Smartphone Application: A Pilot RCT", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Eating Disorders"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05330494", "official_title": "Effects of Perioperative Transcutaneous Electrical Acupoint Stimulation on Postoperative Pain and Agitation in Pediatric Adenoidectomy and Tonsillectomy", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["the Effect of TEAS on the Children' Pain and Agitation"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02617056", "official_title": "Objective Assessment of Behavioral Associations of Patients With Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia", "Psychomotor Agitation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04566731", "official_title": "Using Transcranial Direct Current Stimulation to Reveal Mechanisms of Language Loss and to Treat Progressive Aphasia Associated With FTD and Related Dementias", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02278354", "official_title": "18F-AV-1451 PET Imaging in Professional Fighters", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01661894", "official_title": "Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment", "Age-Related Cognitive Decline", "Dementia"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00190372", "official_title": "Contribution of a Psycho-Educational Program of Help to Help in the Pharmacological Assumption of Responsibility of the Disease of Alzheimer", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01397539", "official_title": "A Randomized, Blinded, Placebo-Controlled Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB037 in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00790075", "official_title": "Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Agitation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05633095", "official_title": "A Prospective Pilot Study to Evaluate Efficacy and Safety of Medical Device-Neuclare in Patient With Mild Cognitive Disorder and Early Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia, Mild", "Cognitive Disorder Mild"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04004767", "official_title": "Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Preclinical Alzheimer's Disease", "Prodromal Alzheimer's Disease", "Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06604507", "official_title": "Feasibility of Using an App for Managing Phantom Limb Pain Associated with Combat Amputation in Ukraine: a Quantitative & Qualitative Observational Trial in the 'Prevention and Management of Phantom Limb Pain' Project", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Amputation, Traumatic", "Pain, Phantom", "Pain, Acute", "Pain, Chronic", "Pain, Neuropathic", "Rehabilitation", "War-Related Trauma"], "locations": [{"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05023564", "official_title": "Peking Union Medical College Hospital (PUMCH) Dementia Longitudinal Cohort Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia", "Dementia, Vascular", "Dementia With Lewy Bodies", "Dementia, Mixed", "Dementia Alzheimers", "Dementia Frontal", "Dementia, Mild"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00685009", "official_title": "Women's Health Initiative Memory Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia Syndromes"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05518409", "official_title": "Immunohistochemical Study of Peripheral Blood Mononuclear Cells in Sporadic Alzheimer's Disease and Dementia With Lewy Body", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Lewy Body Disease", "Neurodegenerative Diseases"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03654911", "official_title": "Sustainable Method for Alzheimer's Prediction in Mild Cognitive Impairment: EEG Connectivity and Graph Theory Combined With ApoE Testing.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Amnestic-Mild Cognitive Impairment"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06359171", "official_title": "Effectiveness of the ARTHE-e App for Exercise Adherence in People With Knee Osteoarthritis: Protocol for a Randomized Controlled Trial (ARTHe 3)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Knee Osteoarthritis"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05094271", "official_title": "Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["OSA", "Sleep Apnea", "Obstructive Sleep Apnea", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02813434", "official_title": "Cerebral Amyloid Imaging Using Florbetapir (18F-AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia", "overall_status": "UNKNOWN", "phase": "PHASE3", "conditions": ["Dementia", "Cognition Disorders"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06841848", "official_title": "Fundus Camera Module for Early Detection of Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02954978", "official_title": "A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotinib Treatment on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Parkinson Disease", "Parkinsons Disease With Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06283225", "official_title": "Pilot Study to Investigate the Influence of a Dysmenorrhoea App on the Quality of Life and Symptoms of Patients", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dysmenorrhea"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02051608", "official_title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Hungary"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05443308", "official_title": "Cerebral Vascular Reserve in Small Vessel Disease and Alzheimers Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Dementia, Vascular"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00627250", "official_title": "Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability: A Randomized, Double-Blind, Placebo-Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Irritable Mood", "Aggression", "Traumatic Brain Injury"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06602258", "official_title": "A Phase 2, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Study to Evaluate Safety, Tolerability, and Biomarker Efficacy of E2814 With Concurrent Lecanemab Treatment in Subjects With Early Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04121208", "official_title": "A Randomised, Placebo-controlled, Single-blind Study to Characterise the Biomarker Effects of the Colony Stimulating Factor-1 (CSF-1) Receptor Antagonist JNJ-40346527 in Participants With Mild Cognitive Impairment", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06450249", "official_title": "Effects of the Humanitude® Care Methodology on Improving Health Professionals' Perception of Competence and Emotional State", "overall_status": "COMPLETED", "phase": null, "conditions": ["Delivery of Health Care", "Education, Medical", "Caregiver"], "locations": [{"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02420535", "official_title": "An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06380725", "official_title": "A Randomized, Double-blind Placebo Controlled Trial of High Intensity Transcranial Current Stimulation in Patients With Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment", "Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06733714", "official_title": "Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive Dysfunction", "Alzheimer Disease", "Mild Cognitive Impairment", "Cognitive Decline", "Frontotemporal Degeneration", "Dementia", "Dementia, Vascular", "Lewy Body Disease", "Beta-Amyloid", "GFAP", "Tau Protein"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06377033", "official_title": "Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure Across a Diverse Health System", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Genetic Predisposition", "Paraganglioma", "Pheochromocytoma", "ALS", "Parkinson Disease", "Polyneuropathies", "Frontotemporal Dementia", "Alzheimer Disease", "Cardiomyopathy Non-ischemic", "Thoracic Aortic Aneurysm"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02256358", "official_title": "Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation : a Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Psychomotor Agitation"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04695743", "official_title": "Virtual CST - A Collaborative Proof of Concept Study With FaceCog HK in Response to the Covid-19 Pandemic", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03641404", "official_title": "Pilot Study to Investigate the Efficacy of Ergothioneine to Delay Cognitive Decline in Mild Cognitively Impaired Subjects", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00283725", "official_title": "Review of Management Strategies in Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01294540", "official_title": "A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Doses of E2609 in Healthy Subjects and an Elderly Cohort", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03636204", "official_title": "A First in Human Phase 1 Study in Healthy Volunteers and in Participants With Frontotemporal Dementia (FTD) With Granulin Mutation", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy", "Frontotemporal Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04363684", "official_title": "ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Frontotemporal Lobar Degeneration (FTLD)", "Progressive Supranuclear Palsy (PSP)", "Corticobasal Degeneration (CBD)", "Behavioral Variant Frontotemporal Dementia (bvFTD)", "Semantic Variant Primary Progressive Aphasia (svPPA)", "Nonfluent Variant Primary Progressive Aphasia (nfvPPA)", "FTD With Amyotrophic Lateral Sclerosis (FTD/ALS)", "Amyotrophic Lateral Sclerosis", "Oligosymptomatic PSP (oPSP)", "C9orf72", "GRN Related Frontotemporal Dementia", "MAPT Gene Mutation", "TBK1 Gene Mutation", "Oligosymptomatic Progressive Supranuclear Palsy"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01517438", "official_title": "Effects of Serotonin Inhibitors on Patient-controlled Analgesia Related Nausea and Vomiting", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Agitation"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01946243", "official_title": "The Feasibility and Reliability of Utilizing Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Qualitative Interpretation of Amyvid Brain Scans", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimers Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03269149", "official_title": "Effects of Adapted Tango on African-American Women Caregivers of Alzheimer's Disease Patients", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05104593", "official_title": "An Integrated Solution for Sustainable Care for Multimorbid Elderly Patients With Mild Cognitive Impairment or Mild Dementia (CAREPATH)", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Comorbidities and Coexisting Conditions", "Alzheimer Disease", "Dementia", "Malnutrition", "Frailty", "Sarcopenia", "Stroke", "Asthma", "Chronic Obstructive Pulmonary Disease", "Chronic Kidney Diseases", "Heart Failure", "Diabetes", "Coronary Artery Disease", "Hypertension", "Behavioral Symptoms"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02956148", "official_title": "Follow-up Measurement of Brain Phosphodiesterase 10 A (PDE10A) Enzyme Levels in Huntington´s Disease Gene Expansion Carriers, 18 to 28 Months After Initial Positron Emission Tomography (PET) Measurement in CHDIKI1201/PET-HD-PDE10A (NCT02061722)", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Huntington's Disease"], "locations": [{"country": "Denmark"}, {"country": "Netherlands"}, {"country": "Norway"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05768425", "official_title": "DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY Dementia - DISPLAY", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Dementia With Lewy Bodies", "Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05138848", "official_title": "Slow-wave Sleep Enhancement in Those at Risk for Alzheimer's Disease: Links With Memory, Excitotoxicity, and Plasma A-beta", "overall_status": "RECRUITING", "phase": "EARLY_PHASE1", "conditions": ["Alzheimer Disease, Late Onset", "Mild Cognitive Impairment", "Sleep", "Cognitive Change", "Amyloid"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05231785", "official_title": "A Randomized, Double-blind, Placebo-controlled Single Ascending Dose and Open-label Multi-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ALN-APP in Adult Patients With Early-onset Alzheimer's Disease (EOAD)", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Early-Onset Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Netherlands"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00242632", "official_title": "Cognitive Effects of Memantine in Postmenopausal Women at Risk of Dementia: a Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02271321", "official_title": "The Effects of White Noise on Agitated Behaviors and Cortisol in Saliva Among the Patients With Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01478204", "official_title": "An Observational Epidemiological Study on Evaluation of Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease in Clinical Practice", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05970315", "official_title": "Priorities Aligned Deprescribing for Persons Living With Dementia and Their Caregiver", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03757325", "official_title": "A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL747 in Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04434898", "official_title": "The Assessment of the Diagnosis and Prognosis of Patients With Alzheimer Disease or Parkinson Disease With Cognitive Impairment by Using Diffusion MRI", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Parkinson Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04408755", "official_title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Agitation in Patients With Dementia of the Alzheimer's Type"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Estonia"}, {"country": "Estonia"}, {"country": "Estonia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04296565", "official_title": "Water-based Activity to Enhance Recall in Veterans: A Randomized Clinical Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE4", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03980392", "official_title": "A Randomized Controlled Study to Evaluate Applicability of Korean Multidomain Intervention Program in the South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Aged"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00002163", "official_title": "A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["AIDS Dementia Complex", "HIV Infections"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00052104", "official_title": "A Telephone Intervention for Dementia Caregivers", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02505035", "official_title": "Default Palliative Care Consultation for Seriously Ill Hospitalized Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["COPD", "ESRD", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT01976832", "official_title": "Music-with-Movement Intervention for People With Early Dementia and Their Families", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Anxiety", "Sleep", "Depression", "Quality of Life"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00110552", "official_title": "Effects of a Cognitive Enhancer on Memory and Cognitive Performance", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04353947", "official_title": "Induction and Recognition of Emotions in Healthy Older Adults, Alzheimer's Disease and Parkinson's Disease", "overall_status": "WITHDRAWN", "phase": null, "conditions": ["Healthy Older Adults", "Alzheimer's Disease", "Parkinson's Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04588649", "official_title": "The Aging Brain and Cognition: Contribution of Vascular Injury, Amyloid Plaque and Tau Protein to Cognitive Dysfunction After Stroke", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Post-stroke Dementia", "Vascular Mild Cognitive Impairment"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04819126", "official_title": "Nintendo Wii Virtual Reality Application In Older People With Alzheimer's Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Age-Related Memory Disorders"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00744978", "official_title": "A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Crossover Trial of Varenicline Tartrate (CP-526,555) in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03075007", "official_title": "White Matter Hyperintensities in Aging and Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "White Matter Hyperintensities", "Dementia", "Aging"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03661034", "official_title": "Multi-Center Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease, Early Onset", "Alzheimer Disease", "Alzheimer Dementia", "Mild Cognitive Impairment", "Memory Disorders", "Memory Loss", "Memory Impairment", "Memory Disorders, Age Related", "Alzheimer Disease, Late Onset", "Cognitive Impairment", "Dementia, Mild", "Dementia, Alzheimer Type", "Cognitive Decline"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02521558", "official_title": "Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Memory Disorders", "Mild Cognitive Impairment", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT05795634", "official_title": "Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease (Stress-AD)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT03351452", "official_title": "Effects of Transcranial Electric Stimulation on Associative Memory Formation in Healthy Elderly Participants as Well as in Individuals With Memory Impairment", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Healthy", "Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT02327845", "official_title": "Phenotype, Genotype & Biomarkers in ALS and Related Disorders", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis", "Frontotemporal Dementia", "Primary Lateral Sclerosis", "Hereditary Spastic Paraplegia", "Progressive Muscular Atrophy", "Multisystem Proteinopathy"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Germany"}, {"country": "South Africa"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT07204145", "official_title": "The Efficacy of Laser Acupuncture for Behavioral and Psychological Symptoms of Dementia: A Randomized Controlled Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Behavioral and Psychological Symptoms of Dementia (BPSD)", "Dementia"], "locations": [{"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06497413", "official_title": "Brain Vascular and Neurocognitive Health", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Decline", "Cognitive Dysfunction", "Alzheimer Disease", "Vascular Disease, Peripheral"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT04575259", "official_title": "Open Label Extension Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Parkinson Disease Dementia"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT06836180", "official_title": "An Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "EARLY_PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:41+00:00"}
{"nct_id": "NCT00211159", "official_title": "Omega-3 Fatty Acid Treatment of 174 Patients With Mild to Moderate Alzheimer's Disease (OmegAD): a Randomized Double-blind Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04079803", "official_title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Biomarker and Safety Study of PTI-125 in Mild-to-moderate Alzheimer's Disease Patients", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04539041", "official_title": "A Randomized, Participant, Investigator and Sponsor Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intrathecally Administered NIO752 in Participants With Progressive Supranuclear Palsy", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Progressive Supranuclear Palsy (PSP)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05887973", "official_title": "Addressing Root Causes for Gun Violence Prevention (ARC-GVP) Outcomes Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Violence", "Adolescent", "Firearm Injury", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00230568", "official_title": "A 12-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05723523", "official_title": "A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05408780", "official_title": "A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin, and Matching Placebo to Include Single-dose and Food Effect (Part A), and Titration Tolerability (Part B), in Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05550727", "official_title": "The PorchLight Project", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Memory Loss", "Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03069391", "official_title": "The Interactive Physical and Cognitive Exercise System (iPACES™): A Neuro-exergame for Preventing Alzheimer's and Ameliorating Cognitive Impairment", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease, Early Onset", "MCI", "Aging", "Mild Cognitive Impairment", "Neurocognitive Disorder", "Cognitive Impairment", "Cognitive Change"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06070818", "official_title": "Healthy Body & Mind Program: A Pilot Randomised Controlled Trial to Improve Quality of Life, Reduce Pain, and Reduce Dementia Risk in People Living With Cognitive Decline and Osteoarthritis", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Cognitive Decline", "Osteoarthritis"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04146818", "official_title": "Study of the Effects of Adapted Tango and Multidimensional Intervention in pREvention of Dementia in agiNG: Developing healTHy Life Style Programs. (STRENGTH)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01856010", "official_title": "Short-term Efficacy and Cognitive Side Effects of Acute Electroconvulsive Therapy (ECT) for Agitation and Aggression in Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Aggression", "Agitation"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02389413", "official_title": "A Phase 2A Multicentre, Randomised, Double Blind, Placebo-Controlled, Parallel-Group Safety and Tolerability Study of PQ912 in Subjects With Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Belgium"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03697759", "official_title": "A Decision Support System for Self-management of Low Back Pain - PILOTSTUDY", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Low Back Pain"], "locations": [{"country": "Denmark"}, {"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06686186", "official_title": "A Prospective Cohort of Hainan Community Elderly Population with Cognitive Impairment", "overall_status": "RECRUITING", "phase": null, "conditions": ["Cognitive Impairment", "Dementia", "Age Problems"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04753320", "official_title": "Remote Monitoring in Progressive Supranuclear Palsy, an Alzheimer's Disease Related Dementia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Progressive Supranuclear Palsy", "Parkinson Disease", "MSA - Multiple System Atrophy"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05597124", "official_title": "Determinants of Individual Differences in the Efficacy of Aerobic Exercise to Improve Brain Health and Reduce Alzheimer's Disease Risk in Older African Americans", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Aging", "Alzheimer Disease", "Healthy Aging", "Cognitive Change"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03881579", "official_title": "Supportive Care for Cognitively Impaired Patients and Families", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Primary Palliative Care", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05222386", "official_title": "Building Online Community to Improve Patient and Caregiver Outcomes in Parkinson Disease, Lewy Body Dementia and Related Disorders", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Parkinson Disease Dementia", "Parkinson Disease", "Parkinson's Disease and Parkinsonism", "Lewy Body Parkinsonism", "Dementia With Lewy Bodies", "Progressive Supranuclear Palsy", "Corticobasal Degeneration", "Multiple System Atrophy", "Vascular Parkinsonism"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04104659", "official_title": "Multicenter Study of Tau Imaging With the Use of [18F]MK-6240 Tracer in Individuals at Risk for and With Autosomal Dominant Alzheimer's Disease", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06079203", "official_title": "ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease Related Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02130661", "official_title": "A Phase I, Two-part, Open-label Study to Evaluate the Pharmacokinetics of Rilapladib (SB-659032) and Its Metabolites, and to Determine the Effect of Repeat Dose Itraconazole on the Pharmacokinetics of Rilapladib in Healthy Volunteers", "overall_status": "WITHDRAWN", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06417086", "official_title": "Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers: A Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Cognitive Impairment"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01994889", "official_title": "A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Transthyretin (TTR) Amyloid Cardiomyopathy"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Brazil"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03774459", "official_title": "A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of ANAVEX2-73 for Cognitive Impairment in Patients With Parkinson's Disease With Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Parkinsons Disease With Dementia"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03733418", "official_title": "Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients (VIOLET-BUD)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Cognitive Decline"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00692588", "official_title": "Magnetic Resonance Imaging to Measure Treatment Effects of Doxycycline and Rifampicin in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00449384", "official_title": "Severe Impairment Study - Norwegian Version. A Validation and Reliability Study.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Diagnostic Tests, Routine"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00046358", "official_title": "The Effect of Short-Term Statin and NSAID Treatment on CSF Beta-Amyloid", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05111249", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study With Open-Label Extension to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of LMI070/Branaplam Administered as Weekly Oral Doses in Participants With Early Manifest Huntington's Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Early Manifest Huntington Disease"], "locations": [{"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00190021", "official_title": "Donepezil as Add-On Treatment of Psychotic Symptoms in Patients With Dementia of the Alzheimer's Type", "overall_status": "UNKNOWN", "phase": "PHASE3", "conditions": ["Dementia of Alzheimer Type"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06538116", "official_title": "A Randomized, Double-Blinded Study to Evaluate the Efficacy and Safety of Mevidalen in Patients With Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02300584", "official_title": "Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer's Disease", "Depression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00368849", "official_title": "Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington Disease", "Chorea"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03193099", "official_title": "Decoding Presymptomatic White Matter Changes in Huntington Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Huntington Disease", "White Matter Alterations"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00954538", "official_title": "A Three Part Study to Evaluate the Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK-3328, a Radiotracer for Use in Positron Emission Tomography", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04593628", "official_title": "Adapting 'Connect for Caregivers' for Hispanic Caregivers: A Pilot Study for Year Two of the Rochester Roybal Center for Social Ties and Aging Research (P30AG064103) and the UR Healthy Aging Research Program (HARP)", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Social Isolation", "Loneliness"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04742465", "official_title": "ARIADE : Augmented Reality for Improving Autonomy in Dementia. Creation, Implementation and Testing of an Augmented Reality Tool to Help People With Alzheimer's Type Dementia in Their Travels.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer or Mild Cognitive Impairment"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT07143006", "official_title": "Innovative Application of Advanced Intelligent Electric Vehicles in Detecting and Analyzing Gait Abnormalities in Patients With Neurodegenerative Diseases, and Adding Value to the Creation of Improved Walking and Balance", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Parkinson Disease", "Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03552484", "official_title": "CarePSP: Care Where It Counts - Interdisciplinary Home Visits for PSP-Related Disorders", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Progressive Supranuclear Palsy", "Dementia With Lewy Bodies", "Multiple System Atrophy", "Corticobasal Syndrome", "Atypical Parkinson Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02147652", "official_title": "Assessing the Effects of a Personalized Music Therapy With Headphones on Agitation in Patients With Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease", "Vascular Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00539747", "official_title": "Meaning Making Among Asymptomatic Individuals With a Positive Presymptomatic Genetic Test Result for Huntington Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03803592", "official_title": "Effects of a Home Based, Dyadic Multisensory and Cognitive Stimulation (MCS) Program for the People With Dementia and Their Family Caregivers: a Pilot Quasi-experimental Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Carer Stress Syndrome"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT07136844", "official_title": "Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Neuromuscular Diseases", "Obesity (Disorder)", "Myotonic Dystrophy 1", "Myasthenic Syndrome", "Charcot Marie Tooth Disease (CMT)", "Glycogen Storage Disease Type II Pompe Disease", "Facio-Scapulo-Humeral Dystrophy", "Myasthenia Gravis", "Huntington Disease", "Progressive Supranuclear Palsy (PSP)", "Hereditary Spastic Paraplegia", "Ataxia, Spinocerebellar"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02585232", "official_title": "Optimizing Dementia Care Through Collaborative Recovery Interventions", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease", "Dementia", "Dementia, Vascular", "Caregivers", "Veterans"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06061406", "official_title": "BE Smart - Bariatric Patient - Empowerment in the Preparation and Follow-up of Bariatric Surgery Using the Smartvisit App (BESmart)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Obesity", "Bariatric Surgery Candidate"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01434667", "official_title": "Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03650816", "official_title": "Evaluation of Cerebrovascular Reactivity in Alzheimer's Disease Patients : A Pilot Clinical Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Subjective Cognitive Impairment"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02021565", "official_title": "Evaluating the CG ASSIST Program for Caregiving Dyads", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Transfer Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01659398", "official_title": "Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06709014", "official_title": "A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blind Dual Clinical Trial Investigating Efficacy and Safety of Buntanetap in Treating Participants of Early Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Early Alzheimers Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00531804", "official_title": "A Multi-center, Multiple-ascending Dose, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO4909832 Following Intravenous Infusion in AD Patients", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Denmark"}, {"country": "Israel"}, {"country": "Netherlands"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03467152", "official_title": "A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00009204", "official_title": "Serotonergic Pharmacotherapy for Agitation of Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia", "Alzheimer Disease", "Dementia, Vascular"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04507633", "official_title": "The Effect of ROMA Therapy on Improving Cognitive Functions, Depressive Symptoms and Behavioral Problems in the Population With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00448799", "official_title": "Evaluation of [123I] AV83 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimers Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05321498", "official_title": "A Phase 2, Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Mild Cognitive Impairment (MCI) With Biomarkers of Inflammation", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment (MCI)", "Alzheimer Disease", "Dementia", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Tauopathies", "Neurodegenerative Diseases", "Mental Disorders"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04617847", "official_title": "A Multicenter, Open-label Extension Study to Evaluate the Safety, Pharmacodynamics, and Clinical Effects of WVE-120101 in Patients With Huntington's Disease", "overall_status": "TERMINATED", "phase": "PHASE1, PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03577418", "official_title": "An Intervention to Reduce Discrepancy in Everyday Preferences", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02860338", "official_title": "Retrospective Analysis of the Comparative Effectiveness of MCI and Dementia Treatment Protocols in a Community-based Specialty Dementia Practice", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Dementia", "Hypoxia", "Hyperhomocysteinemia", "Vitamin B 12 Deficiency", "Iron Deficiency", "Anemia", "TBI", "Neurodegenerative Disorders", "Alzheimer's Disease", "Vascular Dementia", "Brain Injuries", "Tauopathies", "Parkinson's Disease", "Lewy Body Dementia", "Frontotemporal Dementia", "TDP-43 Proteinopathies"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT03648476", "official_title": "Intervention to Change Attributions That Are Negative (ICAN): a New Approach to Reducing Anger and Aggression After Brain Injury", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Trauma, Brain", "Brain Injuries", "Traumatic Brain Injury", "Brain Injuries, Traumatic", "Brain, Trauma"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00568776", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Safety and Efficacy Study of Oral ELND005 (AZD-103) in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00153010", "official_title": "A Phase II Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05895513", "official_title": "Effect of Pimavanserin on Aggression and Social Cognition.", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Intermittent Explosive Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02359552", "official_title": "A 24-week, Three-site, Randomized, Double Blind, Placebo Controlled, Parallel Group, Proof-of-concept Study to Evaluate Rasagiline in the Regional Brain Metabolism on FDG PET in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT07180147", "official_title": "Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease (AD)", "Cardio Vascular Disease", "Mild Cognitive Impairment (MCI)", "Frailty Syndrome", "Disability Physical", "Hypertension", "Metabolic Syndrome (MetS)", "Healthy Aging", "Obesity &Amp; Overweight"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06285448", "official_title": "Feasibility of Lecanemab Registry and Clinical Outcome Measures", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02089555", "official_title": "Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment in African Americans and Caucasians", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00571025", "official_title": "Genetic Risk Assessment and Counseling for Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00545974", "official_title": "A Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Frontal Lobe Dementia", "Frontotemporal Lobe Dementia", "Semantic Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05227118", "official_title": "A Randomized Clinical Study to Evaluate the Safety and Tolerability of MK-8189 in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04284384", "official_title": "Modifiable Risk Factors and Dementia - A Study Examining the Association Between Hearing Impairment in Mid-life and Cognitive Impairment in the HUNT4 70+ Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Hearing Loss"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02444078", "official_title": "Effects of a Long-term Exercise Program on Functional Ability in People With Dementia Living in Nursing Homes: a Cluster Randomised Controlled Trial. The LEDEN Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05475158", "official_title": "Comparison of Optical Coherence Tomography Angiographic Factors of Macula and Optic Disc in Patients With or Without Amyloid Pathology: A Prospective Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Amyloid Angiopathy", "Macular Ischemia", "Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02544074", "official_title": "Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06088121", "official_title": "Effects of a ATNC MDD-V1 (TMS With Cognitive Training), for the Treatment of Mild Alzheimer Disease: a Randomized, Double-blinded, Placebo-controlled Study", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease", "Dementia", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Neurodegenerative Diseases", "Neurocognitive Disorders", "Mental Disorder"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05225818", "official_title": "Preparing Successful Aging Through Dementia Literacy Education And Navigation (PLAN)-Home Pilot", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00117858", "official_title": "Double Blind Trial of DC Polarization in FTD", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01184638", "official_title": "Long-term Outcome Followed-up of the Cognitive Disorders After General Anesthesia", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Delirium,", "Dementia,", "Amnestic,", "Cognitive Disorders"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01374438", "official_title": "A 3-month Randomized, Double-Blind, Placebo-Controlled, Feasibility Study to Evaluate the Effects of MSDC-0160 on Brain Glucose Utilization, Cognition, Safety and Tolerability in Older Persons With Mild Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04384978", "official_title": "Development of Serious Games and Physical Activities Instructed by a Social Robot for Improving the Well-being of Elderly Individuals With Alzheimer's Disease and Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04571697", "official_title": "Comparing Rates of Dementia and Alzheimer's Disease in Patients Initiating Methotrexate Versus Those Initiating Anti-TNF-α Therapy", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04520698", "official_title": "Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05069155", "official_title": "Gamification to Improve Physical Activity in Older Adults at Risk for Alzheimer's: the STEP 4Life Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease, At Risk", "Alzheimer Disease, Protection Against", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06700291", "official_title": "Preoperative Frailty and Postoperative Neurocognitive Disorders in Geriatric Patients in Georgia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Frailty"], "locations": [{"country": "Georgia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00433238", "official_title": "Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors - a Feasibility Study", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Major Depressive Disorder", "Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02388152", "official_title": "Interventional, Open-label, Multiple-immunization Extension Study on the Safety, Tolerability and Immunogenicity of Lu AF20513/Adjuvant in Patients With Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Austria"}, {"country": "Finland"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04036955", "official_title": "Evaluation of an Innovative Information, Training and Social Support Intervention \"INFOSADEM\" to Principal Caregivers of Dementia Patients Living at Home. Experimental Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05762926", "official_title": "Non-invasive Brain Stimulation by Transcranial Pulse Stimulation as a Coadjunctive Treatment in Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02271685", "official_title": "Estimation and Accuracy in Sound Task Perceived to be Medically Diagnostic", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Parkinson's", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01009476", "official_title": "Non-interventional Study on Long-term Application of Galantamine and Nootropics in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Alzheimer Disease", "Dementia, Vascular"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05772689", "official_title": "Caregiving While Black: Optimizing Outcomes for Black Dementia Caregivers", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Caregiver Burden"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06605391", "official_title": "Caregiving While Black-LIVE: Empowering Black Dementia Caregivers to Navigate Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT04064021", "official_title": "Clinical Trial to Measure Efficacy of Acupuncture Treatment for Alzheimer's Dementia as Measured by MOCA(Montreal Cognitive Assessment)", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Cognitive Deficits", "Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT02197884", "official_title": "An Open-Label, Fixed-Sequence Study to Assess Effects of Clarithromycin on the Single-Dose Pharmacokinetics of JNJ-54861911 in Healthy Male Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT01504958", "official_title": "Effects of a Combined TMS and Cognitive Training in Alzheimer Patients: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06984458", "official_title": "Exploring the Impact of Dementia Prevention Programs Using Robots as Intervention Tools on Community Elderly", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)", "Dementia", "Cognitive Decline", "Psychological Well-being", "Aging and Cognitive Health"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00575055", "official_title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Carriers.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT05850715", "official_title": "Translation, Cross-cultural Adaptation, Reliability and Validity of the Greek Version of the Disability Assessment for Dementia Scale (DAD-Gr)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Greece"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT00380276", "official_title": "Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:42+00:00"}
{"nct_id": "NCT06736509", "official_title": "An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Agitation in Patients With Dementia of the Alzheimer's Type", "Alzheimer Disease", "Agitation, Psychomotor"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Puerto Rico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00297414", "official_title": "An Analysis of Mortality in Subjects Who Participated in Three Studies of Galantamine in Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01862640", "official_title": "A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Agitation Associated With", "Alzheimer's Disease", "Alzheimer's Type", "Mental Disorder", "Nervous System Diseases"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04481568", "official_title": "Reducing Behavioral and Psychological Symptoms of Dementia (BPSD) for Acutely-Ill Persons With Alzheimers Disease and Related Dementias Via Patient Engagement Specialists", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease and Related Dementias"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02829892", "official_title": "Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Polypathology and Autonomy Loss"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00191009", "official_title": "Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06199193", "official_title": "Design of Personalised SupplemenTs Based on the Gut MicRobiota of Alzheimer Patients Through Network and Artificial Intelligence Analysis", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Gut Microbiota"], "locations": [{"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00147693", "official_title": "Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Vascular", "Dementia", "Alzheimer Disease", "Lewy Body Disease"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06111014", "official_title": "A Continuation Study of Latozinemab in Participants With Neurodegenerative Disease", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE3", "conditions": ["Neurodegenerative Diseases"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Sweden"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03090958", "official_title": "AllyQuest: Engaging HIV+ YMSM in Care Through Social Networking and Gamification", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Hiv", "HIV/AIDS"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03694431", "official_title": "A Non-Inferiority Comparative Effectiveness Trial of Home-Based Palliative Care in Older Adults", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Cancer", "Chronic Obstructive Pulmonary Disease", "Heart Failure", "Dementia", "End Stage Liver Disease", "End Stage Renal Disease", "Neuromuscular Diseases"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02989402", "official_title": "A Prospective, 16 Week, Phase IV Study to Evaluate Safety, Tolerability and Effectiveness in Patients With Severe Dementia of the Alzheimer's Type Exposed to Rivastigmine (Exelon)15cm2 Transdermal Patch", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "India"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05956665", "official_title": "Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Polypharmacy", "Dementia", "Quality of Life"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT07191821", "official_title": "Modulation of Endothelial Function in Alzheimer's Disease by 18kDa Translocator Protein", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE2", "conditions": ["Alzheimer s Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06775964", "official_title": "Mesenchymal Stem Cell Therapy for Early Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Cognitive Dysfunction"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00901498", "official_title": "A Bioavailability Study of Four Experimental BMS-708163 Formulations Relative to Solubilized Capsule Formulation in Healthy Young Male Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease", "Healthy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04555616", "official_title": "Environmental Design for Behavioral Regulation in People With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03899506", "official_title": "Prospective Observational Investigation of Olanzapine Versus Midazolam for the Treatment of Acute Undifferentiated Agitation in the Emergency Department", "overall_status": "TERMINATED", "phase": null, "conditions": ["Agitation,Psychomotor"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00334906", "official_title": "An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients With Moderate Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02844699", "official_title": "A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer", "overall_status": "UNKNOWN", "phase": "PHASE1, PHASE2", "conditions": ["Prostate Cancer"], "locations": [{"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05997784", "official_title": "Disrupting Noxious Synergies of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing, Using Advanced Intelligent Multisensing", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Asthma in Children", "Allergy"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00574132", "official_title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non- Carriers.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06203106", "official_title": "NYSCF Scientific Discovery Biobank", "overall_status": "RECRUITING", "phase": null, "conditions": ["ALS", "Amyotrophic Lateral Sclerosis", "Alzheimer Disease", "Alzheimer Disease, Early Onset", "Alzheimer Disease, Late Onset", "Batten Disease", "Corticobasal Degeneration", "Dementia", "Frontotemporal Dementia", "Huntington Disease", "Lewy Body Disease", "Multiple Sclerosis", "Multiple System Atrophy", "Parkinson Disease", "Parkinson's Disease and Parkinsonism", "Progressive Supranuclear Palsy", "INAD", "Diabetes", "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Diabetes Mellitus, Type 1", "Macular Degeneration", "Ovarian Cancer", "Cervical Cancer", "Uterine Cancer", "Vaginal Cancer", "Vulvar Cancer", "PTSD", "Post Traumatic Stress Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06069934", "official_title": "Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (PL101-ALS501)", "overall_status": "NO_LONGER_AVAILABLE", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Puerto Rico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01083316", "official_title": "Phase II Trial of Induction Therapy With Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation in Patients With AL Amyloidosis", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Amyloidosis"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03918616", "official_title": "P2X7 Receptor, Inflammation and Pathophysiology of Neurodegenerative Diseases", "overall_status": "COMPLETED", "phase": null, "conditions": ["Neuro-Degenerative Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00459784", "official_title": "How to Reach Evidence Based Practice in Diagnostic Assessment and Management of Dementia by General Practitioners and Primary Care Nurses? The Effectiveness of an EASYcare Based Educational Program.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02552147", "official_title": "Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Autism Spectrum Disorder", "Aggression", "Irritability"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT07200739", "official_title": "Development and Validation of Non-Invasive Danish Language and Speech Biomarkers for Neurodegenerative Disease Classification by Means of Automatic Speech Recognition With Artificial Intelligence (DetectAI)", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Dementia (Diagnosis)", "Alzheimer Dementia (AD)", "Vascular Dementia (VaD)", "Lewy Body Dementia (LBD)", "Frontotemporal Dementia (FTD)", "Mild Cognitive Impairment (MCI)", "Depression - Major Depressive Disorder"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00959881", "official_title": "Combined Administration Of Begacestat And Donepezil: A Multiple-Dose Study In Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Subjects"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02471911", "official_title": "A Phase I Investigator-Initiated Study of Selinexor (KPT-330) Plus RICE in Patients With Relapsed or Refractory Aggressive B-cell Lymphomas", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Diffuse Large B-Cell Lymphoma"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05514106", "official_title": "Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE4", "conditions": ["Lewy Body Disease", "Dementia", "Parkinsonism", "Mild Cognitive Impairment", "REM Sleep Behavior Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02238652", "official_title": "Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy (The KOSMOS Study)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Quality of Life"], "locations": [{"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06322121", "official_title": "Clarifying the Vascular Aspects of Dementia; Natural History Study", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01042314", "official_title": "A Study of the Effect of Concomitant Administration of BMS-708163 on the Pharmacokinetics of Donepezil in Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05433493", "official_title": "Effect of Individual Cognitive Stimulation on Memory and Executive Functioning in Older Adults With Mild to Moderate Alzheimer's Disease: A Multicentre Randomised Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Neurocognitive Disorders", "Cognitive Impairment", "Cognitive Dysfunction", "Cognitive Decline"], "locations": [{"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05783414", "official_title": "Effectiveness and Cost-effectiveness of Virtually Delivered Cognitive Stimulation Therapy (vCST) and Online Dementia Carer Support", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT07040904", "official_title": "Mindfulness to Enhance Cognitive Health in Latinx Older Adults", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mindfulness", "Alzheimer's Disease Related Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03384784", "official_title": "Targeting the Cholinergic Pathway in HIV-associated Inflammation and Cognitive Dysfunction", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["HIV Associated Cognitive Motor Complex"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05040048", "official_title": "Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease (AETIONOMY)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Parkinson's Disease"], "locations": [{"country": "France"}, {"country": "Germany"}, {"country": "Spain"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01554033", "official_title": "Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN).", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03545126", "official_title": "Human CNS Tau Kinetics in Tauopathies", "overall_status": "COMPLETED", "phase": null, "conditions": ["Progressive Supranuclear Palsy (PSP)", "Corticobasal Degeneration (CBD)", "Frontotemporal Dementia (FTD MAPT Mutation)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02858778", "official_title": "A Randomized Allocation of Palliative Care Consultation in the Emergency Department Compared to Usual Practice", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Multiple Organ Failure", "End Stage Cardiac Failure", "End Stage Chronic Obstructive Airways Disease", "Chronic Kidney Disease Stage 5", "Hepatic Encephalopathy", "Sepsis", "Dementia", "Multiple Sclerosis", "Parkinson's Disease", "In-Hospital Cardiac Arrest", "Solid Organ Cancer"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00677885", "official_title": "Measurement of P-Glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Parkinson Disease", "Frontotemporal Lobar Degeneration"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02336633", "official_title": "Metabolic Intervention Using Resveratrol in Patients With Huntington Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Huntington Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06823752", "official_title": "A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia Disorder: a Randomised Placebo-controlled Cross-over Study.", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Insomnia"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04479033", "official_title": "Caring for Persons With Dementia and Their Caregivers in the Community: Towards a Sustainable Community Based Dementia Care System", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Cognitive Impairment"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05004558", "official_title": "Effects of a 24-week Remote-based Resistance Training Program on Parameters of the Metabolic Syndrome, Cognitive Function, and Quality of Life in Older Adults Living With Mild Cognitive Impairment and Alzheimer's Disease and/or a Related Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Dementia, Vascular", "Lewy Body Disease", "Frontotemporal Dementia", "Mild Cognitive Impairment", "Aging", "Hypertension", "Obesity, Abdominal", "Obesity", "Body Weight", "Blood Pressure", "Blood Glucose, High", "Blood Glucose, Low", "Dyslipidemias", "Quality of Life", "Cognitive Impairment"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05655793", "official_title": "The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03722316", "official_title": "Immersive Nature-based Multimedia Videos to Improve Health in Older Adults With and Without Mild Cognitive Complaints: A Feasibility and Pilot Study.", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Mild Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04491006", "official_title": "A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Dementia of Alzheimer Type"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03672552", "official_title": "Implementing the Frazier Free Water Protocol to Improve Hydration and Quality of Life in Long Term Care Residents", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dysphagia", "Respiratory Tract Infections"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04513106", "official_title": "Promoting Advance Care Planning in Persons With Early Stage Dementia and Their Family Caregivers in the Community: a Feasibility Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia Mild", "Mild Cognitive Impairment"], "locations": [{"country": "Hong Kong"}, {"country": "Hong Kong"}, {"country": "Hong Kong"}, {"country": "Hong Kong"}, {"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00103649", "official_title": "A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05225415", "official_title": "A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06870474", "official_title": "Psychoeducational Intervention Against Support Groups for Caregivers: A Randomised Controlled Trial of Its Effectiveness", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00357227", "official_title": "Atrial Fibrillation and the Risk for Neurological Complications", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Atrial Fibrillation"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04937127", "official_title": "Efficacité du E-learning et du Jeu de rôle Pour la Formation Des Soignants Des EHPAD à l'Accompagnement de l'Agitation Dans Les Maladies neurodégénératives : Essai randomisé en Cluster", "overall_status": "COMPLETED", "phase": null, "conditions": ["Neuro-Degenerative Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04846426", "official_title": "A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting - FUTURE Extension Study.", "overall_status": "TERMINATED", "phase": null, "conditions": ["Alzheimer Disease", "Preclinical Alzheimer's Disease", "Prodromal Alzheimer's Disease", "Alzheimer's Disease (Incl Subtypes)", "Mild Cognitive Impairment"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02176226", "official_title": "Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Major Depressive Disorder", "Anxiety Disorders"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00767091", "official_title": "A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentric Trial", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Parkinson's Disease", "Apathy", "no Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04235374", "official_title": "Testing the Efficacy of FFC-AC-EIT in Patients With Alzheimer's Disease and Related Dementias", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Acute Medical Event", "Hospitalization"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01736124", "official_title": "Computerized Cognitive Training to Improve Cognition in Diabetic Elderly Veterans", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Diabetes Mellitus, Type 2"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04404959", "official_title": "Correlation Between Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Delirium", "Delirium in Old Age", "Hip Fractures", "Dementia", "Pain", "Analgesia", "Mental Status Change"], "locations": [{"country": "Greece"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02690896", "official_title": "Caregiver Burden and Depression: Caring for Those Who Care for Others", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03081533", "official_title": "Brazilian Circle Dance Program for Family Caregivers of the Elderly With Alzheimer's Disease (CircleCare): a Single-blind, Parallel-group Randomized Controlled Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Family Caregiver"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05822908", "official_title": "A Phase 1/2a, Open-label Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered VO659 in Participants With Spinocerebellar Ataxia Types 1, 3 and Huntington's Disease", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 3", "Huntington Disease"], "locations": [{"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01041989", "official_title": "Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Cognitive Impairment", "Dementia"], "locations": [{"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04510168", "official_title": "Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02302482", "official_title": "Predictive Factors of the Autonomy Level Change Related to Memory Disorders", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Memory Impairment"], "locations": [{"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02792179", "official_title": "A Pilot Longitudinal Follow-Up Study of Tau Burden in The Brain of Subjects With Alzheimer's Disease Who Previously Participated in Study BP29409 Using [18F]RO6958948 Positron Emission Tomography", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04993755", "official_title": "A Phase 2a Study of TPN-101 in Patients With Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD) Associated With Hexanucleotide Repeat Expansion in the C9orf72 Gene (C9ORF72 ALS/FTD)", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Amyotrophic Lateral Sclerosis", "Frontotemporal Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03935568", "official_title": "A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05877391", "official_title": "A Novel Intervention to Improve Care for Older Sexual and Gender Minority (SGM) Adults With Serious Illness and Especially Those With Alzheimer's Disease and Related Dementias (ADRD)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Sexual and Gender Minorities", "Hospice", "Alzheimer's Disease and Related Dementias"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02431091", "official_title": "Evaluation of the Role of Optical Coherence Tomography (OCT) in the Detection of HIV-associated Neurocognitive Disorder", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["AIDS-Related Dementia Complex"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06079190", "official_title": "A Phase 2, Parallel Group, Randomized, Double- Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared With Placebo in Patients With Early Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06628297", "official_title": "Small Vessel Disease of the Brain and Heart a PET Perfusion Study of Training Effects", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Microvascular Disease", "Microvascular Complications", "Dementia", "Diabetes Mellitus Type 2", "Cerebral Hypoperfusion"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04276610", "official_title": "Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning?", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Age-related Macular Degeneration", "Dementia", "Low Vision", "Low Vision Aids", "Hearing Loss", "Reading Problem", "Cognitive Impairment"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05890313", "official_title": "Pilot Study on Clinical Decision Support Tools for Referral for Dementia Consultation", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Cognitive Dysfunction", "Mild Cognitive Impairment"], "locations": [{"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05250323", "official_title": "Energy Balance in Huntington's Disease. A Multidisciplinary Study Approach for a Complex Problem (BEHD-EM)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01325662", "official_title": "A Clinical Study to Evaluate a Modified Serial CSF Sampling Method by Indwelling Lumbar Catheter in Healthy Volunteers", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05565976", "official_title": "Dapagliflozin Effect in Cognitive Impairment in Stroke Trial", "overall_status": "UNKNOWN", "phase": "PHASE2, PHASE3", "conditions": ["Stroke, Ischemic", "Mild Cognitive Impairment", "Dementia, Vascular", "Metabolic Syndrome"], "locations": [{"country": "Mexico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06052397", "official_title": "Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium", "overall_status": "RECRUITING", "phase": null, "conditions": ["Delirium, Postoperative", "Cognitive Decline", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06805578", "official_title": "Exploring and Evaluating the Impact of 'Refresh and Reconnect!': A Museum-based Heritage Programme for Older Persons With Cognitive Impairment", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)", "Ageing", "Mild Dementia", "Well-being"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04715750", "official_title": "An Open Label, Single Center Study to Evaluate the Safety and Imaging Characteristics of [18F]PI-2620 as PET Radioligand for Imaging Tau Deposition in the Brains of Patients With Mild to Moderate Alzheimer's Disease (AD) and Patients With Progressive Supranuclear Palsy (PSP) After i.v. Application of [18F]PI-2620 With High and Low Specific Activity", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Progressive Supranuclear Palsy"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01886820", "official_title": "A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology", "overall_status": "UNKNOWN", "phase": "PHASE3", "conditions": ["Dementia", "Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT06445582", "official_title": "Synaptic Vesicle Glycoprotein 2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04658823", "official_title": "A Randomized Placebo-controlled Double-blind Pilot / Phase II Study to Assess the Efficacy and Safety of HOV-12020 in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Cadasil"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02126514", "official_title": "A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion After Oral Administration of [14C]-AZD3293 to Healthy Male Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Volunteers", "Mass Balance Study"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05217004", "official_title": "Systematic Evaluation of Mobile Applications for Informal Caregivers of People Living With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burden", "Stress", "Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01478633", "official_title": "Evaluation of Efficacy and Safety of Galantamine in Subjects With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT04797715", "official_title": "A Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Agitation in Patients With Dementia of the Alzheimer's Type", "Alzheimer Disease", "Agitation,Psychomotor"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01928420", "official_title": "A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT05203523", "official_title": "Investigating the Effect of Cognitive Training with and Without Transcranial Alternating Current Stimulation on the Executive Brain Functions in Dementia Population", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Mild"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01860625", "official_title": "A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00934050", "official_title": "A Long-Term Follow-Up Study of Oral ELND005 (AZD-103) in Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT00951197", "official_title": "Estimation of Microstructure Alteration by MRI in Dementia Among Elderly Subjects Retired From Agricultural Profession and Living in Rural Area in Gironde - Participants From the AMI Cohort.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03584568", "official_title": "Reappraising Intergeneration Relationships in Dementia Caregiving Through Perspective Taking", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Dementia"], "locations": [{"country": "Hong Kong"}, {"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT03853291", "official_title": "Developing a Pain Identification and Communication Toolkit for Family Caregivers of Persons With Dementia", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Dementia", "Chronic Pain"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT02686190", "official_title": "Effects of Bright Light to Improve Agitation and Sleep Disorders in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:43+00:00"}
{"nct_id": "NCT01746706", "official_title": "Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease?", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03225833", "official_title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease", "overall_status": "TERMINATED", "phase": "PHASE1, PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06641726", "official_title": "Developing an Internationally-diverse, Linked Genomic and Longitudinal Phenotypic Research Dataset to Accelerate Precision Psychiatry for Patients With Serious Mental Illness", "overall_status": "RECRUITING", "phase": null, "conditions": ["Bipolar Disorder (BD)", "Schizophrenia Disorders", "Major Depressive Diorder", "Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07037550", "official_title": "Effectiveness of Strength-based Intervention for Elders With Dementia Living in the Community and Residential Units: a Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Mild Cognitive Impairment", "Caregiver", "Dementia Alzheimer Type"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04656808", "official_title": "Guilt Feelings, Dysfunctional Thoughts, Cultural Values and Mental and Physical Health of Dementia Family Caregivers: Longitudinal, Intervention and Experimental Analysis", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Guilt", "Depressive Symptoms", "Anxious Symptoms", "Stress, Physiological"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05814276", "official_title": "San Rocco Study: an Observational Study on Implementation of the Non-pharmacological Therapies for People With Dementia Living in Nursing Home", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Nursing Home", "Dementia", "Staff"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03507790", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild to Moderate Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05535790", "official_title": "PAX: A Randomized Single-blind Controlled Trial of the Effect of Circadian Light on Hospitalized Persons With Dementia and Older Adults With Cognitive Impairments", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Cognitive Impairment"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05393388", "official_title": "Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Cognitive Decline", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05292560", "official_title": "A Randomized Controlled Trial on the Effectiveness of a Positive Psychology App for Adults in the General Population Dealing With Negatives Consequences of the Corona Crisis", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mental Health", "Well-being", "Depression", "Anxiety", "Adults", "App", "Positive Psychology"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04769024", "official_title": "Evaluation of the Benefits of an Immersive Virtual Reality Intervention (LUMEEN) for Behavioral and Psychological Symptoms of Dementia in People Living in Residential Aged Care.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer's Disease", "Neurocognitive Disorders"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05515679", "official_title": "The BRAIN App: Building Relationships Using Artificial Intelligence and Nostalgia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Dementia, Vascular", "Alzheimer Disease", "Dementia, Mixed"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06711510", "official_title": "Predict to Prevent PGRN Disease", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Frontotemporal Dementia (FTD)", "GRN Related Frontotemporal Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00056524", "official_title": "An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease", "Stroke", "Parkinson's Disease", "Traumatic Brain Injury"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00665223", "official_title": "A Multicentre, Multinational, Randomised, Double-Blind, Parallel-Group Study Comparing ACR16 45 mg Once-Daily or Twice-Daily Versus Placebo for the Symptomatic Treatment of Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Huntington's Disease"], "locations": [{"country": "Austria"}, {"country": "Austria"}, {"country": "Belgium"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05644262", "official_title": "Life's End Benefits of cannaBidiol and tetrahYdrocannabinol (LiBBY)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Agitation", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05138588", "official_title": "Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) in Cognitive Fluctuations of Dementia With Lewy Bodies (DLB): Proof of Concept", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia With Lewy Bodies Diagnosis", "Significant Cognitive Fluctuations in DLB"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01453127", "official_title": "DaTSCAN Imaging in Aging and Neurodegenerative Disease", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE4", "conditions": ["Dementia", "Parkinsonism", "Mild Cognitive Impairment", "REM Sleep Behavior Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04944420", "official_title": "Evaluating an App-based Treatment for Distressed Caregivers of Persons With Moderate Dementia: Health enSuite Caregivers Study", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Caregiver Burnout"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00002246", "official_title": "A Pilot Open Label, Multicenter Study to Evaluate the Role of Stavudine (d4T) in the Treatment of AIDS Dementia Complex", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["AIDS Dementia Complex", "HIV Infections"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04943003", "official_title": "Neurobiological Predictors of Response to Non-invasive Neurostimulation and Genetic Susceptibility to Dementia in Patients With Amnestic Mild Cognitive Impairment (CCL)", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01738386", "official_title": "Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual", "overall_status": "TERMINATED", "phase": null, "conditions": ["Adaptation"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01568086", "official_title": "Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD03 Applied During AFFiRiS 005A", "overall_status": "TERMINATED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Austria"}, {"country": "Austria"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05015374", "official_title": "Effect of Astaxanthin on the Patients With Alzheimer Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04631120", "official_title": "Team-based Technology-enabled Integrated Patient/Caregiver-focused Dementia Study", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01436188", "official_title": "A Biomarker Study to Measure CSF Proteins Upon Application of an Indwelling Lumbar Catheter for 36 Hours in Elderly Healthy Subjects and Subjects With Mild Cognitive Impairment or Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Healthy", "Alzheimer Disease"], "locations": [{"country": "Belgium"}, {"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05738486", "official_title": "Investigating the Effect of Different Donanemab Dosing Regimens on ARIA-E and Amyloid Lowering in Adults With Early Symptomatic Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer's Disease", "Dementia", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Neurodegenerative Diseases", "Neurocognitive Disorders", "Mental Disorders"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01302340", "official_title": "Two Phase, Repeated Crossover Study With Dose Escalation on Delta(9)-Tetrahydrocannabinol (Delta-THC) in Behavioral Disturbances in Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06072274", "official_title": "Efficacy of Virtual Reality Educational Program on Empathy and Attitudes Toward Dementia in Caregivers", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Caregiver Burden"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00026988", "official_title": "Creatine Therapy for Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04935060", "official_title": "The Acceptability and Feasibility of a Guide for Sharing the Outcome of a Memory Assessment", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01421420", "official_title": "Arizona Alzheimer's Disease Core Center", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment", "Age-Related Memory Disorders"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00301574", "official_title": "Placebo-Controlled, Double-Blind Study of Galantamine (R113675) in the Treatment of Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07051096", "official_title": "Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery: A Pilot Randomized Controlled Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Delirium - Postoperative", "Agitation", "Anxiety", "Cardiac Surgery Recovery"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04730635", "official_title": "A Clinical Study to Evaluate a Cognitive Platform to Support Development of Symptomatic Therapies in Participants at Risk for Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00440050", "official_title": "A Randomized Double-Blind Placebo-Controlled Trial Of The Effects Of Docosahexaenoic Acid (DHA) In Slowing The Progression Of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04710550", "official_title": "Exploring the Utility of [18F]3F4AP for Demyelination Imaging in Controls, Neurodegeneration and Traumatic Brian Injury", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE1", "conditions": ["Brain Injuries, Traumatic", "Demyelinating Disorder", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01600859", "official_title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02018913", "official_title": "Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease", "Vascular Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01255046", "official_title": "A Phase II Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of STA-1 as an Add-on Treatment to Donepezil in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05326009", "official_title": "A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04334200", "official_title": "The Development and Evaluation of a Culturally Tailored Support Group Program on the Psychosocial Wellbeing of Family Caregivers of Individuals Living With Dementia in Hong Kong", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04514432", "official_title": "Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation", "overall_status": "COMPLETED", "phase": null, "conditions": ["Agitated; State, Acute Reaction to Stress", "Agitation,Psychomotor"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01233414", "official_title": "Randomized Trial of Parent Training for Young Children With Autism", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Child Development Disorders, Pervasive"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01441726", "official_title": "Palliative and End-of-life Care in Advanced Dementia: Evaluation of a Program of Organization of Care in Long-term Care Settings", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03896711", "official_title": "MEMORI Corps: A Novel Activity-based Companion Care Program to Benefit Community-living Persons With Dementia, Their Families, and Senior Volunteers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03899844", "official_title": "Blood Amyloid-Beta Relationship With Amyloid Plaques and CSF Amyloid-Beta", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Alzheimer Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05413655", "official_title": "A Phase 2, Randomized, Double Blind, Placebo-Controlled Study of Oral EX039 As Add-on to Acetylcholine Esterase Inhibitors in Subjects with Mild Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02925650", "official_title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamic (PD) Effects of Posiphen® in Subjects With Early Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04958707", "official_title": "Evaluating the Feasibility of a Mobile Phone-based Intervention (Zalo App) on Depression, Anxiety, and Stress of Family Caregivers of People With Dementia.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Vietnam"}, {"country": "Vietnam"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01993836", "official_title": "Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimers Disease", "Postoperative Delirium", "Post Operative Cognitive Dysfunction"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03340571", "official_title": "mtDNA Damage in Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00205699", "official_title": "Metabolic Effects of Antipsychotics in Children", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Aggression", "Attention Deficit-Hyperactivity", "Oppositional Defiant Disorder", "Pervasive Development Disorders", "Bipolar Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06189963", "official_title": "A Phase I/IIa, Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants With Moderate Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Moderate Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02448784", "official_title": "Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia With Lewy Body Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01454115", "official_title": "Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-708163 in Healthy Male Subjects and a Comparison to Elderly Male and Female Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06547099", "official_title": "Blood Amyloid, Tau, and Neurodegeneration Biomarkers and Prediction of Clinical Onset, Cognitive Decline, and Dementia Diagnosis", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02839187", "official_title": "Neuro Imaging and Multimodal Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06570993", "official_title": "A Cluster Randomised Controlled Trial (cRCT) Evaluating the Effects of Cool Roofs on Health, Environmental and Economic Outcomes in Niue", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Resting Heart Rate", "Blood Glucose Control", "Depression", "Heat-related Symptoms", "Physician Diagnosed Heat-related Illnesses", "Food Insecurity", "Diet Quality", "Health-related Quality of Life", "Indoor Thermal Comfort", "Coping Ability", "Life Satisfaction", "Healthcare Provider Utilization", "Hospitalization", "Systolic Blood Pressure", "Diastolic Blood Pressure", "Inner Ear Canal Temperature", "Dehydration", "Sleep Quality", "Cognition", "Productivity", "Aggression", "Indoor Air Temperature", "Indoor Relative Humidity", "Indoor Heat Index", "Household Energy Expenditure"], "locations": [{"country": "Niue"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05942404", "official_title": "Investigation of the Effect of Preoperative Bowel Cleansing on Lipopolysaccharide Binding Protein, Brain-Derived Neurotrophic Factor and Tau Protein Levels and Their Relationship With Postoperative Cognitive Impairment", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["POCD - Postoperative Cognitive Dysfunction", "Mechanical Bowel Preparation"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04305652", "official_title": "Impact of the Progressively Lowered Stress Threshold Model on Alzheimer's Patient and Caregivers' Care Outcomes: A Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "CAREGİVER"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07110207", "official_title": "Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Frontotemporal Lobar Degeneration (FTLD)"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05516134", "official_title": "All About Me: An Intervention to Ease the Transition to Long-term Care, Build Community, and Improve Quality of Care for Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Dementia, Vascular", "Dementia, Mixed", "Dementia of Alzheimer Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03987633", "official_title": "EMPOWER-1: A Multi-site Clinical Cohort Study to Reduce Health Inequality: Identifying Ethnic Disparities in Treatment Failures for Medicines Prescribed to Treat Diseases That Cause Significant Mortality and Morbidity in the UK Population", "overall_status": "RECRUITING", "phase": null, "conditions": ["Atrial Fibrillation", "Coronary Heart Disease", "Cardiovascular Diseases", "Heart Failure", "Hypertension", "Peripheral Arterial Disease", "Stroke, Ischemic", "Asthma", "Chronic Obstructive Pulmonary Disease", "Obesity", "Cancer", "Chronic Kidney Diseases", "Diabetes Mellitus", "Dementia", "Depression", "Epilepsy", "Mental Health Disorder", "Rheumatoid Arthritis", "Blood Pressure", "Breast Cancer Risk", "Prostate Cancer", "Lung Cancers"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03507192", "official_title": "Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Dementia"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01287767", "official_title": "A Support Program for Carers of Persons With Dementia - a 24 Months RCT", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Depression"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06825663", "official_title": "Brain Insulin Resistance Index in Plasma Neuronal Exosomes As Predictive Biomarkers of Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Prognosis Biomarker of AD", "Mild Cognitive Impairment", "Brain Insuline Resistance"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01439555", "official_title": "Endothelial Facilitation in Alzheimer's Disease. An Open Label Pilot Study of the Sequential and Cumulative Effects of Simvastatin, L-Arginine, and Sapropterin (Kuvan) on Cerebral Blood Flow and Cognitive Function in Patients With Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03811847", "official_title": "A Pilot, Multiple Crossover, Randomized Block Sequence, Double-Blind, Placebo-Controlled Trial for Use of Methylphenidate for Cognitive and Behavioral Symptoms in Mild Cognitive Impairment and Dementia", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06585449", "official_title": "A Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered Single Ascending Doses of ALN-HTT02 in Adult Patients With Huntington's Disease", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Huntington's Disease"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03679026", "official_title": "The \"Motoric Cognitive Risk\" Syndrome in the Canadian Population: Analysis of Baseline Assessment of the Canadian Longitudinal Study on Aging (CLSA)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Cognition Disorders in Old Age", "Cardiovascular Diseases", "Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07139678", "official_title": "Turkish Reliability and Validity of the Safe Use of Mobility Aids Checklist (SUMAC) For 4-wheeled Walker Use", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00814801", "official_title": "Placebo-controlled Confirmatory Study of Galantamine (R113675) for Alzheimer's Type Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04025801", "official_title": "Heidelberg Retina Tomograph (HRT) in Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Healthy Individuals", "Diabetes", "Hypertension", "Fabry Disease", "Metabolic Disease", "Alzheimer Disease", "Dementia", "Limbal Insufficiency", "Phlyctenulosis", "Ocular Rosacea", "Graft Versus Host Disease in Eye", "Dry Eye Syndrome"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02216396", "official_title": "MARQUE (Managing Agitation and Quality of Life) Stream 2: A Naturalistic Two-year Cohort Study of Agitation and Quality of Life in Care Homes", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia", "Agitation"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00174382", "official_title": "An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Dementia, Vascular", "Dementia, Mixed"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02992561", "official_title": "Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means: A Randomized Controlled Trial in Eastern DR Congo", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Appetitive Aggression"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05231954", "official_title": "Digital Detection of Dementia (D Cubed) Studies: D2", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease and Related Dementias (ADRD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05985486", "official_title": "The Impact of Weight Loss on Alzheimer's Disease Risk in Adults With Down Syndrome", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Down Syndrome", "Alzheimer Disease", "Obesity"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01496170", "official_title": "A Study to Assess the Safety, Tolerability, and Pharmacodynamics of MK-8931/SCH 900931 in Patients With Alzheimer's Disease [Phase 1b; Protocol No. 010-00 (Also Known as P07820)]", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06644573", "official_title": "Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1", "conditions": ["Chronic Insomnia", "Sleep Deprivation", "REM Behavior Disorder", "REM Sleep Behavior Disorder", "REM Sleep Measurement", "Insomnia", "Insomnia Related to Specified Disorder", "Insomnia Due to Other Mental Disorder", "Insomnia Comorbid to Psychiatric Disorder", "Insomnia Due to Anxiety and Fear", "Insomnia Related to Another Mental Condition", "Insomnia Disorders", "Idiopathic Hypersomnia", "Sleep Disorders, Circadian Rhythm", "Post Trauma Nightmares", "PTSD - Post Traumatic Stress Disorder", "Sleep Quality", "Anesthesia", "Anxiety", "Depression", "Mental Health", "Alzheimer Disease or Associated Disorder", "Parkinsons", "Circadian Rhythm", "Circadian Dysregulation", "PTSD", "Post-Traumatic", "Post-Traumatic Stress Disorder Complex", "Military Combat Stress Reaction", "Sleep", "Military Activity", "Veterans", "Shift Work Sleep Disorder", "Menopause Related Conditions", "Pain", "Cancer Pain", "Athletes"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03325556", "official_title": "A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-related Psychosis", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia-related Psychosis"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Bulgaria"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02547818", "official_title": "A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02537496", "official_title": "Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Enhancement of Dorsolateral Prefrontal Cortex Neuroplasticity: A TMS-EEG Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00079651", "official_title": "Programming for Dementia: Maximizing Abilities", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06543602", "official_title": "A Multi-modal Recognition Model and Efficacy Evaluation for Agitation Behavior in Critically Ill Patients Based on Remote -Ultra-sensitive Detection Wave ---A Multi-center, Open-label, Observational Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Critically Ill Patients"], "locations": [{"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06875739", "official_title": "An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Neurodegenerative Disorders", "Parkinson Disease", "Alzheimer Disease", "Parkinsonian Disorders", "Fronto-temporal Dementia", "Amyotrophic Lateral Sclerosis"], "locations": [{"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03122288", "official_title": "Individualized-Targeted Cognitive Training in Older Adults With HAND", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["HIV-Associated Cognitive Motor Complex", "Aging", "Cognitive Impairment", "Cognitive Decline", "Attention Impaired", "Processing, Visual Spatial", "Cognitive Deficit in Attention", "Cognitive Disorder in Remission"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06922188", "official_title": "Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Financial Hardship", "Alzheimer&#39;s Disease (AD)", "Alzheimer&#39;s Disease and Related Dementia (ADRD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02912169", "official_title": "An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Vascular Fraction (AD-SVF) Cells Delivered Intravenous (IV) and Intranasal in Patients With Alzheimer's Disease", "overall_status": "WITHDRAWN", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04764669", "official_title": "An Open-Label Study To Evaluate the Pharmacodynamic Effects, Efficacy, Safety, and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies or Parkinson's Disease Dementia With or Without Amyloid Copathology", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Lewy Body Disease", "Parkinson Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03419039", "official_title": "A Randomized, 24-week Parallel-group Placebo-controlled Multicenter (Phase 2) Study of Anthocyanins in People at Risk for Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Inflammation", "Mild Cognitive Impairment", "Coronary Artery Disease"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01925196", "official_title": "Natural History and Biomarkers of C9ORF72 Amyotrophic Lateral Sclerosis and Frontotemporal Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis", "Frontotemporal Lobar Degeneration"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03798327", "official_title": "Video-Assisted Palliative Care Intervention for Patients With Advanced Dementia at Home", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00164970", "official_title": "Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00142805", "official_title": "Safety, Tolerability and Efficacy Study of Tricaprilin (AC-1202) Administered for Ninety Days in Subjects With Probable Alzheimer's Disease of Mild to Moderate Severity", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02956694", "official_title": "Design, Implementation and Evaluation of a Tailored Intervention to Improve Shared Decision Making Among Seniors With Dementia, Their Caregivers and Healthcare Providers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Professional-Patient Relations", "Professional-Family Relations", "Aging"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04846322", "official_title": "Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department", "overall_status": "COMPLETED", "phase": null, "conditions": ["Cognitive Impairment", "Emergency Care", "Dementia", "Delirium"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06490822", "official_title": "The Skin as a Window to the Central Nervous System in Frontotempolar Lombar Degeneration", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Frontotemporal Lobar Degeneration"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00380302", "official_title": "A Double-Blind Placebo-Controlled Study of the Activity of AVE1625 at Doses of 10 mg and 40mg for 12 Weeks in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "France"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06347172", "official_title": "Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04812769", "official_title": "Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer's Dementia", "Nursing Homes", "Antibiotics", "Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02843529", "official_title": "Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) as a Pre-Clinical or Pro-Dromal Alzheimers Diagnosis (Prognosis) for Optimum Outcomes", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Memory Disorders", "Cognitive Impairment", "Dementia", "Presymptomatic Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05295966", "official_title": "Effects of Multisensory Physical Exercises in People With Moderate Cognitive Impairment or Mild Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00548951", "official_title": "The Connection Between Sensory Deprivation and Social Withdrawal in Clients of a Long Term Care Facility Living With Alzheimer's Disease and the Effects of a Snoezelen Program.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00819429", "official_title": "A Nutritional and Social Skills Intervention on Conduct Disorder and Hyperactivity", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Conduct Disorder", "Attention Deficit Hyperactivity Disorder", "Oppositional Defiant Disorder"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03008161", "official_title": "A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose Escalation Study of NPT088 in Patients With Probable Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00024531", "official_title": "Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06307197", "official_title": "HAAL: HeAlthy Ageing Eco-system for peopLe With Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Devices", "Artificial Intelligence", "Older People", "Caregiver Burden"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00692510", "official_title": "A Phase I, Double Blind, Randomized, Two-Way Cross Over, Single- Centre Study in Healthy CYP2D6 Extensive Metabolizers and Poor Metabolizers to Investigate the Potential of AZD3480 to Inhibit Cytochrome P450 1A2, 2C19, 3A4, 2C8, 2B6 and UGT1A1 Activity", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Metabolism", "Alzheimer's Disease"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01348061", "official_title": "Experimental Medicine Study to Evaluate the Kinetics of Cerebrospinal Fluid Biomarkers in Subjects With Alzheimer's Disease and Progressive Supranuclear Palsy Compared to Healthy Subjects Using a Heavy Water Labeling Method", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Progressive Supranuclear Palsy"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06470061", "official_title": "A Randomized Phase II Study to Evaluate Oral RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Cognitive Decline"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07176286", "official_title": "An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F-mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With and Without Lewy Body Diseases", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2", "conditions": ["Parkinson Disease (PD)", "Lewy Body Dementia (LBD)"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02415062", "official_title": "The Efficacy of 23mg Versus 10mg of Donepezil in ParkInson's Disease With Dementia", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Parkinson's Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05383027", "official_title": "Examining the Feasibility of Implementation, Patterns of Association, and Outcomes in HRV Biofeedback (HRVB) Intervention and Music Listening Control (MLC) on Alzheimer's Disease (AD) Family Caregivers (FCGs) Public Title: Caring Relationship Expression Study(CARES)", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease and Related Dementias Family Caregivers"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02118727", "official_title": "Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Amyotrophic Lateral Sclerosis", "Frontal Temporal Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03683394", "official_title": "Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03132805", "official_title": "An Evaluation of an Integrated Approach to Prevention and Early Intervention in the Elementary School Years", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03508024", "official_title": "Patients With Alzheimer's Disease or Related Youth Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease, Early Onset", "Lewy Body Disease", "Frontotemporal Lobar Degeneration"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00855062", "official_title": "Minocycline in the Treatment of HIV-Associated Cognitive Impairment in Uganda", "overall_status": "TERMINATED", "phase": "PHASE1, PHASE2", "conditions": ["HIV-associated Cognitive Impairment", "HIV Infections"], "locations": [{"country": "Uganda"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02440646", "official_title": "The Natural History of Coronary Atherosclerosis Within the Concept of the Glagovian Arterial Remodeling in REAL-world Stable Chest Pain Population Who Underwent nonInvasive compuTed tomographY Angiography in Comparison With Invasive Quantitative Coronary Angiography and Multimodality Imaging Handled by the Advanced Post-processing Software: Clinical potentIal and Safety", "overall_status": "TERMINATED", "phase": null, "conditions": ["Coronary Atherosclerosis", "Coronary Artery Disease", "Contrast-induced Nephropathy", "Cerebrovascular Disease", "Alzheimer Disease", "Chronic Coronary Insufficiency", "Stable Chronic Angina"], "locations": [{"country": "Estonia"}, {"country": "Netherlands"}, {"country": "Russia"}, {"country": "Russia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06467461", "official_title": "Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia With Lewy Bodies", "Parkinson Disease", "REM Sleep Behavior Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02103673", "official_title": "DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Behavioral and Psychological Symptoms in Alzheimer's Disease", "Behavioral and Psychological Symptoms in Vascular Dementia"], "locations": [{"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07032350", "official_title": "E-Tailored Pain Management Support for Dementia Family Caregivers", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Care Giving Burden", "Dementia", "Chronic Pain", "Pain Management", "Palliative Care"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02104297", "official_title": "The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Agitation"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04177160", "official_title": "The Effects of Music on Autonomic Nervous System and Anxiety in Healthy Elderly and Persons With Subjective Cognitive Decline", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04171323", "official_title": "ACTIVE MIND: An Adaptive Clinical Trial of Cognitive Training to Improve Function and Delay Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Age-related Cognitive Decline", "Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03938870", "official_title": "CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Brain Diseases", "Central Nervous System Diseases", "Delirium, Dementia, Amnestic, Cognitive Disorders", "Dementia", "Mental Disorders", "Nervous System Diseases", "Neurodegenerative Diseases", "Tauopathies"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03981159", "official_title": "Effect of Exercise Training on Biochemical and Gait/Balance Parameters in Alzheimer's Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04661280", "official_title": "Donepezil Use Versus Non-drug Approach in Treatment of Newly Diagnosed Alzheimer's Disease : a Multicentric, Randomized, Open Study : the CHOLINE-2 Study", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06085196", "official_title": "Evaluation of an Outdoor Mindful Walking Program for Sustaining Cognitive Function in Older African Americans at Risk for Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive Function", "Aging Well", "Behavior, Health"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03548142", "official_title": "Palliative and Hospice Care in Advanced Dementia: Experiences of Care Givers and Benefit of a Brochure Serving as a Decision-making Aid", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Advanced Dementia"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02109705", "official_title": "Porphyromonas Gingivalis - a Responsible Pathogen in Alzheimer's Disease?", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Dementia", "Periodontitis"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05395624", "official_title": "A Phase 1/2 Study to Evaluate Safety, PK and Biodistribution of an Imaging Agent, 18F-OP-801, After Intravenous Administration to Patients With ALS, Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease and Healthy Volunteers", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)", "Parkinson Disease (PD)", "Alzheimer Disease (AD)", "Multiple Sclerosis (MS)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02987842", "official_title": "Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06976983", "official_title": "Effects of Transcranial Static Magnetic Stimulation (tSMS) in the Treatment of Hyperkinetic Symptoms of Huntington's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Huntington Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05867641", "official_title": "VR&R: Providing Respite to Caregivers by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02821780", "official_title": "CADASIL Disease Discovery", "overall_status": "COMPLETED", "phase": null, "conditions": ["Germline Mutation in the NOTCH 3 Gene", "Cardiovascular Disease", "Arterial Stiffness", "Pathogenesis of CADASIL", "Clinical Phenotype of CADASIL"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01709188", "official_title": "The Effects of Musical Dual Task Training on Attention Control and Associated Gait Stability of Patients With Mild to Moderate Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04997642", "official_title": "Parkinson's Disease and Movement Disorders Clinical Database", "overall_status": "RECRUITING", "phase": null, "conditions": ["Parkinson Disease", "Parkinson Disease Dementia", "Lewy Body Parkinson Disease", "Lewy Body Dementia with Behavioral Disturbance"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01188070", "official_title": "Caregiver Stress: Interventions to Promote Health and Wellbeing", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Health Promotion"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05043441", "official_title": "A Ten-Week Online Acceptance and Commitment Therapy Intervention Guided by a Coach for Family Caregivers of People With Dementia: A Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depressive Symptoms"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05331144", "official_title": "Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid, and Tau in Older Adults (IPAT Study)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Cognitively Normal Older Adults", "Hypertension", "Subjective Cognitive Decline", "Family History of Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07071649", "official_title": "Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease", "Biomarkers", "Non-invasive Diagnosis", "Phosphorylated Protein p-tau217"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02181543", "official_title": "Use of Intraoperative Clonidine for Prevention of Postoperative Agitation in Pedriatic Anesthesia With Sevoflurane.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Is an Only Child"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03070535", "official_title": "APOE Genotype and Diet Influences on Alzheimer's Biomarkers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease; Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01193608", "official_title": "A Phase 1, Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptive, Multiple Ascending Dose Study Of The Safety, Tolerability And Pharmacokinetics Of Aab-003 (Pf-05236812) In Subjects With Mild To Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02854033", "official_title": "Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Mild Cognitive Impairment (MCI)", "Alzheimer's Disease (AD)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05205135", "official_title": "Feasibility Study of Project Carer Matters for Family Caregivers of People With Dementia Receiving Home-based Caregiving", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Caregivers", "Caregiver Burden", "Caregiver Burnout", "Dementia"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06019117", "official_title": "Effectiveness of a Probiotic K10 in Managing Health Outcomes in Parkinson's Disease and in Early Stage (Mild Cognitive Impairment to Mild Dementia) and Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Parkinson Disease", "Alzheimer Disease"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01584440", "official_title": "A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Agitation", "Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06354933", "official_title": "Neurological Soft Signs in Neurodegenerative Dementias", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Dementia With Lewy Bodies", "Frontotemporal Dementia", "Corticobasal Degeneration"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04318626", "official_title": "The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Post-stroke Cognitive Impairment", "Neuroinflammation"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03087526", "official_title": "Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells (CFTC) for Triplet Repeat Diseases", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Non Invasive Prenatal Diagnosis"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06176625", "official_title": "Prospective Initiative to Examine and Address Hearing Loss, Vision Loss, and Delirium in a Hospital Setting", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Hearing Loss", "Hearing Loss, Age-Related", "Hearing Disability", "Delirium", "Delirium in Old Age", "Delirium of Mixed Origin", "Delirium With Dementia", "Delirium on Emergence", "Delirium, Cause Unknown", "Delirium Superimposed on Dementia", "Delirium Confusional State", "Delirium;Non Alcoholic", "Hearing Loss, Bilateral", "Hearing Loss, Sensorineural", "Hearing Loss, Functional", "Hearing Loss, High-Frequency", "Hearing"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00544791", "official_title": "The Effect of Melatonin on Memory and Other Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment (MCI): A Placebo- Controlled Study.", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment (MCI)"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01626378", "official_title": "A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Behavioral Variant Frontotemporal Dementia (bvFTD)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Romania"}, {"country": "Singapore"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01411150", "official_title": "Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03092050", "official_title": "Group Therapy for Depressed Caregivers of Alzheimer's Disorder and Related Dementias", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04213391", "official_title": "Randomized,Double-blind, Placebo-controlled, Efficacy and Safety Study of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT07060391", "official_title": "A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the Treatment of Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT02625818", "official_title": "The Genetic and Affective Prediction Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mental Disorders"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06163716", "official_title": "GOIZ ZAINDU Trial: a FINGER-like Multidomain Lifestyle Intervention Feasibility Study to Prevent Dementia in Southern Europe.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Decline", "Dementia Risk Factors", "Prevention", "Multidomain Intervention"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01378026", "official_title": "Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis", "Alzheimer Disease", "Parkinson's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06185543", "official_title": "A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease (AD)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04818255", "official_title": "Stimulation to Improve Memory: PET Education & Disclosure", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Dementia; Alzheimer's Type (Etiology)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06435078", "official_title": "Developments of Novel Virtual Visual and Haptic Stimulation Systems for the Elderly", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Healthy Elderly", "Alzheimer Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03038035", "official_title": "The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study : Assessing the Safety and Efficacy of Neuroaid II (MLC901) in Patients With Mild to Moderate Alzheimer's Disease Stable on Cholinesterase Inhibitors or Memantine: A Randomized, Double Blind, Placebo Controlled Trial", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03019289", "official_title": "A Phase I, Open-Label, Single-Dose, Adaptive (S)-(-)-[18F]Fluspidine and [18F]Fallypride Positron Emission Tomography Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Health Volunteers, Huntington Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01525368", "official_title": "Outcome Predictors of a Complex Cognitive Intervention in Amnestic Mild Cognitive Impairment (aMCI)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Amnestic Mild Cognitive Impairment"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01143350", "official_title": "Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03709238", "official_title": "Pain Processing and Pain Reporting in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Pain"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05060848", "official_title": "Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04150055", "official_title": "Piloting an mHealth Mindfulness Therapy Intervention to Alleviate Symptoms of Stress for Caregivers of Older Adults With Cognitive Impairment.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burnout", "Stress", "Anxiety"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00933608", "official_title": "Effects of Memantine on the Magnetic Resonance Spectroscopy (MRS) Measures of Neuronal Integrity in Subjects at Risk for Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03208491", "official_title": "AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00620191", "official_title": "Metformin in the Prevention of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03383289", "official_title": "Resident-to-Resident Elder Mistreatment Intervention for Dementia Care in Assisted Living", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Assisted Living, Resident to Resident Elder Mistreatment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03851523", "official_title": "AlfaCognition: Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Subjective Cognitive Decline"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01340950", "official_title": "Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["HIV Infections", "Central Nervous System Diseases", "Dementia"], "locations": [{"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05139290", "official_title": "Decision-Making Experiences for Culturally Inclusive Dementia Engagement: Dyads and Families (DECIDE: Dyads and Families)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Caregiver Burden"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00645190", "official_title": "A Randomized, Double Blind, Active Control, Flexible Dose, Multicenter Study to Evaluate Galantamine HBr in the Treatment of Alzheimer's Disease:Safety and Effectiveness of an Immediate-release Table Formulation.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05189210", "official_title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Prospective, 52-Week, Phase 2 Clinical Study to Evaluate the Safety and Efficacy of GV1001 Administered Subcutaneously for the Treatment of Mild to Moderate AD", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild to Moderate Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03308123", "official_title": "PERFECTED WP1 P4: A Qualitative Exploration of Lay and Professional Stakeholder Views of Care Delivery in Hospitals for Patients With Hip-fracture & Memory Difficulties", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Hip Fractures"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01733355", "official_title": "A Phase 0, Open Label, Non-randomized, Multi-center Exploratory and Safety Study of [F-18]T807", "overall_status": "TERMINATED", "phase": "EARLY_PHASE1", "conditions": ["Alzheimers Disease", "AD"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00052143", "official_title": "Prospective Huntington At Risk Observational Study (PHAROS)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01690117", "official_title": "German Adaptation of Resources to Enhance Alzheimer's Caregiver Health", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Family Caregiver"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06850597", "official_title": "Randomized, Double-blind, Placebo- Controlled Trial Evaluating Efficacy and Safety of Dimethyl Fumarate in Brain Atrophy Reduction, Synaptic Functional Connectivity, Cognitive Functions, Quality of Life, and Activity of Daily Living Improvement Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["MCI", "MCI-AD, Early Stage Alzheimer's Disease", "Alzheimer's Disease"], "locations": [{"country": "Poland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05385913", "official_title": "Digital Evaluations and Technologies Enabling Clinical Translation for AD", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01716897", "official_title": "A Randomized, Open-label, 3-treatment Crossover Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption in Healthy Caucasian Male Adults", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03909347", "official_title": "PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06572748", "official_title": "Evaluation Study for the Chef Anchor 3.0 Program for Older People With Mild Cognitive Impairment/Dementia and Their Informal Caregivers", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT05374278", "official_title": "First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in the Brains of Healthy Controls and Patients With Dementia.", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease", "Frontotemporal Dementia", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06427668", "official_title": "A Phase 2, Randomized, Placebo-controlled, Double-Blind Multicenter Study to Assess the Safety, Tolerability, and Pharmacodynamics (PD) in Adult Participants With Mild-to Moderate Alzheimer's Disease (AD) Administered SPG302", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00448318", "official_title": "Evaluating the Effects of Music Interventions on Hospitalised People With Dementia", "overall_status": "UNKNOWN", "phase": "PHASE2, PHASE3", "conditions": ["Dementia", "Alzheimer's Disease", "Dementia, Vascular", "Lewy Body Disease"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT00476008", "official_title": "Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT06237218", "official_title": "Effets Du Programme COTID (Community Occupational Therapist in Dementia) Et D'une Prise En Soins Ergothérapique Habituelle Sur La Récidive De Chutes À 12 Mois De Personnes Âgées Atteintes De Troubles Neurocognitifs Et Ayant Été Hospitalisées Pour Chute, Après Leur Retour À Domicile", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Nervous System Diseases"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01002079", "official_title": "A Study of the Effect of Concomitant Administration of Rifampin on the Pharmacokinetics of BMS-708163 in Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "India"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT01382849", "official_title": "F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)", "overall_status": "WITHDRAWN", "phase": null, "conditions": ["Cerebral Amyloid Angiopathy"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT04573985", "official_title": "Impact of the Eurékoi Serious Game on Family Caregivers of Patients With a Major Neurocognitive Disorder", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Family Caregiver of Patient With Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:44+00:00"}
{"nct_id": "NCT03513549", "official_title": "A Postmarketing Observational Study to Evaluate the Safety of ADASUVE® (STACCATO® Loxapine for Inhalation) in Patients With Agitation Associated With Schizophrenia or Bipolar I Disorder", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Agitation,Psychomotor"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02297035", "official_title": "Linguistic, Anatomic/Metabolic and Biologic Characterisation of the Three Main Variants of Primary Progressive Aphasia : Towards the Rationale for Drug Trials and Specific Language Rehabilitations", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Aphasia Primary Progressive"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00210717", "official_title": "A Randomized, Double-Blind, Parallel Group, Comparative Study of Flexibly Dosed Paliperidone Palmitate (25, 50, 75, or 100 mg eq.) Administered Every 4 Weeks and Flexibly Dosed RISPERDAL CONSTA (25, 37.5, or 50 mg) Administered Every 2 Weeks in Subjects With Schizophrenia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Schizophrenia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00547560", "official_title": "An Ascending Multiple Dose Study Of The Safety, Pharmacokinetics, And Pharmacodynamics Of GSI-953 Administered Orally To Healthy Elderly Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02863081", "official_title": "Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission", "overall_status": "COMPLETED", "phase": null, "conditions": ["Delirium", "Ventilators", "Pain", "Agitation", "Anxiety"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03230071", "official_title": "Efficacy and Safety of Twice Daily TMBCZG in Mild to Moderate Vascular Dementia: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Trial", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Vascular Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06530732", "official_title": "Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03902548", "official_title": "A Positron Emission Tomography (PET) Study to Compare the [18F]P16-129 and [18F]Florbetapir for Investigations of Amyloid β Pathology in Subjects With Alzheimer's Disease and Investigate the Biokinetics, Radiation Dosimetry, and Safety of [18F]P16-129 in Healthy Volunteers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06264258", "official_title": "Evaluating Game-based Pediatric Diabetes Education", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Diabetes Mellitus, Type 1", "Behavior, Health"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03382444", "official_title": "A Longitudinal Assessment of Cognitive Impairment in Advanced CKD Transitioning Into Renal Replacement Therapy", "overall_status": "COMPLETED", "phase": null, "conditions": ["Cognitive Impairment", "Chronic Kidney Diseases", "End Stage Renal Disease", "Dementia", "Hemodialysis Complication", "Peritoneal Dialysis Complication", "Renal Transplant"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01564706", "official_title": "Positron Emission Tomography Whole Body Biodistribution Using 18F-AV-45", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT07094438", "official_title": "Study Safety and Efficacy of Deep Brain Stimulation (DBS) and Cervical Deep Lymphoid-venous Anastomosis (LVA) in Patients With Severe Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06194552", "official_title": "A Multiple Ascending Dose, Phase 1, Double-Blind, Study to Investigate the Safety and Pharmacokinetics of NTRX-07 in Healthy Volunteers and Patients With Early Alzheimer's Disease (AD), With an Exploratory Fed-Fasted Assessment", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "Hungary"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06385106", "official_title": "Effects of Repetitive Transcranial Magnetic Stimulation on Sleep and Cognitive Function in Patients With Alzheimer's Disease: a Randomized, Double-blind, Controlled Study", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03823404", "official_title": "GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01485952", "official_title": "An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients to Assess Pharmacokinetics, Candidate Pharmacodynamic Measures of Target Engagement and Disease Modulation as Well as Acute Phenotypical Effects Following Multiple Oral Doses of SEN0014196.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Huntington Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00205621", "official_title": "Positron Emission Tomography of Cerebral Amyloid Load as a Potential Diagnostic Marker for Pre-Symptomatic Alzheimer's Disease.", "overall_status": "SUSPENDED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01181921", "official_title": "Phase IV Study for the Assessment of Modulating Effect of Galantamine (Reminyl PRC) on Circadian Rhythm in Patients With Moderate Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE4", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04045600", "official_title": "Stimulus Control Refinements of Functional Communication Training", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Aggression", "Self-injurious Behavior"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00146263", "official_title": "The Effect of Computerized Cognitive Training on Neuropsychological Measures of Cognitive Function in the Elderly", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02428387", "official_title": "Evaluation of a Transition Intervention for Family Caregivers of Persons With Alzheimer Disease and Multiple Chronic Conditions", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Family", "Dementia"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05886114", "official_title": "A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive Impairment", "Alzheimer Disease", "Vascular Cognitive Impairment", "Dement", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Neurocognitive Disorders", "Mental Disorder", "Cognition Disorder"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06682767", "official_title": "A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE) - A Randomized Open-label Intervention of the Fasting-mimicking Diet (FMD)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cerebral Blood Flow", "APOE 4"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05271552", "official_title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy And Safety Study of PRN Dosing of BXCL501 Over A 12 Week Period In Subjects With Agitation Associated With Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Agitation", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05251649", "official_title": "Transcranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment of Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06629844", "official_title": "Education Program for Enhancing Attitude Toward People Living with Dementia Among Healthcare Students Using Virtual Reality: Pilot Study", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Nursing Students", "Education Program on Dementia"], "locations": [{"country": "Indonesia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02535884", "official_title": "Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD): A Prospective, Randomised, Controlled, International, Multi-centre Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Huntington Disease"], "locations": [{"country": "Austria"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Switzerland"}, {"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06040905", "official_title": "Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease", "Hyperglycemia", "Pre-sarcopenia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05460494", "official_title": "Increasing Meaning to Reduce Loneliness in Care Partners of Persons With AD/ADRD", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Loneliness"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04407351", "official_title": "Develop Phototherapy of Improving the Quality of Sleep and Healthcare for Patients With Sleep Disorder, Mild Cognitive Impairment, or Dementia: a Novel Light Emitting Diode (LED) Application on Health Promotion", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Sleep Disorder", "Mild Cognitive Impairment", "Phototherapy"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00056329", "official_title": "Multicenter Vitamin E Trial in Aging Persons With Down Syndrome", "overall_status": "UNKNOWN", "phase": "PHASE3", "conditions": ["Down Syndrome", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06397339", "official_title": "Indian Transforming Alzheimer's Care Training (INTACT)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01839422", "official_title": "Functionnal Magnetic Resonnance Imaging (fMRI)Study of Cerebral Substrates of New Musical and Pictorial Learning in Alzheimer Patients", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01039194", "official_title": "A Study of the Effect of Concomitant Administration of Multiple Doses of BMS-708163 on the Pharmacokinetics of Galantamine in Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02403245", "official_title": "The Impact of a Social Stimulation on Social Interactions in Institutionalized People With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Social Interactions"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00203775", "official_title": "Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Psychosis", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03581305", "official_title": "PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Depression", "HIV Infections", "HIV-Associated Cognitive Motor Complex"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04897464", "official_title": "Validation Study of a New Digital Treatment Test Based on Interactive Video Games for Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "MCI"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05178992", "official_title": "Impact of a Novel Socially Assistive Robotic Architecture on Engaging Older Adults With Mild Cognitive Impairment, Alzheimer's Disease and Related Dementia in Long Term Care Settings", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05194163", "official_title": "A Phase 2a Study of MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05618834", "official_title": "Optimizing Daily Care Interactions Between Staff and Assisted Living Residents With Alzheimer's Disease and Related Dementias", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease and Related Dementias"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02267499", "official_title": "The Effects of Combined Cognitive and Physical Exercises Through Computer Games in Elderly: The Long Lasting Memories Project (LLM)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Mild Dementia", "Healthy"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01099332", "official_title": "CopperProof-2: Prospective, Randomized, Double-Blind Placebo-Controlled Clinical Trial Comparing the Effects of a Novel Once-Daily Oral Zinc Cysteine Preparation on Zinc and Copper Parameters in Mild Cognitive Impairment and Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03438604", "official_title": "A Phase 1, 2-Way Crossover Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil 5 mg Transdermal Delivery System (TDS) in Healthy Volunteers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03507504", "official_title": "REspectful CAring for the AGitated Elderly. How to Best Meet the Needs of People With Dementia With Severe Behavioural Disturbances. Toward a Respectful and Cost-effective Model", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Belgium"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Norway"}, {"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06827678", "official_title": "Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Positron Emission Tomography"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05830214", "official_title": "Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS (CAPTURE ALS Smarwatch)", "overall_status": "WITHDRAWN", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis", "Primary Lateral Sclerosis", "Muscular Atrophy, Progressive", "Frontotemporal Dementia", "Healthy"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04134806", "official_title": "Evaluation of a Navigation Experiment in the Gait Real-Time Analysis Interactive Lab: Gait Analysis by Induced Disorientation in a VR Environment", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment", "Mild Dementia", "Disorientation", "Young Adults", "Older Adults"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04426838", "official_title": "Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06620393", "official_title": "Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients (DEX-TBI)", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2, PHASE3", "conditions": ["Traumatic Brain Injury", "Agitation,Psychomotor"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00888706", "official_title": "Effect of Activities and Exercise on Sleep in Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia", "Elderly", "Sleep"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03732521", "official_title": "Clinical, Randomized and Double-blind Controlled Trial of an Educational Therapeutic Intervention for Family Caregivers on the Psychological and Behavioral Symptoms of Dementias (PRESTA Study)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Family Relations", "Psychological and Behavioral Symptoms"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06547021", "official_title": "Investigating the Effect of Different Frequencies of Transcranial Electrical Stimulations Paired With Cognitive Training on the Executive Brain Functions in Dementia Population", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00474552", "official_title": "An Ascending Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 Administered Orally to Healthy Young Adult and Elderly Subjects", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02052947", "official_title": "Co-LEsions in Alzheimer Disease and Related Disorders", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease", "Cerebrovascular Disease", "Lewy Body Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05028114", "official_title": "A Phase 1, Three-part, Part-randomised, Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Different Formulations of Tricaprilin, to Include Single-dose, Food Effect, and Titration Tolerability, in Healthy Participants", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01872858", "official_title": "Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05930249", "official_title": "Effect of a fNIRS-based Personalized Multi-domain Intervention on Cognitive in Elderly Population With High Risk of Stroke", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Cognitive Impairment", "Stroke", "Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06295458", "official_title": "Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Gait Disorders, Neurologic", "Parkinson Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03852121", "official_title": "Bibliotherapy for Improving Caregiving Appraisal Among Informal Caregivers of People With Dementia: A Pilot Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02871921", "official_title": "Internet-based Conversational Engagement Clinical Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aging", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04220021", "official_title": "A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["C9orf72 Amyotrophic Lateral Sclerosis (ALS)", "Frontotemporal Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03462121", "official_title": "A 6-Month, Double-Blind, Phase 2 Study and 6-Month Open- Label Extension Evaluating the Safety, Tolerability, and Clinical Benefit of RPh201 in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild to Moderate Dementia Due to Alzheimer's Disease", "With or Without Coexisting Cerebrovascular Disease"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00831506", "official_title": "A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF-01913539) On The Safety, Tolerability, And Steady-State Pharmacokinetics Of Digoxin In Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06417333", "official_title": "A Smart-wrist Band Connected Mobile Application for the Assessment and Management of Dementia Symptoms", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Mild"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06083233", "official_title": "Role of Brain Specific Biomarkers in Hydrocephalus", "overall_status": "COMPLETED", "phase": null, "conditions": ["Hydrocephalus, Normal Pressure", "Biochemical Lesions Head Region", "Brain Damage"], "locations": [{"country": "Czechia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03352258", "official_title": "Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease: a Randomized Pilot Study", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00165763", "official_title": "An Open Label Study on the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Vascular Dementia"], "locations": [{"country": "Philippines"}, {"country": "Philippines"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT07187921", "official_title": "Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers (eDROP-AD)", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01325714", "official_title": "Preventing Aggression in Veterans With Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia", "Aggression", "Pain"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05990114", "official_title": "Evaluation of the Effect of Structured Caregiver Support Program on the Levels of Care Burden, Psychological Well-Being and Psychological Resilience of Informal Caregivers of Alzheimer's Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02633111", "official_title": "DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["B-cell Non-Hodgkin Lymphoma", "Aggressive"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04920006", "official_title": "Developing and Testing the Enhancing Active Caregiver Training (EnACT) Intervention for Dementia Family Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Familial"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02769234", "official_title": "ERP and qEEG Measures Collected in Outpatient Settings as Indices of Disease Progression in Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01277809", "official_title": "Community Alliance for Quality of Life in Long Term Care: The Effects of a Walking Program on Balance, Falls and Well Being in Individuals Residing in Long-term Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Accidental Falls", "Muscle Weakness", "Gait, Unsteady", "Depression", "Behavior"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05509387", "official_title": "Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05307692", "official_title": "A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Tolerability, and Clinical Efficacy of Seltorexant (JNJ-42847922) on Behavioral and Psychological Symptoms of Dementia in Patients With Probable Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05245799", "official_title": "\"Effectiveness of Adding a Novel Digital Storybook Intervention Platform in Therapy to Improve Speech, Language, and Literacy Outcomes in Children With Hearing Loss\"", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Hearing Loss", "Deafness", "Hearing Disorders in Children", "Hearing Impaired Children", "Speech Therapy", "Speech Disorders in Children", "Literacy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06561906", "official_title": "Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease, Late Onset", "Mild Cognitive Impairment", "Subjective Cognitive Decline"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04785300", "official_title": "ALSENLITE: an Open-Label Pilot Study of Senolytics for Alzheimer's Disease", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE1, PHASE2", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06999434", "official_title": "Exploring the Utility of [18F]3F4AP for Demyelination Imaging", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Demyelinating Disorders", "MCI", "Alzheimer's Disease (AD)", "MS (Multiple Sclerosis)", "SCI - Spinal Cord Injury", "Spinal Radiculopathy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00833300", "official_title": "Haloperidol vs Olanzapine for the Management of ICU Delirium: A Randomized Clinical Trial", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Delirium", "Agitation"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04777409", "official_title": "A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects With Early Alzheimer´s Disease (EVOKE Plus)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE3", "conditions": ["Early Alzheimer´s Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Ireland"}, {"country": "Ireland"}, {"country": "Ireland"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovenia"}, {"country": "Slovenia"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04443621", "official_title": "Changes in the Perception of Personal Dignity Over the Course of Dementia", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia", "Dignity"], "locations": [{"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06880406", "official_title": "Early Alterations of Peripheral Mitochondrial Function and Metabolomic Profile in Patients With Alzheimer's Disease and Related Dementias", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03136692", "official_title": "Analysis of De-identified Data From Commercially-available App Lose It!", "overall_status": "COMPLETED", "phase": null, "conditions": ["Overweight and Obesity"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04220593", "official_title": "Effects of Transcranial Direct Current Stimulation Associated With Cognitive Training in Alzheimer's Disease: Clinical Trials, Triple-blind and Randomized", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06953167", "official_title": "Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer&#39;s Disease (AD)"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05956834", "official_title": "A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes", "overall_status": "RECRUITING", "phase": null, "conditions": ["PSP", "CBD", "Progressive Supranuclear Palsy", "FTD", "Corticobasal Degeneration", "Frontotemporal Dementia", "Frontotemporal Lobar Degeneration"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04478734", "official_title": "Multicentric Trial on the Use of Combined Therapy of Thiamine and Biotine in Patients With Huntington´s Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00842608", "official_title": "Pharmacological Management of Delirium", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Delirium", "Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00723606", "official_title": "A Randomized, Open Label, Rater Blind, Flexible Dose Multi-Center Study Comparing The Efficacy And Safety Of Intramuscular Ziprasidone With Haloperidol For Three Days In Patients With Agitation Of Schizophrenia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Schizophrenia"], "locations": [{"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT00555204", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Study Using a Bayesian Adaptive Design to Evaluate the Efficacy and Safety of ABT-089 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04956549", "official_title": "Reducing African Americans' Alzheimer's Disease Risk Through Exercise-Mild Cognitive Impairment Cohort", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia of Alzheimer Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04542317", "official_title": "Cluster Randomized Controlled Trial to Test the Efficacy of a Psychosocial Intervention (REACH VN) to Support Alzheimer's Family Caregivers in Vietnam", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Vietnam"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT03702543", "official_title": "Managing Vascular Dementia Risk Factors With SymTrend", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Vascular Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT01399125", "official_title": "A 24-Week, Randomized, Double-blind, Double-dummy, Parallel-group, Active-controlled Study to Assess the Efficacy, Safety, and Tolerability of the Once-daily Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (Mini-Mental State Examination (MMSE) 10-20)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT06632990", "official_title": "An Open-label, Randomized, Three-arm Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates in Healthy Adult Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE1", "conditions": ["Drug Drug Interaction (DDI)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT02541097", "official_title": "Preventing Language Decline in Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT05375513", "official_title": "A Home-based Personalized Multidomain RCT from the Canadian Therapeutic Platform for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:45+00:00"}
{"nct_id": "NCT04760860", "official_title": "a Randomized, Double Blind, Placebo Controlled Clinical Trial Exploring the Target Engagement and Tolerability of Terazosin Hydrochloride in Patients With Dementia With Lewy Bodies", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06168604", "official_title": "The Pain Identification and Communication Toolkit: A Training Program to Support Family Caregivers of Persons With ADRD", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Caregiver Burden", "Cognitive Impairment", "Dementia", "Alzheimer Disease", "Pain, Chronic"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00893750", "official_title": "Effects of Trauma-Therapy and Truth Education, Conflict Resolution and Social Skills Trainings and Traditional Ways of Coping in Northern Uganda", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["PTSD", "Depression", "Aggression"], "locations": [{"country": "Uganda"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05469360", "official_title": "A Randomized, Participant and Investigator Blinded, Placebo-Controlled Study to Evaluate the Ability of a Single Intrathecally Administered Dose of NIO752 to Lower Cerebrospinal Fluid Total Tau Levels in Participants With Early Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00190450", "official_title": "Multicentric Intracerebral Grafting in Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04281784", "official_title": "Using the Electronic Health Record to Identify and Promote Goals-of-Care Communication for Older Patients With Serious Illness", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Chronic Disease", "Neoplasm Metastasis", "Lung Neoplasm", "Pulmonary Disease, Chronic Obstructive", "Heart Failure，Congestive", "Liver Cirrhosis", "Kidney Failure, Chronic", "Lung Diseases, Interstitial", "Peripheral Vascular Disease", "Diabetes With End Organ Injury"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05661084", "official_title": "Multifocal Transcranial Current Stimulation for Cognitive and Motor Dysfunction in Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Memory Loss", "Alzheimer Disease", "Executive Dysfunction", "Mobility Limitation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04512040", "official_title": "Feasibility of At-Home Telehealth Yoga for Treating Chronic Pain", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Musculoskeletal Pain", "Chronic Pain"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01313806", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy of the Application of Magnetic Fields Using the Resonator for the Treatment of Alzheimer\"s Disease in Addition to Standard of Care", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05094817", "official_title": "Feasibility of an Online, Self-administered Cognitive Screening Tool in Older Patients Undergoing Ambulatory Surgery (FOCUS)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Delirium in Old Age", "Alzheimer Disease", "Mild Cognitive Impairment", "Neurocognitive Disorders"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03208517", "official_title": "An eLearning Optimized Person Centred Intervention to Improve Staff Attitudes and Quality of Care for People With Dementia Living in Care Homes", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00743418", "official_title": "The Use of Advanced Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease and Related Cognitive Disorders", "overall_status": "UNKNOWN", "phase": "PHASE1, PHASE2", "conditions": ["Dementia"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00479349", "official_title": "An Ascending Multiple Dose Study of the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Japanese Young Male and Elderly Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02991235", "official_title": "Evaluation of the Efficacy and Safety of PRJ212 on Improving the Memory of Patients With Mild Severity Alzheimer's Disease: A 6-month Randomized, Double-blind and Placebo-controlled, Followed by a 6-month Open Label Extension Study", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02015884", "official_title": "Impact of a Program to Prevent the Risk of Antisocial Behavior and Attacks of Patients or Attendant on Healthcare Workers in an Ophthalmic Emergency Unit.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Rudeness/Incivility, Aggression or Violence Against Healthcare Workers in an Ophthalmic Emergencies Unit."], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00151333", "official_title": "A Randomized, Double-blind, Placebo-controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics Trial of Multiple Ascending Fixed Doses of SRA-333 in Subjects With Mild to Moderate Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05603533", "official_title": "The Effectiveness of a Music and Video-based Group Exercise Therapy in Older Adults With Moderate Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04788238", "official_title": "Dual-Task Zumba Gold for Improving the Cognition of Community-Dwelling Older Adults With Mild Cognitive Impairment: A Pilot Randomized Controlled Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Philippines"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03670615", "official_title": "Exercise Augmenting Cognition tDCS (EXACT): A Pilot Study of a Combined Exercise and Transcranial Direct Current Stimulation Intervention for Cognition", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03643991", "official_title": "Decreasing Agitation in Patients With Dementia Through the Use of Weighted Blankets: A Pilot Study", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01318408", "official_title": "A Prospective, Phase 4, Open-Label, Twelve-Week Study to Examine the Cognitive Impact and Tolerability of Levetiracetam (Keppra) in Elderly Patients With Seizures of Partial Onset", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Epilepsy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00035191", "official_title": "A Randomized 26-Week, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia, Vascular"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00010920", "official_title": "Preventing Cognitive Decline With Alternative Therapies", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia", "Memory Disorders"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04957238", "official_title": "Impact of a Decision-making Tool to Guide the Use of Physical Restraints in Intensive Care Unit Patients. A Multicentre Randomized Stepped-wedge Trial.", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Critically Ill", "Intensive Care Unit Delirium", "Delirium Confusional State", "Agitation,Psychomotor"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04281550", "official_title": "Supporting Optimal Hydration With Those Living With Dementia in Care Homes", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03399591", "official_title": "Correlation Between Gait Disorders and Neuropsychological Profile in Patients With Alzheimer's Disease and Lewy Body Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Gait Disorders, Neurologic"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05967390", "official_title": "Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE): A Project of MRI-informed Computational Head Model", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Aging", "Dementia Alzheimers", "Parkinson Disease", "Dementia Frontotemporal", "Depression in Old Age"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04385797", "official_title": "Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06088810", "official_title": "The Impact of Music Intervention on Sleep: CoMPoSER Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00338117", "official_title": "A European Multi-Center Study to Determine the Safety and Efficacy of Galanthamine Hydrobromide 40mg/Day (32 mg /Day GAL Base, Tid Dose Regimen) in Patients Diagnosed With Alzheimer-Type Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06285240", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MK-1167 Administered to Patients With Alzheimer's Disease Receiving Stable Donepezil Treatment", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01238991", "official_title": "A Phase Iia, Multicenter, Treatment Assigned, Open-label, Long-term Extension Study To Determine Safety, Tolerability, And Immunogenicity Of Acc-001 With Qs-21 Adjuvant In Japanese Subjects With Mild To Moderate Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04313582", "official_title": "Feasibility of the SmartPrompt for Improving Everyday Function in Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Dementia, Vascular", "Dementia Alzheimers", "Dementia, Mixed", "Dementia, Mild", "Dementia of Alzheimer Type", "Mild Cognitive Impairment", "Mild Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04635124", "official_title": "Optimal Dog Visits", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Aging"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02503488", "official_title": "Decreasing Youth Involvement in Violence in Burundi", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Posttraumatic Stress Disorder", "Depression", "Aggression"], "locations": [{"country": "Burundi"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03328676", "official_title": "A Phase II, Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Avidekel Oil for the Treatment of Subjects With Agitation Related to Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Agitation Related to Dementia"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06667817", "official_title": "Exercise From Afar: Progressing At-Risk Rural Adults to Effective Independent Exercise for Dementia Risk Reduction", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Sedentary Behavior"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05598697", "official_title": "Economic Evaluation of the Men Engagement in Women Empowerment (MEWE) Intervention (MEWE-EE)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depression", "Mental Health Issue", "Intimate Partner Violence", "Domestic Violence", "Gender-based Violence", "Rape Sexual Assault", "Battered Women"], "locations": [{"country": "Pakistan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04005313", "official_title": "Development and Application of Portable Multisensory Stimulation Device: Vibroacustic Therapy", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Cognitive Impairment"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06821568", "official_title": "Long-term Home-based Transcranial Electrical Stimulation for Cognitive and Motor Function in Older Adults With an Increased Risk of Dementia: a Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease and Related Dementias", "Cognition", "Mobility Disability"], "locations": [{"country": "United States"}, {"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04597827", "official_title": "Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Semantic Dementia", "Alzheimer Disease", "Healthy"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03375697", "official_title": "A 2-Part Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Belgium"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06264362", "official_title": "Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Pain, Chronic", "Dementia, Mild", "Mobility Limitation", "Physical Disability", "Osteo Arthritis Knee", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05697588", "official_title": "Studies on Biomarkers for Mild Cognitive Impairment Conversion to Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Biomarkers", "MCI Conversion to Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05943925", "official_title": "Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia Alzheimers", "Dementia With Lewy Bodies", "Parkinson Disease Dementia", "Dementia Frontotemporal", "Mild Cognitive Impairment"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05145868", "official_title": "Evaluation and Optimization of a Just-in-Time Messaging Intervention to Reduce Alcohol-Facilitated Intimate Partner Violence Perpetration Among At-Risk Young Adult Men and Women", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alcohol Drinking", "Aggression", "Emotion Regulation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00319891", "official_title": "Computer-Based Training for Mild Cognitive Impairment and Mild Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00029874", "official_title": "Minocycline Dosing and Safety in Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03954210", "official_title": "SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Insomnia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00479297", "official_title": "Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Japanese Male Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02377713", "official_title": "A Phase 1 Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06362824", "official_title": "De Pie y a Movernos Study: Promoting Physical Activity in Older Hispanic/Latino(a) Adults", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Sedentary Behavior", "Physical Inactivity", "Alzheimer Disease, Protection Against"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00142324", "official_title": "A Randomised Placebo Controlled Trial of a Cholinesterase Inhibitor in the Management of Agitation in Dementia That is Unresponsive to a Psychological Intervention", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00205179", "official_title": "Alzheimer's Disease: Potential Benefit of Isoflavones", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06040294", "official_title": "Evaluation of a Dementia and Disability Simulation Program for Senior Activity Facilitation Skills Among College Nursing Students", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02059356", "official_title": "Prevalence of High Ammonia Levels in Patients With Cognitive Impairment. Does Treatment Help?", "overall_status": "TERMINATED", "phase": null, "conditions": ["Dementia", "Cognitive Decline", "Cognitive Impairment", "Developmental Delay"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03772977", "official_title": "The Brain Health Champion Study: Promoting Non-pharmacological Interventions in Cognitive Disorders and Those at Risk", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Dementia, Mild", "Subjective Cognitive Decline", "At Risk for Cognitive Decline"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01849042", "official_title": "A Multicenter, Randomized, Open-label, Prospective Study to Estimate the add-on Effects of Memantine as Ebixa Oral Pump on Language in Moderate to Severe Alzheimer's Disease Patients Already Receiving Donepezil.", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00666445", "official_title": "Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test: AD Template Development Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05422339", "official_title": "Efficacy of Gamification in Enhancing User Engagement in Visual Mapping Assistive Technology", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Gamification", "Assistive Technology"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00000657", "official_title": "Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["AIDS Dementia Complex", "HIV Infections"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06721156", "official_title": "A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04404153", "official_title": "Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04560088", "official_title": "Mindfulness Training to Reduce Social Isolation and Feelings of Loneliness in Older Caregivers for Family Members With Alzheimer's Disease and Related Dementias", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Social Isolation", "Loneliness"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04412083", "official_title": "Primary Progressive Aphasia (PPA) Tele-Savvy: A Pilot Study of an Online Intervention for Caregivers of Persons Living With PPA", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "Caregiver Burnout"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01428362", "official_title": "A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Safety, Tolerability and Efficacy of VI-1121 in Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01595646", "official_title": "Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04263194", "official_title": "Novel Tailored Network-based rTMS Treatments in Alzheimer's Disease: an Integrated Multiimaging Approach", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease, Late Onset", "Alzheimer Disease", "Cognitive Deterioration"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04829656", "official_title": "Identifying Factors Predicting ACcurately End-of-Life in Dementia With Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT07116473", "official_title": "A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients With Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE3", "conditions": ["Amyloidosis in Transthyretin (TTR)", "Amyloidosis, Familial", "Amyloid Cardiomyopathy", "Amyloid Cardiomyopathy, Transthyretin-Related", "Amyloidogenic Transthyretin (ATTR) Amyloidosis", "Heart Disease", "Cardiomyopathies", "Amyloidosis, Hereditary, Transthyretin-Related", "Polyneuropathies", "Amyloidosis"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04300569", "official_title": "A Prospective, Non-Interventional Study to Determine Signs and Symptoms That Impact Daily Life of Patients With Irregular Sleep-Wake Rhythm Disorder and Their Caregivers", "overall_status": "COMPLETED", "phase": null, "conditions": ["Irregular Sleep Wake Rhythm Disorder"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06377241", "official_title": "A Proof-of-concept Pilot Study to Determine the Efficacy of SensifyAware and Retinal Imaging in Differentiating Mild Cognitive Impairment (MCI) From Cognitively Unimpaired Controls (HC)", "overall_status": "TERMINATED", "phase": null, "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06224205", "official_title": "Digital Detection of Dementia (D Cubed) Studies: D3", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease and Related Dementias (ADRD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06445894", "official_title": "Accelerated Intermittent Theta-burst Stimulation to Modify Cognitive Function and Balance in Dementia and Memory Loss", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia Alzheimers"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06880237", "official_title": "Sing Out Loud: a Choral Singing Program for Persons Living with Dementia", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Nursing Homes Residents"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04129060", "official_title": "Health of the Cholinergic System and Risk for Alzheimer's Disease in Postmenopausal Women", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Postmenopausal Symptoms", "Aging", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT07091279", "official_title": "Randomized Controlled Trial of Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Autism Spectrum Disorder", "Challenging Behaviour", "Aggression", "Severe Disruptive Behaviour Disorders", "Self-injury"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01168466", "official_title": "Pilot Study of EEG and Cerebral Blood Flow Biofeedback Training in Remediating Cognitive and Behavioral Deficits in Adults With a Dementing Illness.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01097096", "official_title": "A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Norway"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06937541", "official_title": "Family Interventions iN Dementia Mental Health Environments", "overall_status": "RECRUITING", "phase": null, "conditions": ["Carers", "Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06079827", "official_title": "Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00165750", "official_title": "Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients", "overall_status": "TERMINATED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03174886", "official_title": "A 24-month Randomised Parallel Group Single-blinded Multi-centre Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Primary Progressive Nonfluent Aphasia"], "locations": [{"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06768450", "official_title": "Online Mindfulness Meditation for Mild Cognitive Impairment and Mild Dementia: a Feasibility Study", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)", "Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03997591", "official_title": "Effect of Ready2E.A.T. in Risk Populations", "overall_status": "COMPLETED", "phase": null, "conditions": ["Upper Extremity Dysfunction", "Dementia", "Cerebral Palsy", "Cognitive Decline", "Eating Disorders"], "locations": [{"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00833274", "official_title": "Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01874418", "official_title": "Study for Usefulness and Standardization of CSF and Blood Biomarkers in Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03011723", "official_title": "Positive Emotions, Communication and Quality of Life in Dementia: A Tailored Music Therapy Intervention", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Dementia", "Dementia, Vascular", "Dementia, Lewy Body", "Dementia Parkinson's Disease"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02155946", "official_title": "Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT07127510", "official_title": "Measurement of Brain NAD Levels in Alzheimer's Patients and Control Subjects by 1H-MRS", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Alzheimer Disease (AD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01565642", "official_title": "Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01061489", "official_title": "Computer-based Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment (MCI) and Mild Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)", "Mild Alzheimer's Disease"], "locations": [{"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03671889", "official_title": "Assessment of Safety and Efficacy of ExAblate Blood-Brain Barrier Disruption for the Treatment of Patients With Probable Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06473220", "official_title": "Evaluation of the Effectiveness of Narrative Nursing in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Narrative", "Depression, Anxiety"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00096824", "official_title": "International Neurological Study: A Stand Alone Study for Participants of A5175 (A Phase IV, Randomized, Open-Label Evaluation of the Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combination for Initial Treatment of HIV-1 Infected Individuals From Diverse Areas of the World)", "overall_status": "COMPLETED", "phase": null, "conditions": ["HIV Infections"], "locations": [{"country": "Brazil"}, {"country": "Brazil"}, {"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "India"}, {"country": "Malawi"}, {"country": "Malawi"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "Zimbabwe"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05477862", "official_title": "Neural Mechanisms of Induced Calmness After Listening to Improvisatory Music: An Investigation for Healthy Individuals and Persons With Alzheimer's Dementia", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01351142", "official_title": "Cytokines and Cognitive Decline in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00794625", "official_title": "Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Attention Deficit Disorder With Hyperactivity"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04295889", "official_title": "Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Albuminuria"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00824590", "official_title": "A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease", "Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05658510", "official_title": "Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Agitation,Psychomotor", "Bipolar I Disorder", "Bipolar II Disorder", "Schizophrenia", "Schizoaffective Disorder", "Schizophreniform Disorders"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02345213", "official_title": "A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Dementia, Lewy Body", "Lewy Body Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00001323", "official_title": "Neuropsychiatric Evaluation of Normal Subjects and Psychiatric and Neurologic Contrast Groups", "overall_status": "COMPLETED", "phase": null, "conditions": ["Brain Injury", "Dementia", "Healthy", "Mental Disorder", "Schizophrenia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04592874", "official_title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "New Zealand"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06343220", "official_title": "Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research", "overall_status": "RECRUITING", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05673759", "official_title": "The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment", "overall_status": "SUSPENDED", "phase": null, "conditions": ["Alzheimer Disease", "Dementia, Mild", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06891703", "official_title": "Phase 1 Study to Evaluate [18F]ACI-15916 as a Potential PET Radioligand for Imaging α-synuclein Deposits in the Brain of Patients With Suspected α-synuclein Pathology Compared With Healthy Volunteers", "overall_status": "RECRUITING", "phase": "EARLY_PHASE1", "conditions": ["Parkinson's Disease (PD)", "Multiple System Atrophy (MSA)", "Dementia With Lewy Bodies (DLB)"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04321486", "official_title": "Natural History and Patient Journey in Dementia: a Nationwide Linked Electronic Health Records Study of 5.6 Million Individuals.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia, Alzheimer, Electronic Health Records, Hospitalizations, Epidemiology, Comorbidity, United Kingdom, Incidence, Mortality, Cause of Death"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05326750", "official_title": "Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Frontotemporal Dementia", "Dementia With Lewy Bodies"], "locations": [{"country": "Finland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01806896", "official_title": "A Phase 2, Double-blind Randomized, Sequential Treatment Group, Placebo-controlled Study To Evaluate The Safety, Tolerability And Brain Cortico-striatal Function Of 2 Doses Of Pf-02545920 In Subjects With Early Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02878486", "official_title": "Intervention to Reduce Sitting Time in Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06289569", "official_title": "Home Tele Rehabilitation Therapy for Vascular Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia, Vascular", "Stroke Sequelae"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05804383", "official_title": "A Phase 1B Multiple Ascending Dose Study of The Safety and Tolerability of BMS-984923 in Healthy Older Adults and Patients With Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01880151", "official_title": "NEw approacheS for The dIagnosis of AlzeiMer's diseAse Through neuroElectrical Changes in the Brain", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04226872", "official_title": "Supporting Family Caregivers of Persons Living With Dementia: Effectiveness and Sustainability of My Tools 4 Care-In Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Family"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT07005895", "official_title": "Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes: User Engagement and Individual Variability of Transdermal Optical Imaging Features Before and After Acute Fluid Ingestion", "overall_status": "RECRUITING", "phase": null, "conditions": ["Hydration"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT07191028", "official_title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parellel-group Study to Assess the Efficacy and Safety of MLC901 (NeuroAiD™II) in Subjects With Mild to Moderate Alzheimer's Disease (AD).", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer's Disease Dementia"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04884529", "official_title": "Virtual Chair Yoga for Stress in Older Adults (60+) With Mild/Moderate Dementia or Mild Cognitive Impairments and Caregivers (18+) During COVID-19", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01978353", "official_title": "Episodic Memory Training for Face Name Association in Patients With Amnestic Mild Cognitive Impairment: Cognitive Measures and Functional Resonance Magnetic Imaging Outcomes", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05922137", "official_title": "Oriental Intervention for Enhanced Neurocognitive Health (ORIENT) Diet in Patients With Intracranial / Carotid Stenosis : a Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive Decline", "Cognitive Change", "Stenosis", "Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03095170", "official_title": "Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Memory Disorders", "Mild Dementia", "Impaired Cognition", "Mild Cognitive Disorder", "Amnestic Disorder", "Dementia and Amnestic Conditions", "Poor Short-term Memory", "Memory Impairment", "Mild Neurocognitive Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05564169", "official_title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Masitinib as add-on Therapy in Patients With Mild Alzheimer's Disease, Treated With Standard of Care", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06373094", "official_title": "A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy Subjects", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02902822", "official_title": "Tele-dermatology of Skin Cancer: a Randomized Trial Comparing Remote Assessment With Conventional Visits in a Cohort of Local Health Authority Employees in the Province of Bergamo (the Shoot the Mole Study)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Erysipelas", "Impetigo", "Herpes Zoster", "Molluscum Contagiosum", "Warts", "Tinea", "Melanoma", "Actinic Keratosis", "Basal Cell Carcinoma", "Squamous Cell Carcinoma"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03814902", "official_title": "A Prospective Pilot Study to Characterize the Impact on Families of Electronic Tracking Device Use by Children With Autism Spectrum Disorders Who Wander", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Autism Spectrum Disorder", "Wandering Behavior"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06088212", "official_title": "Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor: the Cog-HF Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Heart Failure", "Cognitive Impairment", "Dementia", "Left Ventricular Dysfunction", "Cognitive Change", "Cognitive Decline"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03403257", "official_title": "Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Dementia", "Dementia Alzheimers", "Dementia, Vascular", "Dementia, Mixed"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04570761", "official_title": "Effects of Auditory Brain Stimulation by \"Pink Noise\" on Memory Capacities in Alzheimer's Disease: Proof of Concept Study", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease (AD)"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02350270", "official_title": "Gait, cOgnitiOn & Decline (GOOD)", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment", "Mild Dementia", "Moderate Dementia", "Healthy"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02094729", "official_title": "A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05891431", "official_title": "Acceptability and Preliminary Effectiveness of a Mobile Health Intervention (Untire App) for Adult Cancer Patients and Survivors With Cancer Related Fatigue: A Pilot Clinical Study", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Cancer-related Problem/Condition", "Cancer-related Fatigue"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03840837", "official_title": "Cholinergic Neurotransmission - A Common Underlying Mechanism of Cognitive and Gait Impairment in Parkinson Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Parkinson Disease", "Parkinson Disease Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03631069", "official_title": "Detecting Dementia in the Retina: a Big Data Machine Learning Approach", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia Alzheimers", "Dementia", "Dementia, Vascular", "Dementia Senile"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01025466", "official_title": "A Multicenter, Randomized, Open-label Study to Compare the Tolerability Between Rivastigmine Patch Monotherapy and Combination Therapy With Memantine in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03901456", "official_title": "Care to Plan: Preliminary Efficacy of a Tailored Resource for Family Members of Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Memory Loss"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04350801", "official_title": "Usefulness of a Home-based Cognitive Monitoring in Non-demented Patients With High-risk of Dementia: a Prospective Observational Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06637228", "official_title": "Effects of Integrated Exercise on Sarcopenia, Depression Symptoms, and Quality of Life of Community-Dwelling Older Adults With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Depressive Symptoms", "Quality of Life (QOL)", "Sarcopenia in Elderly"], "locations": [{"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05811000", "official_title": "A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease: Double-Blind, Randomized Between Placebo Control Group and Dose Groups, Parallel-Design, Multicenter Study", "overall_status": "UNKNOWN", "phase": "PHASE2, PHASE3", "conditions": ["Mild Alzheimer Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT07010705", "official_title": "Digital Measures for Clinical Trial Endpoints in Huntington's Disease (MEND-HD)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Huntington Disease", "Healthy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03030365", "official_title": "The Orientation System, the Default-network and Brain Metabolism in Patients With Early Stage Alzheimer's Disease: a Multimodal Functional Study.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00718770", "official_title": "Rexinoid Therapy for Poorly Differentiated Thyroid Cancer: A Pilot Clinical Trial and Correlation to Retinoid and PPARy Receptor Expression", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Thyroid Cancer"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02864056", "official_title": "A Randomised Controlled Trial Comparing the Effectiveness of Tai Chi Alongside Usual Care With Usual Care Alone on the Postural Balance of Community-dwelling People With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Accidental Falls"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02295462", "official_title": "Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05905822", "official_title": "DIetary plAnt Extracts, Colonic MicrObes, and Apoe geNetics Interactions stuDy", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02064920", "official_title": "A Clinical Trial to Assess Cognitive Function by Repeated Computerized Testing in Patients With Mild Alzheimer's Disease Treated With Donepezil", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00987220", "official_title": "A Methodology Study To Evaluate Cerebrospinal Fluid Acetylcholine Following A Single Dose Administration Of Donepezil In Healthy Subjects", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00481520", "official_title": "A Randomized, Double-blind, Placebo-controlled, Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) Trial of Multiple Ascending Fixed Doses of SAM-531 in Subjects With Mild to Moderate Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03946696", "official_title": "Bonding at the Very End Emerging Personhood During End-of-life and Palliative Care Through Animal-Assisted Therapy (AAT)", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00937846", "official_title": "An Open Label Positron Emission Tomography (PET) Study to Investigate Brain Penetration by [Carbonyl-11C] GSK1034702 in Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Cognitive Disorders"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00112073", "official_title": "A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04606420", "official_title": "Lifestyle Intervention for Early Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03856359", "official_title": "Pilot, Single Center, Open, Trial of Rifaximin in Probable Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00001480", "official_title": "The Evaluation and Follow-up of Patients With Memory Disorder and Normal Controls", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Dementia", "Healthy", "Memory Disorder"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04918251", "official_title": "Investigation of EEG and TMS-based Biomarkers of Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Frontotemporal Dementia", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis", "Frontotemporal Dementia", "Multiple Sclerosis"], "locations": [{"country": "Ireland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01578161", "official_title": "The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Psychomotor Agitation"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03120741", "official_title": "Dementia Patient's Behavior Evaluation Using Noninvasive Ambient Sensor", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment, Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04911803", "official_title": "Does Using a Self-help App to Improve Wellbeing Work? - An Experimental Follow-up Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Anxiety and Worry"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04023942", "official_title": "Lifestyle Intervention Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Obesity"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01124773", "official_title": "Women's Health Initiative Memory Study of Younger Women", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03280251", "official_title": "Potentiation of Cognitive Functions in Healthy Elderly by Association of Methylphenidate and Cognitive Training: Proof of Concept Study in Order to Develop a Synergic Symptomatic Treatment for the Cognitive Disorders Before Dementia", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Healthy Volunteers"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00259454", "official_title": "Managing Problem Behaviors of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia, Alzheimer Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT07205003", "official_title": "Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders of Vascular Origin or Linked to Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Neurocognitive Disorders", "Alzheimer&#39;s Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05735041", "official_title": "The Efficacy of Computerized Cognitive Training in Patients With Coronary Heart Disease and Cognitive Impairment, no Dementia: a Randomized Controlled Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Coronary Heart Disease"], "locations": [{"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05048966", "official_title": "Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons: A Randomized Clinical Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Traumatic Brain Injury", "Mild Traumatic Brain Injury", "Alzheimer's Disease", "Brain Injury Traumatic Moderate", "Brain Injury Traumatic Severe", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06394388", "official_title": "A Cultural Adaptation of the Caregiver TLC Psychoeducational Program to Support Latino Caregivers (CUIDANDO JUNTOS)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregivers of People With Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03787758", "official_title": "A Phase 1, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine the Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Healthy Adults With an Open-label Cohort of Patients With Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02697435", "official_title": "Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Chronic Low Back Pain", "Hip Ostearthritis", "Myofascial Pain Syndrome", "Fibromyalgia", "Depression", "Maladaptive Coping", "Lumbar Spinal Stenosis", "Insomnia", "Sacroiliac Joint Pain", "Lateral Hip and Thigh Pain", "Anxiety", "Dementia", "Recent Leg Length Discrepancy"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03855735", "official_title": "\"Sufficiency, Accuracy, Clarity, Contextualization, and Interpersonal Adaptation - Safe, Digitally Supported Communication in Gynecology and Obstetrics: TeamBaby\"", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Pregnancy Related"], "locations": [{"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04601038", "official_title": "Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease", "Memory Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06169826", "official_title": "Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease", "overall_status": "WITHDRAWN", "phase": "PHASE4", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00100035", "official_title": "Polarity Therapy for Dementia Caregivers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Stress", "Depression", "Anxiety"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04845789", "official_title": "Case Manager Approach in Dementia Care From a Caregiver Perspective: A Grounded Theory Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04132193", "official_title": "Correlation of Musicality and Cognitive Skills in Persons With Alzheimer´s Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Dementia", "Amusia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04060355", "official_title": "Developing a Distance Education System to Train Savvy Caregiver Program Interventionists: Extending Access and Capacity in Community-Based Delivery of Evidence-Based Interventions", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burnout", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02072252", "official_title": "Mobile Phone and Internet-Based Intervention for Vulnerable Youth", "overall_status": "WITHDRAWN", "phase": "PHASE1, PHASE2", "conditions": ["Depressive Symptoms", "Anxiety Generalized"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03022149", "official_title": "Remote Ischemic Preconditioning for Subcortical Vascular Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Subcortical Vascular Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05406778", "official_title": "SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and Alzheimer's Disease Status- The REMIND Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02494778", "official_title": "A Multi-Center, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Pridopidine in Patients With Huntington's Disease (Open PRIDE-HD)", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00980785", "official_title": "Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease", "Hypertension"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04396015", "official_title": "Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Function 1, Social"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05925621", "official_title": "Cognitive Neurology Unit's Anti-amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease Clinical Registry", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03876314", "official_title": "The Effect of Physical Activity on Cognition Relative to APOE Genotype (PAAD-2)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Healthy", "Dementia", "Alzheimer Disease", "Physical Activity"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03373604", "official_title": "Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01350349", "official_title": "Home-delivered Intervention for Depressed, Cognitively Impaired Elders", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depression", "Dementia", "Geriatrics"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03887455", "official_title": "A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE3", "conditions": ["Early Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Russia"}, {"country": "Singapore"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05535478", "official_title": "Deprescribing of Diabetes Treatment Regimens in Long Term Care (LTC) Residents With Alzheimer's Disease or Related Dementias (ADRD)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Diabetes", "Dementia", "Hypoglycemia; Drug"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01942343", "official_title": "Etude de l'Effet du dropéridol et de l'Ondansetron Sur l'Incidence de l'Akathisie Post opératoire en Chirurgie Ambulatoire", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Akathisia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04533815", "official_title": "Enhancing Sleep Quality for Nursing Home Residents With Dementia: Pragmatic Trial of an Evidence-Based Frontline Huddling Program", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Sleep Disorder", "Sleep Disturbance"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01385033", "official_title": "A Clinical Trial to Characterize the Performance of [18F]MK-3328 in Subjects With Alzheimer's Disease or Mild Cognitive Impairment, and Healthy Young, and Healthy Elderly Subjects", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT02417558", "official_title": "Study to Evaluate the Effectiveness of Personalized Brain Network Activation Technology in a Cognitive/Physical Computer-Game Blended Training of Elderly (Alterniity AR)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment, So Stated", "Mild Dementia", "Healthy"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06400108", "official_title": "Dementia Moves: Protocol for a Pilot Feasibility Study Testing a Physical Rehabilitation Program for Long-Term Care Residents With Moderate to Severe Dementia", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Moderate to Severe Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06535308", "official_title": "A Dose-block Randomized, Double-blind, Placebo-controlled, Single and Multiple Dosing, Dose-escalation, Phase 1 Clinical Trial to Evaluate the Safety/Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics, Food Effect, Ethnic Difference of BnH-015B After Oral Administration in Healthy Adult Korean and Caucasian Male Volunteers and in Patients With Moderate Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT06241287", "official_title": "Better Living With Non-memory-led Dementia: a Randomised Controlled Trial of a Web-based Caregiver Educational Programme", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT00235716", "official_title": "CSP #546 - A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (TEAM-AD)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Puerto Rico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT05098652", "official_title": "Coaching Dementia Caregivers to Master Care-Resistant Behavior and Improve Coping Strategies", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Care-resistant Behavior", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03289143", "official_title": "A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of MTAU9937A in Patients With Prodromal to Mild Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT01660815", "official_title": "PET Whole Body Biodistribution Using Florbetapir (18F)", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03080051", "official_title": "Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Progressive Supranuclear Palsy", "Alzheimer Disease", "Healthy Volunteers"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT03297177", "official_title": "Use Of Autologous Stem Cell Use In Neurological Non-neoplastic Disorders And Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Parkinson", "Altered Behavior in Alzheimer Disease", "Demyelinating Autoimmune Diseases, CNS", "Demyelinating Sensorimotor Neuropathy", "Corticobasal Degeneration"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04718207", "official_title": "Interest of PFS Modelling in the Quantitative Analysis of Brain PET Scans in Patients With Alzheimer's Disease Acquired on a Numerical System", "overall_status": "COMPLETED", "phase": null, "conditions": ["Patients With Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:46+00:00"}
{"nct_id": "NCT04669028", "official_title": "A Phase 3, Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter Study of NE3107 in Subjects Who Have Mild to Moderate Probable Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06152211", "official_title": "Using Music-Based Interventions to Improve the Quality of Life and Wellbeing of Older Adults With or at Risk of Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Speech Perception", "Anxiety", "Social Behavior"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03673722", "official_title": "A Randomised Controlled Trial Investigating the Feasibility of a Multi-domain Intervention to Increase Mediterranean Diet (MedDiet) Score and Physical Activity (PA) of Older UK Adults Who Are at Above Average Risk of Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05808153", "official_title": "Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Huntington Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01860339", "official_title": "Growth and Development of Striatal-Cerebellum Circuitry in Subjects At Risk for Huntington's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05787028", "official_title": "Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01303367", "official_title": "Medication Management and Care of Demented Patients With Behavioral and Psychological Symptoms of Dementia in Taiwan: A Retrospective Pilot Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04374136", "official_title": "A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of AL001 in Individuals at Risk for or With Frontotemporal Dementia Due to Heterozygous Mutations in the Progranulin Gene", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE3", "conditions": ["Frontotemporal Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Switzerland"}, {"country": "Turkey (Türkiye)"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06792877", "official_title": "Mechanisms of Mindfulness for Cognition in Early-Stage Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)", "Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease", "TBI (Traumatic Brain Injury)", "Aging", "Healthy Elderly", "Alzheimer&Amp;Amp;#39;s Dementia (AD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01692977", "official_title": "Orienting Oneself in a Healing Garden: What Elements of the Design Are Used as Landmarks by Patients With Alzheimer's Disease ?", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05405075", "official_title": "Arizona Alzheimer's Disease Research Center (ADRC)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00304629", "official_title": "Long Term Safety and Efficacy of Galantamine in Alzheimer's Disease (Extension INT-8)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05323812", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Croatia"}, {"country": "Croatia"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01485965", "official_title": "A Phase 1b, Open-label, Parallel-group Study in Subjects With Huntington Disease to Assess the Safety, Tolerability, and Fed/Fasted Pharmacokinetics of Repeated Oral Doses of SEN0014196", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02038192", "official_title": "Living With Hope: Pilot Study of the Living With Hope Program for Family Caregivers of Persons With Dementia Residing in Long Term Care Facilities", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01424436", "official_title": "Modulation of Beta-amyloid Levels in CSF and Plasma by GSK933776 in Patients With Mild Alzheimer's Disease or Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01447719", "official_title": "Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01513967", "official_title": "A Randomized Single and Multiple Dose Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Healthy Volunteers", "Moderate to Severe Alzheimer Patients"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05558709", "official_title": "Social-cognitive Functioning: Validation of a New Neuropsychological Test and Prediction of Social Behavioural Disorders in Daily Life", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease (AD)", "Lewy Body Dementia (LBD)", "Frontotemporal Degeneration (FTD)"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02426398", "official_title": "Developing a New EEG Method for the Early Diagnosis of Dementia. Using Novel EEG Analyses to Create a Diagnostic Test and Biomarker for Use With People With Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03305809", "official_title": "Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Lewy Body Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00159198", "official_title": "Genetic Linkage in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia", "overall_status": "TERMINATED", "phase": null, "conditions": ["Frontotemporal Dementia", "Amyotrophic Lateral Sclerosis"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04394767", "official_title": "Couple and Spouse Caregiver in Huntington's Disease", "overall_status": "TERMINATED", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01792167", "official_title": "Multi-site Evaluation of Second Step: Student Success Through Prevention (Second Step - SSTP) in Preventing Bullying and Sexual Violence", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04413344", "official_title": "Double-Blind Comparative Trial and Open-Label Extension Trial to Investigate the Safety and Efficacy of TW-012R in Alzheimer's Disease With Presenilin 1 (PSEN1) Mutations", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Familial Alzheimer Disease (FAD)", "PSEN1 Mutation"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02159014", "official_title": "DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention to Reduce the Risk of Heart Disease, Stroke, Diabetes, and Dementia in Inactive Adults, in Primary Care Settings - A Feasibility Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cardiac Diseases", "Stroke", "Diabetes Mellitus", "Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01278407", "official_title": "A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia With Lewy Bodies (DLB)"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05943834", "official_title": "Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis", "overall_status": "RECRUITING", "phase": null, "conditions": ["Neurocognitive Disorders"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04885114", "official_title": "A Phase 1B, Open-label, Randomized, Controlled, Multicenter, Dose Escalation Study of the Safety, Tolerability, and Biological Effects of VY-HTT01 Administered Via Intraparenchymal Infusion of the Putamen and Thalamus in Adults With Huntington's Disease", "overall_status": "WITHDRAWN", "phase": "PHASE1", "conditions": ["Huntington Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03424200", "official_title": "Coaching for Cognition in Alzheimer's (COCOA)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01745198", "official_title": "Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Related Disorders", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer's Disease", "Alzheimer's Disease Related Disorders"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02640716", "official_title": "The Cog-VACCINE Study: a Randomized Controlled Clinical Trial to Evaluate the Effect of Cognitive Training in Patients With Vascular Cognitive Impairment, no Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Vascular Cognitive Impairment no Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04012398", "official_title": "Cross-cultural Validation of the German Version of the Amsterdam Instrumental Activities of Daily Living Questionnaire® in Elderly People With and Without Mild Neurocognitive Disorder", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Mild Dementia"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02769065", "official_title": "A Phase 1 Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Oral Doses of TAK-071 in Healthy Subjects and Subjects With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability and Food Effect of TAK-071 in Healthy Subjects", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Healthy Volunteers"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05430867", "official_title": "Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Treatment", "Efficacy", "Safety", "Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06618807", "official_title": "A Pilot Study Evaluating the Feasibility, Safety, and Efficacy of the Neuro RX Gamma (Version 2) for the Treatment of Mild Cognitive Impairment (MCI)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04139707", "official_title": "An Information and Computer Technology-based Mobile Application for Training of Family Members Caring for Someone With Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06834893", "official_title": "A Cluster Randomised Controlled Trial (cRCT) Evaluating the Effects of Cool Roofs on Health, Environmental and Economic Outcomes in Hermosillo, Mexico", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Resting Heart Rate", "Blood Glucose Control", "Depression", "Heat-related Symptoms", "Physician Diagnosed Heat-related Illnesses", "Food Insecurity", "Diet Quality", "Health-related Quality of Life", "Indoor Thermal Comfort", "Coping Ability", "Life Satisfaction", "Healthcare Provider Utilization", "Hospitalization", "Systolic Blood Pressure", "Diastolic Blood Pressure", "Inner Ear Canal Temperature", "Dehydration", "Sleep Quality", "Cognition", "Productivity", "Aggression", "Indoor Air Temperature", "Indoor Relative Humidity", "Indoor Heat Index", "Household Energy Expenditure"], "locations": [{"country": "Mexico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06746909", "official_title": "Identification of Neuroinflammation and Neuroimaging Biomarkers Through Data Driven Artificial Intelligence Techniques for Unraveling the Heterogeneity of Aged Subjects at Risk of Dementia and to Better Inform Prevention Strategies", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["MCI", "SCD", "Healthy"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00698165", "official_title": "Observational Study on Costs and Caregiver Burden in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05021211", "official_title": "Whole Egg Intake and Choline Concentration in the Aging Brain", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02928211", "official_title": "An Evaluation of Aftobetin-HCl and Fluorescence Detection as Measured by Sapphire II to Determine the Number and Timing of Administrations in Subjects With Normal Cognition, Mild Cognitive Impairment, and Mild Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Mild Cognitive Impairment", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00289471", "official_title": "Dementia in Primary Care: Setting the Stage for Quality Improvement", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Memory Disorders"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02092987", "official_title": "Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depressive Symptoms", "Burden"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00663936", "official_title": "A Phase 2a Multi-center, Randomized, Double Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of T-817MAa in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT07041034", "official_title": "The Effectiveness of the Systematic Unmet Needs Assessment and Management (SUNAM) Protocol on Behavioral and Psychological Symptoms of Institutionalized Residents With Dementia", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Behavioral and Psychological Symptoms of Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05276830", "official_title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of BXCL501 For The Treatment of Agitation Associated With Dementia", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Agitation", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06717971", "official_title": "Evaluating the Clinical Effectiveness of an Exergame-Based Training Program Using \"WarioWare: Move It!\" to Enhance Physical and Cognitive Function in Older Adults With Mild Cognitive Impairment and Dementia in Rural Long-Term Care Facilities: A Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer&#39;s Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05741853", "official_title": "Cognitive Reserve and Linguistic Resilience in Bilingual Hispanics With Primary Progressive Aphasia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "Dementia", "Dementia, Frontotemporal", "Alzheimer Disease", "Neurodegenerative Diseases", "Frontotemporal Lobar Degeneration", "Apraxia, Motor", "Dysarthria", "Communication Disorders", "Language Disorders", "Speech Disorders", "Neurocognitive Disorders", "Aphasia", "Bilingual Aphasia"], "locations": [{"country": "United States"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02640339", "official_title": "Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Parkinson Disease", "Multiple System Atrophy", "REM Sleep Behavior Disorder", "Pure Autonomic Failure", "Dementia With Lewy Bodies"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02833792", "official_title": "A Phase IIa Study of Allogeneic Human Mesenchymal Stem Cells in Subjects With Mild to Moderate Dementia Due to Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02248636", "official_title": "Cholinesterase Inhibitor Discontinuation", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02703636", "official_title": "A 24-week, Open-label, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patch With 1-step Titration in Patients With Mild to Moderate Alzheimer's Disease (MMSE 10 - 23) Switched Directly From Holinesterase Inhibitors (Donepezil, Galantamine)", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Mild to Moderate Alzheimer's Disease"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02463734", "official_title": "Development of the Dementia Quality of Life Scale for Older Family Carers of People With Dementia (DQoL-OC) and Evaluation of Its Psychometric Properties", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Quality of Life"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00812565", "official_title": "Prospective 24-week, Double-blind, Randomised, Placebo-controlled, Multicenter Study Evaluating Safety and Change in Efficacy-related Surrogate Parameters in Patients With Dementia of the Alzheimer's Type Under Treatment With Increasing Dosages of Intravenous Immunoglobulin (Octagam 10%)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05343611", "official_title": "Combining Vitamin E-functionalized CHOcolate With Physical Exercise to Reduce the risK Of Protein Energy Malnutrition in Pre-dementia AGEd People", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Dementia, Mild", "Dementia Moderate", "Dementia Senile", "Malnutrition", "Deficiency Nutritional", "Deficiency Diseases"], "locations": [{"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00303277", "official_title": "Do HMG CoA Reductase Inhibitors Affect Abeta Levels?", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease", "Aging"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00348192", "official_title": "A Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Investigate the Effects of SB-742457, Donepezil and Placebo on Cognition in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Estonia"}, {"country": "Estonia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03724344", "official_title": "Correlation Analysis Between Mental Behavioral Symptoms in Dementia Patients and Mood Disorders of Caregivers", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05669495", "official_title": "Remote Sleep Assessment in Adults at Risk for Dementia Using the ANNE Vital Sign System", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Dementia", "Mild Cognitive Impairment", "Sleep Apnea"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01845636", "official_title": "Olfactory Deficits in Mild Cognitive Impairment as a Predictor of Improved Cognition on Donepezil", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06933095", "official_title": "Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Eldery People", "Cognitive Decline", "Memory Decline", "DHA CNS Delivery"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01843075", "official_title": "Evaluating the Effects of the Novel GLP-1 Analogue, Liraglutide, in Patients With Mild Alzheimer's Disease (ELAD Study)", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01859767", "official_title": "An Exploratory, Open-label, Non-randomized Phase 1 Study to Evaluate the Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in Patients With Alzheimer's Disease Compared to Healthy Volunteers.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01384344", "official_title": "Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Interest on Video Recognition and Actigraphy", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04559828", "official_title": "Attenuation of Inflammatory Processes Associated With Alzheimer's Disease After Consumption of Pomace Olive Oil.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01315717", "official_title": "Maladie d'Alzheimer et Troubles Locomoteurs : Caracterisation Des Anomalies Temporelles de la Marche et Etude Des Correlats Anatomo-cognitifs", "overall_status": "COMPLETED", "phase": null, "conditions": ["Gait Apraxia", "Alzheimer Disease", "Impaired Cognition", "Cerebral Atrophy"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00779324", "official_title": "A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Brain Injury", "Aggression"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01590888", "official_title": "A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03955380", "official_title": "Single-center, Randomized, Prospective, Double-blind, Placebo Controlled Phase Ib Study With an Adaptive Multiple Ascending Dose (MAD) Design to Investigate the Safety, Tolerability, Pharmacokinetics of Contraloid Acetate (Healthy Subjects)", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Dementia", "Alzheimer Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03706261", "official_title": "Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00605059", "official_title": "Evaluation of [123I] AV94 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05313386", "official_title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled, Ascending Starting Dose Finding, Safety, and Efficacy Study of BXCL501 in Agitation Associated With Delirium in ICU Patients.", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Agitation", "Delirium"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05561205", "official_title": "Repetitive Transcranial Magnetic Stimulation for Apathy Clinical Trial (REACT)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Apathy in Dementia", "Dementia", "Mild Behavioural Impairment", "Mild Cognitive Impairment", "Neurocognitive Disorders"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06817122", "official_title": "Mechanistic Study of the \"Let's Talk Tech\" Dyadic Behavioral Intervention to Support Decision Making About Technology Use", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia, Mild", "Mild Cognitive Impairment (MCI)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT00087724", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of FK962 in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02199262", "official_title": "Quality Improving Program on Agitation in the Surgical Intensive Care Unit", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Agitation"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05691842", "official_title": "Efficacy of a High-Intensity Interval Exercise Program Versus a Dual-Task Training Program in People With Alzheimer's: A Randomized Clinical Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06059313", "official_title": "Relationship Between Premorbid Personality Traits and Cognitive and Behavioral Disorders", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Behavioral Variant of Frontotemporal Disorder (bvFTD)", "Phenocopy Frontotemporal Dementia (phFTD)", "Frontal Variant of Alzheimer Disease", "Bipolar Disorder"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02008513", "official_title": "A Randomized, Controlled, Parallel Group, Double-blind, Multi-centre, Phase IIb Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in the AFFITOPE® AD02 Phase II Study AFF006.", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer´s Disease"], "locations": [{"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Slovakia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04821960", "official_title": "Improving Emotional Well-being and Quality of Life in Older Adults Experiencing Dementia-related Fear.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Anxiety and Fear"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02588729", "official_title": "A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With Gestational Diabetes Mellitus - RCT", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Gestational Diabetes Mellitus"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03998423", "official_title": "Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04495686", "official_title": "An Innovative Supportive Care Model for Dementia and Traumatic Brain Injury", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia, Mixed", "Dementia Mild", "Dementia Moderate", "Traumatic Brain Injury", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04457973", "official_title": "Home-based Transcranial Direct Current Stimulation (tDCS) for Pain Management in Persons With Alzheimer's Disease and Related Dementias", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease and Related Dementias"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02180269", "official_title": "A Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Japanese Male Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02795780", "official_title": "An Open Label, Multicenter Study Evaluating the Imaging Characteristics of a Follow up 18F-AV-1451 Scan in Subjects That Participated in the Confirmatory Cohort of 18F-AV-1451-A05", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03748303", "official_title": "Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: IV to IM Bridging Study", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Alzheimer Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06622135", "official_title": "Development of a Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease Using Tasso Lancet Device", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease", "Healthy Subjects"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05169008", "official_title": "A Multicenter, Randomized, and Open-label Clinical Trial to Evaluate the Safety and Immunogenicity of Intramuscular and Inhaled COVID-19 Vaccine in Children Aged 6-12 Years and Adolescents Aged 13-17 Years Who Have Been Immunized With Two Doses of CoronaVac", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["COVID-19"], "locations": [{"country": "Chile"}, {"country": "Chile"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT07161089", "official_title": "Correlation Between Knowledge, Attitudes and Practices of Caregivers and Oral Health Status of Alzheimer's Disease Patients in Cairo: A Cross-Sectional Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Practices of Caregivers", "Knowledge of Caregivers", "Attitudes of Caregivers", "Oral Health Status of Alzheimer Patients"], "locations": [{"country": "Egypt"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT04920318", "official_title": "Enhancing Language Function in Primary Progressive Aphasia (PPA) With Transcranial Direct Current Stimulation (tDCS)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Primary Progressive Aphasia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05703490", "official_title": "An Innovative Platform for Objective Monitoring of Instrumental Activities of Daily Living", "overall_status": "TERMINATED", "phase": null, "conditions": ["Dementia", "Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT06546488", "official_title": "Cognitive Assessment Tools for Individuals With Huntington's Disease.", "overall_status": "RECRUITING", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02118688", "official_title": "Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium: A Four-arm Prospective, Randomized, Double-blind, Placebo-controlled Pilot Study", "overall_status": "WITHDRAWN", "phase": "PHASE4", "conditions": ["Delirium", "Agitation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01481961", "official_title": "Feasibility Study: Cognitive Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)on add-on in Patients With Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease", "Cognition Disorders"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT01713491", "official_title": "Influence of the Pre-existing Cognitive Status on the Outcome in Patients Treated by Thrombolytic Therapy for Acute Cerebral Ischaemia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Brain Ischemia", "Adverse Effect of Thrombolytic Drugs", "Impaired Cognition", "Dementia"], "locations": [{"country": "France"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05159596", "official_title": "Commercializing In-Home Supportive Technology for Dementia Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT05696483", "official_title": "Phase 1 Randomized, Double-Blind, Single Ascending Dose, Multiple Ascending Dose, and Food Effect Study of the Safety, Tolerability, and Pharmacokinetics of OLX-07010 in Healthy Adult and Elderly Participants", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT03538405", "official_title": "Short-term Effect of Positioning Cushions and Harmonic Techniques on Paratonia in Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Paratonia"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:47+00:00"}
{"nct_id": "NCT02880956", "official_title": "A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "New Zealand"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00000172", "official_title": "Placebo Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy Under a Slow-Titration Regimen", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02921477", "official_title": "Open Label Study for the Use of Tyrosine Kinase Inhibitors for Treatment of Cognitive Decline Due to Degenerative Dementias", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE1", "conditions": ["Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05407857", "official_title": "Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention (TaiPEI)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05644977", "official_title": "A Phase 1, Randomized, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Emraclidine Following Multiple Oral Doses in Healthy Elderly Participants (Part A) and to Evaluate the Safety and Tolerability of Emraclidine in Participants With Dementia Due to Alzheimer's Disease (Part B)", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Participants", "Alzheimer's Disease Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01458470", "official_title": "A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease; a Phase IIb Study", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01741194", "official_title": "A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02882802", "official_title": "Mindfulness Treatment for Anger in Veterans With PTSD", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Anger", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05102045", "official_title": "The Effects of Repetitive Transcranial Magnetic Stimulation and Aerobic Exercise on Cognition, Balance and Functional Brain Networks in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04514367", "official_title": "A Phase 2a Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02907294", "official_title": "Randomized, Double Blind, Placebo Controlled, Parallel Groups Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 (160 mg and 320 mg) \"After Multiple Oral Doses\" in Healthy Volunteers", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Huntington Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05528302", "official_title": "Technology Assisted and Remotely Delivered Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment: Randomised Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Cognitive Impairment", "Anxiety"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04509271", "official_title": "Shanghai Mental Health Center", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01314131", "official_title": "Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing Home", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02638519", "official_title": "Hyperpolarized Xenon-129 Functional Magnetic Resonance Imaging of Healthy Volunteers and Participants With Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "EARLY_PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06878430", "official_title": "Reducing Risk of Stroke and DementIa In patientS With COVert cERebrovascular Disease: a Pilot and Development Study", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Covert Cerebrovascular Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03015428", "official_title": "\"Living Together With Dementia\"_Creation and Validation of a Training Program for Family Caregivers of People With Dementia to Live at Home", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00488007", "official_title": "Clinical Trial on Cognitive, Behavioural, Quality of Life and Medico-economic Benefits of Hearing Aids in Alzheimer Disease Patients Suffering From Presbycusis", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Presbycusis"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03016741", "official_title": "Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE4", "conditions": ["Castration-Resistant Prostatic Cancer", "Metastatic Prostate Carcinoma", "Recurrent Prostate Carcinoma", "Stage IV Prostate Cancer", "Hormone-Refractory Prostate Cancer"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05927805", "official_title": "Effects of E-bibliotherapy on the Psychological Well-being of Informal Caregivers of People With Dementia: A Randomized Controlled Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Caregiver Stress Syndrome", "Psychological Well-Being"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02142777", "official_title": "S-Equol in Alzheimer's Disease (SEAD) Trial", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04018157", "official_title": "Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Agitation, Emergence"], "locations": [{"country": "Egypt"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00034567", "official_title": "Alzheimer's Disease Prevention Instrument Protocol", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02020356", "official_title": "Impact of Music Therapy on Prescription of Neuroleptics in Alzheimer's Disease ou Related Symptoms Associated With Disruptive Behaviours.", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer's Type Dementia"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03900156", "official_title": "A Goal-setting With Mentoring Lifestyle Modification Intervention to Reduce Risk of Dementia in Later Life", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Risk Reduction Behavior", "Reduce Risk of Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01482351", "official_title": "Mild Cognitive Impairment and Obstructive Sleep Apnea", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Obstructive Sleep Apnea", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00038545", "official_title": "A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Patients With Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Non-Hodgkin's Lymphoma"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06664229", "official_title": "Development of the Flexible and Printed Electronic Device for Dementia and Fall Prevention of Older Adults", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia, Mild", "Accidental Falls", "Mild Cognitive Impairment"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03657745", "official_title": "An Observational Trial of Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Dementia", "Cognition Disorders in Old Age", "Cognitive Decline", "Cognitive Deterioration"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04026919", "official_title": "OK en Casa - ZAINDOO an Online Support Program for Caregivers of People With Dementia, a Randomized Controlled Trial.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Effect Increased"], "locations": [{"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02671630", "official_title": "Computerized Cognitive Training Program for Older Persons With Mild Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00065767", "official_title": "Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00599469", "official_title": "Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04639622", "official_title": "GENetic Fronto Temporal Dementia Initiative in Lille", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Frontotemporal Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03931148", "official_title": "Feasibility Study of the Interest of Functional Neuroimaging in Assessing Decision-making Capacity of Older People With Neurocognitive Disorders", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Decision Making", "Dementia", "Aging"], "locations": [{"country": "Canada"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01777789", "official_title": "The Role of Mid-Life Adiposity in Functional Brain Connectivity", "overall_status": "TERMINATED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04311515", "official_title": "A Phase 2A Study to Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild Alzheimer's Disease (AD) Dementia", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04798989", "official_title": "A Phase 2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CY6463 When Administered to Participants With Alzheimer's Disease and Vascular Pathology", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease With Vascular Pathology"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01195389", "official_title": "A Randomized, Single-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Efficacy of the Application of Magnetic Fields Using the Resonator for the Treatment of Alzheimer's Disease in Addition to Standard of Care", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06051123", "official_title": "Effects of Probiotics on Lipidomic Profile and Disease Evolution in ALS-FTDSD Patients: A Randomized Multicenter, Double-blind, Phase II, Placebo-controlled, Parallel Trial.", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["ALSFTD"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04118985", "official_title": "Compensatory Training to Support Everyday Function and Adherence to Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Symptom", "Pre Senile Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02646982", "official_title": "Candesartan's Effects on Alzheimer's Disease And Related Biomarkers", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00329082", "official_title": "LY2062430: Multiple-Dose Safety in Subjects With Mild-to-Moderate Alzheimer's Disease and Single-Dose Safety in Healthy Volunteers", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04021888", "official_title": "The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Aerobic Exercise", "Breathing Exercise", "Resistance Training"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03643003", "official_title": "Music Therapy for Persons With Dementia: A Randomized Clinical Crossover Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Quality of Life", "Social Interaction", "Emotions", "Mood", "Feelings", "Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01466543", "official_title": "Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity in Normal and Subcortical Vascular Cognitive Impairment Subjects", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Vascular Dementia", "Subcortical Vascular Dementia"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06346223", "official_title": "Effect of a Single-Session Mindfulness-Based Intervention for Reducing Stress in Family Caregivers of People With Dementia: A Randomized Controlled Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Caregiving Stress"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00988624", "official_title": "A Phase 1, Randomized, Open-Label, Single Dose Cross-Over Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease", "Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02899403", "official_title": "Neurophysiological Correlates of Cognitive Tasks in Healthy Volunteers -A Pilot Study WP3 P003", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "ELECTROENCEPHALOGRAPHIC VARIANT PATTERN 1 (Disorder)"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00920946", "official_title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Dimebon in Patients With Mile-to-Moderate Huntington Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Sweden"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02140983", "official_title": "Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Insulin Resistance", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03991988", "official_title": "Effects of Montelukast Therapy on Alzheimer's Disease (EMERALD)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00777361", "official_title": "An Open, Two Period, Single Dose, Phase I Study of the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics Following Oral Administration of [14C]-AZD3480 and the Pharmacokinetics of AZD3480 Following Intravenous Administration to Healthy Male Volunteers With Different CYP2D6 Genotype", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02986386", "official_title": "Oral Health for Healthy Cognitive Aging", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Malocclusion", "Dementia"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04847986", "official_title": "A Guided Eight-week Online Acceptance and Commitment Therapy (ACT) Intervention for Distressed Family Caregivers of People With Dementia: A Mixed-methods Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Psychological Distress"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02033941", "official_title": "Phase II Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06444841", "official_title": "Smartphone-Based Solutions for Prospective Memory in Mild Cognitive Impairment and Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia, Mild", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02286505", "official_title": "Automated Brain Morphometry for Dementia Diagnosis", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05655403", "official_title": "Investigating the Effects of Step Training and the Mediating Effects of Prefrontal Cortex Functioning in Older Adults with Mild Dementia: a Randomized Wait-list Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05749146", "official_title": "Palliative Care At Home for Patients with Dementia and Their Caregivers", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00799786", "official_title": "Building Better Caregivers Online", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia", "Brain Injuries", "Stress Disorders, Traumatic"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05640141", "official_title": "Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects - Prediction of Cognitive Decline and Identification of Underlying Mechanisms", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Motoric Cognitive Risk Syndrome", "Mild Cognitive Impairment", "Alzheimer Disease", "Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05218018", "official_title": "Triglyceride Effects on Blood Flow in the Human Brain", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00021723", "official_title": "Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT07075770", "official_title": "Novel Personalized Non Invasive Combined Magnetic and Electrical Stimulation of the Default Mode Network in Mild AD Patients (CMES-AD)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}, {"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00420420", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of MK0249 for the Symptomatic Treatment of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05227820", "official_title": "Anti-Inflammatory, Insulin-Sensitizing Agent for Treatment of Cognitive Decline Due to Degenerative Dementias", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06669182", "official_title": "Effects of Cerebellar Transcranial Magnetic Stimulation on Patients with Alzheimer's Disease：A Multicenter Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Transcranial Magnetic Stimulation", "Cerebellum"], "locations": [{"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04174287", "official_title": "Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06846658", "official_title": "Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Parkinson Disease", "MSA - Multiple System Atrophy", "Lewy Body Dementia (LBD)", "Neurodegenerative Disease", "Healthy Subjects (HS)"], "locations": [{"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04760015", "official_title": "Characteristics of Patients With Disruptive Vocalizations Residing in Nursing Homes Supported by the Mobile Gerontopsychiatry Team : Retrospective Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01819714", "official_title": "Evaluation of the Impact of Care Based on Sensory Support for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04137926", "official_title": "Shanghai Mental Health Center", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01094340", "official_title": "\"Twenty-Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fixed Dose Regimens of Thalidomide and Placebo on CSF and Plasma Biomarkers in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01303133", "official_title": "Natural History of Amyloid Deposition in Adults With Down Syndrome", "overall_status": "COMPLETED", "phase": null, "conditions": ["Down Syndrome"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04548089", "official_title": "Mindful-Compassion Art Therapy for Dementia Care (MCAT-DC) - Empowering Resilience and Holistic Wellbeing for Sustaining Family Caregiving: A Waitlist Randomized Controlled Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Caregiver Burnout", "Caregiver Stress"], "locations": [{"country": "Singapore"}, {"country": "Singapore"}, {"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00673140", "official_title": "Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Amyotrophic Lateral Sclerosis"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04418232", "official_title": "Feasibility of a Novel Systems Approach for Improving Utilization of Alzheimer's Disease Services Among Latinos Attending Primary Care Practices", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01774448", "official_title": "The Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) to Improve Depression Symptoms and Quality of Life in Individuals With Dementia and Their Caregivers: A Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06182085", "official_title": "Randomised, Double-blind, Placebo-controlled Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (PRImus-AD)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment Due to Alzheimer's Disease", "Alzheimer's Disease, Early Onset"], "locations": [{"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05651308", "official_title": "Improving How People Living With Dementia Are Selected for Care Coordination: A Pragmatic Clinical Trial Embedded in an Accountable Care Organization", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06752616", "official_title": "Advancing the Quality of Treatment and Care for Acute Agitation in Emergency Psychiatry", "overall_status": "RECRUITING", "phase": "PHASE2, PHASE3", "conditions": ["Agitation"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06586606", "official_title": "A Two-Period Study to Evaluate the Effects of Multiple Oral Doses of Itraconazole on the Single Dose PK of MK-1708 in Healthy Participants", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03434548", "official_title": "Longitudinal Adaptive Study of Molecular Pathology and Neuronal Networks in Huntington's Disease Gene-Expansion Carriers (HDGEC) and Healthy Controls Using Positron Emission Tomography (PET) and Multi-modal Magnetic Resonance Imaging (MRI)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06406348", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Single Ascending Dose Trial to Assess the Safety, Tolerability and Pharmacokinetic Effects of ALIA-1758 in Healthy Participants", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05538455", "official_title": "ProCare4Life Pilot 3 Clinical Study: Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Neurodegenerative Diseases", "Parkinson Disease", "Alzheimer Disease", "Quality of Life"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03543878", "official_title": "Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01703117", "official_title": "Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02994719", "official_title": "Gait Pattern Analysis in Neurological Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Parkinson's Disease", "Parkinsonian Disorders", "Atypical Parkinson Disease", "Progressive Supranuclear Palsy", "Multiple System Atrophy", "Corticobasal Degeneration", "Gait, Frontal", "Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06870838", "official_title": "Neuroinflammation in Frontotemporal Lobar Degeneration - a Multimodal Biomarker Study", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Corticobasal Syndrome(CBS)", "Primary Progressive Aphasia(PPA)", "Progressive Supranuclear Palsy(PSP)", "Behavioral Variant Frontotemporal Dementia (bvFTD)", "Frontotemporal Lobar Degeneration (FTLD)"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05919355", "official_title": "BoVEL: Bo Lenger Hjemme Med Sosial Velferdsteknologi [Live Longer at Home With Social Welfare-Technology]", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Social Isolation", "Well-being", "Quality of Life", "Mental Health", "Dementia", "Older Adults", "Loneliness", "Safety", "Feeling Anxious", "Technology", "Home Care"], "locations": [{"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT07127133", "official_title": "A Gait and Path Tortuosity System for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04686838", "official_title": "READyR-II: Dynamic Tailoring Phase for a Remote Assessment and Dynamic Response Intervention to Support Couples in Planning for Changing Dementia Care Needs", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Relationship, Marital", "Caregiver Stress Syndrome"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04903938", "official_title": "Primary And Secondary Abilities Among The Individuals With Antisocial Personality Disorder Within The Scope Of Positive Psychotherapy: Their Relationship With Criminal Behaviors, Aggression And Anger.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Antisocial Personality Disorder"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01129115", "official_title": "Dose Response Study of Exercise for Age-related Cognitive Changes", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02292238", "official_title": "Benfotiamine in Alzheimer's Disease: A Pilot Study", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05155748", "official_title": "Deprescribing Inappropriate Medication in Residents Suffering From Severe Dementia: OptimaMed Long Term Care, a Demonstration Project", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03185208", "official_title": "Evaluation of Brain and Cognitive Changes in Older Adults With MCI Taking Lithium to Prevent Alzheimer Type Dementia", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02568540", "official_title": "preSmartphone App for Monitoring and Reporting of Hepatitis C Related Health Information: C Tracker Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study", "overall_status": "TERMINATED", "phase": null, "conditions": ["Hepatitis C"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00018291", "official_title": "Specific Interventions for Agitation in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01870518", "official_title": "Neurocognitive Effects of Bilateral Subthalamic Nucleus Versus Globus Pallidus Interna Deep Brain Stimulation in Parkinson's Disease Patients With Mild Cognitive Impairment", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Parkinson's Disease", "Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01089582", "official_title": "Quality Of Life Assessment In AD Patients Receiving Aricept Tablets (Donepezil Hydrochloride)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05634317", "official_title": "Supporting Family Caregivers of People With Dementia and Identifying an Effective Adaptive Intervention to Reduce Their Depressive Symptoms: a Sequential Multiple Assignment Randomized Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04394260", "official_title": "Equality in Caregiving: Facilitating Caregiver Mastery Among LGBT Caregivers of PLWD", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Caregiver Burnout"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06810960", "official_title": "A 6-Year Postmarketing Safety and Clinical Outcome Study of Lecanemab in the Treatment of Alzheimer's Disease Using Real-World Data From South Korean Patients Enrolled Into the South Korean JOint RegistrY for ALZheimer's Treatment and Diagnostics (JOY-ALZ) Registry", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02005380", "official_title": "Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Jordan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03623542", "official_title": "Risk Factors for Adverse Drug Reactions in Older Subjects Hospitalized in a Dedicated Dementia Unit", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02073318", "official_title": "Effects of Task-oriented Balance Training in Institutionalized Older Adults With Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02243982", "official_title": "Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in Cerebrospinal Fluid and Positron Emission Tomography in the Dementia of Parkinson's Disease", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Parkinson's Disease", "Parkinson-Dementia Syndrome"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01466088", "official_title": "Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04699786", "official_title": "Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies: Quantitative Analyses of a Randomized Clinical Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia of Alzheimer Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06575218", "official_title": "The Effectiveness of Virtual Reality Training Program in Community Dwelling Older Adults With Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00260624", "official_title": "Escitalopram in the Treatment of Patients With Agitated Dementia", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease", "Psychomotor Agitation"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04739423", "official_title": "A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover, Study of the Pharmacodynamic Effects of CST-103 Co-administered With CST-107 on the Central Nervous System in Subjects With Neurodegenerative Disorders", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "New Zealand"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06862960", "official_title": "Ozanimod for the Treatment of Alzheimer's Disease: a Proof-of-concept Study", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00598650", "official_title": "A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia With Lewy Bodies (DLB)"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03149380", "official_title": "Evaluating the Effectiveness of Web-based Education Via Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior: A Randomized Trial", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Alzheimer Disease, Late Onset", "Memory Loss", "Patient Education as Topic"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06934720", "official_title": "Active Physical Activity - Virtual Reality Cognitive Therapy", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Dementia", "Neurodegenerative Disease", "Mild Cognitive Impairment (MCI)", "Virtual Reality", "Physical Activity", "Alzheimer&#39;s Disease (AD)", "Cognitive Therapy"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00239759", "official_title": "Genetic Epidemiological Studies of Apolipoprotein E and Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Germany"}, {"country": "Greece"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04141891", "official_title": "Decision Making Among Older Adults: the AUTO Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Diabetic Retinopathy", "Macular Degeneration", "Glaucoma", "Retinitis Pigmentosa", "Vision Disorders", "Acute Coronary Syndrome", "Implantable Defibrillator User", "Congestive Heart Failure", "Hypertrophic Obstructive Cardiomyopathy", "Orthostatic Hypotension", "Syncope", "Presyncope", "Narcolepsy", "Dementia", "Multiple Sclerosis", "Parkinson Disease", "Brain Injuries", "Spinal Cord Injuries", "Stroke", "Vertigo", "Dizziness", "Seizures", "Substance Use", "Insulin Dependent Diabetes Mellitus", "Arthritis", "Foot--Abnormalities", "Chronic Obstructive Pulmonary Disease", "Obstructive Sleep Apnea", "End Stage Renal Disease", "Sleep Apnea", "Insomnia", "Restless Legs Syndrome"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00838110", "official_title": "A Phase 3, Multi-Center, Randomized, Double-Blind Placebo-Controlled Study To Evaluate The Safety And Tolerability Of Dimebon (PF-01913539) For Up To 26-Weeks In Patients With Mild To Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04440020", "official_title": "Management of Dementia With Olive Oil Leaves - GOLDEN", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Prevention"], "locations": [{"country": "Greece"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02667496", "official_title": "A Study Examining the Safety and Activity of Innate Immune System Stimulation With Leukine® (Sargramostim) to Reduce Brain Amyloid Load in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Dementia Alzheimer's Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04319796", "official_title": "European Registry on Rare Neurological Diseases", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Rare Diseases"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00818662", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Two Dose Arm, Parallel Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer´s Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06978946", "official_title": "Clinical Efficacy and Safety of Deep Cervical Lymphaticovenous Anastomosis (DLVA) in Moderate-to-Severe Neurodegenerative Dementia", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Lewy Body Dementia (LBD)", "Frontotemporal Dementia (FTD)", "Dementia", "Parkinsons Disease With Dementia (PDD)"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01599689", "official_title": "Can an Evidence-based Mirrors Intervention Reduce Postoperative Delirium in Older Cardiac Surgical Patients? A Pilot and Feasibility Cluster Randomised Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Postoperative Delirium"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00621010", "official_title": "A Phase 1 Single Escalating Dose Study to Assess the Safety and Pharmacokinetics of CTS21166 Administered Intravenously to Healthy Adult Males", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06338215", "official_title": "A Non-inferiority Randomized Trial Testing an Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["All Cause Mortality", "Cardiovascular Diseases", "Invasive Cancer", "Liver Cirrhosis", "Type 2 Diabetes", "Depression", "Dementia", "Injury Traumatic", "Tuberculosis", "Infections"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06156735", "official_title": "The Effect of Music Therapy on Cognition in Neurorehabilitation - A Feasibility Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Stroke", "Traumatic Brain Injury"], "locations": [{"country": "Malaysia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03667924", "official_title": "Utilizing Senior Companions to Enhance Dementia Care Services and Supports", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00013923", "official_title": "A Nutritional Brain Metabolic Enhancer for Alzheimer Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06063161", "official_title": "Music Therapy for Hospitalized Patients With Parkinson's Disease and Lewy Body Dementia: A Randomized Controlled Pilot Trial to Prevent Delirium", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Parkinson Disease", "Dementia, Lewy Body", "Delirium"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05254873", "official_title": "Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study: Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease and Study of the Consequences on Gaze Strategy, Behavior Disorders and Family Caregivers' Burden", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Dementia (AD)", "Family Caregivers"], "locations": [{"country": "Monaco"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01554202", "official_title": "Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer's Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT07066137", "official_title": "Motor Planning, Execution, and Modulation in Healthy Individuals and Patients With Movement Disorders or Neuromuscular Diseases Using Traditional Physical Activity or Advanced Devices to Enhance Motor Learning and Sensorimotor Processing", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Healthy Individuals (Controls)", "Parkinson Disease", "Multiple Sclerosis", "Alzheimer Disease", "Dementia", "Stroke"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT07100470", "official_title": "Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["FTD", "AD", "Healthy Controls"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06211673", "official_title": "Psychiatric Phenotype Characterization of Individuals With FOXP1 Syndrome", "overall_status": "COMPLETED", "phase": null, "conditions": ["FOXP1 Syndrome"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00457366", "official_title": "A Comparison Study of the Efficacy of a Rapid Titration of Quetiapine and Haloperidol in Agitated Adults in an Emergency Setting.", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Agitation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02434666", "official_title": "Safety and Tolerability of CPC-201 in Patients With Dementia of the Alzheimer's Type Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia of the Alzheimer's Type"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04221386", "official_title": "Melodic Intonation Therapy for Tone Language Speakers", "overall_status": "SUSPENDED", "phase": "NA", "conditions": ["Dementia", "Speech Therapy"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03721705", "official_title": "A Randomized Pivotal Study of RenewTM NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease", "Cognitive Dysfunction", "Mild Cognitive Impairment", "Mild Dementia", "Cognitive Decline", "Dementia, Alzheimer Type"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Ireland"}, {"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06033066", "official_title": "A Randomized Trial of Financial Incentives for the Recruitment of County Health System Patients to the Alzheimer Prevention Trials (APT) Webstudy", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Preclinical Alzheimer's Disease", "Prodromal Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00000179", "official_title": "Agitation in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04726527", "official_title": "Clinical Evaluation of Florbetapir F 18 (18F-AV-45) / Determinants of Neurodegenerative Decline in Primary Progressive Aphasia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Primary Progressive Aphasia", "Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02013518", "official_title": "Cognitive Behavioural Therapy for Persons With Mild Cognitive Impairment or Dementia in the Early Stages", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimers' Disease"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06745583", "official_title": "An Open-label, Exploratory, Phase II, Proof-of Concept, Clinical Study to Assess the Safety and Tolerability of EI-1071 in Patients With Alzheimer's Disease (AD)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Mild, Moderate, or Severe Alzheimer's Disease"], "locations": [{"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06976294", "official_title": "The Effect of Cognitive Behavioral Approach-Based Psychoeducation on Post-Traumatic Growth, Psychological Resilience, and Ruminative Thoughts in Primary Caregivers of Individuals Diagnosed With Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease, Posttraumatic Growth"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06961760", "official_title": "A Single-arm, Open-label, Expanded Access Program to Provide 100 mg CT1812 (Zervimesine) and to Collect Long-term Safety and Efficacy Data in Participants With Mild-to-moderate Dementia With Lewy Bodies (DLB).", "overall_status": "AVAILABLE", "phase": null, "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03306888", "official_title": "Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03672474", "official_title": "Pilot Study Evaluating the Safety and Efficacy of a Photobiomodulation Prototype, REGEnLIFE RGn530 Device, on Cognitive Performances Evolution From Mild-to-moderate Alzheimer's Disease Patients", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05741060", "official_title": "Arterial Stiffness, Cognition and Equol", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Arterial Stiffness", "White Matter Lesions", "Cognitive Decline"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00820859", "official_title": "Treatment of Agitation in the Nursing Home", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Behavior Problems"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04486586", "official_title": "Effects of Transcranial Direct Current Stimulation in Primary Progressive Aphasia (PPA)", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Primary Progressive Aphasia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04180683", "official_title": "Comparison Study of the Different Abbreviated Versions of the Geriatric Depression Scale (GDS) in Elderly With Neurocognitive Disorders Attending Social Responses", "overall_status": "COMPLETED", "phase": null, "conditions": ["Depression", "Depressive Disorder", "Neurocognitive Disorders", "Dementia"], "locations": [{"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02886494", "official_title": "A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease or Vascular Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00161473", "official_title": "Alzheimer's in Long-Term Care--Treatment for Agitation", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Psychomotor Agitation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03308773", "official_title": "Physiology of Disease Prevention Observational Study in Clinical Practice", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["PreDiabetes", "Insulin Resistance", "Type2 Diabetes", "NASH - Nonalcoholic Steatohepatitis", "Diastolic Dysfunction", "Dementia", "Atrial Fibrillation", "Cancer", "Atherosclerosis", "Carotid Plaque"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05347966", "official_title": "The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia: Brain Health Support Program Intervention", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia Prevention", "Mild Cognitive Impairment", "Subjective Cognitive Impairment", "Cognitive Change"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06037629", "official_title": "Premature Enhanced Automated Capture of Comfort Knowledge (PEACOCK)", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Acute Pain", "Pain, Procedural", "Agitation", "Discomfort"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03846154", "official_title": "Reintegrating Children Living at Landfills in Burundi Into Society by Means of a Comprehensive Family Program Addressing Maltreatment and Trauma-related Mental Health Symptoms", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Posttraumatic Stress Disorder", "Aggressive Behaviour", "Parental Maltreatment", "Days Spent at the Landfill"], "locations": [{"country": "Burundi"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01823666", "official_title": "Study on Risk Factors for Prediction of Conversion to Dementia in Patients With Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease", "Dementia, Vascular"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01001637", "official_title": "Phase II Study of Curcumin Formulation (Longvida) or Placebo on Plasma Biomarkers and Mental State in Moderate to Severe Alzheimer's Disease or Normal Cognition", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "India"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00165737", "official_title": "A 24-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy, Safety and Tolerability of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia, Vascular"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05769972", "official_title": "Randomized, Single-blind Clinical Trial to Evaluate the Efficacy of Cognitive Rehabilitation Using Inmersive Virtual Reality and Computer-based Cognitive Stimulation Versus Music Therapy on Cognitive Impairment Associated With Movement Disorders", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Parkinson Disease", "Huntington Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04600726", "official_title": "Application of VR-based Working Memory Screening Test to Facilitate Early Detection of Dementia", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Older Adults With Mild Neurocognitive Disorders", "Older Adults With Non-communicable Diseases", "Healthy Age-matched Older Adults"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06519643", "official_title": "Building Your Successful Nursing Career: Evaluating the Effectiveness of a Career Planning Mobile Application for Male Nurses - a Randomized Double-blind Controlled Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Nurse's Role", "Gender", "Professional Burnout"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06401915", "official_title": "Intelligent Assistive Technologies for Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Healthy Adult"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05658913", "official_title": "Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02187627", "official_title": "Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Tau Imaging With Positron Emission Tomography in Healthy Control Subjects and Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease, Healthy Volunteer"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06832761", "official_title": "Secondary Prevention of Dementia in Memory Clinics: Implementation and (Cost-)Effectiveness of an Integrated Lifestyle Intervention", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Lifestyle Intervention", "Lifestyle Risk Reduction", "Cognitive Decline", "Dementia"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02319005", "official_title": "A Phase 3 Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALN TTRSC in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)", "Amyloidosis, Hereditary", "Amyloid Neuropathies, Familial", "Amyloid Neuropathies", "Amyloidosis, Hereditary, Transthyretin-Related", "Familial Transthyretin Cardiac Amyloidosis"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01565291", "official_title": "A Preliminary Evaluation of the Amyloid Binding Properties, Pharmacokinetics and Safety of 18F-AV-45 in Healthy Elderly Volunteers and Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02317523", "official_title": "Alzheimer's Caregiver Coping: Mental and Physical Health", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Alzheimer Dementia", "Alzheimer's Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03672279", "official_title": "Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia Alzheimers", "Mild Cognitive Impairment", "Cognition Disorders", "Neurocognitive Disorders"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT00231946", "official_title": "A Double-Blind Placebo-Controlled Study of VP4896 For the Treatment of Mild-to-Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04643327", "official_title": "Double-blind Randomised-controlled Within-subject Crossover Trial to Determine Levetiracetam Efficacy for Memory Impairment in Parkinson's Disease: A Proof-of-concept Study", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Parkinson Disease", "Mild Cognitive Impairment", "Memory Impairment"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03859245", "official_title": "Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders (Diabetic Retinopathy, Dry AMD, Hard Drusen Formation) for Alzheimer's Disease Prevention", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Diabetic Retinopathy (DR)", "Age-related Macular Degeneration (AMD)", "Mid-peripheral Drusen Formation", "Diabetic Macular Edema (DME)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04615169", "official_title": "Multi-component Cognitive Intervention for Older Adults With Mixed Cognitive Abilities", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Training", "Dementia", "Occupational Therapy", "Aging", "Long Term Care"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05072483", "official_title": "Natural History Study of CADASIL", "overall_status": "RECRUITING", "phase": null, "conditions": ["Cardiovascular Disease", "Arterial Stiffness", "Germline Mutation in the NOTCH 3 Gene", "Pathogenesis of CADASIL", "Clinical Phenotype of CADASIL"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02681822", "official_title": "Multi-center Imaging Genetics Studies in China", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Schizophrenia", "Major Depressive Disorders"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03822286", "official_title": "E-training and Mentoring Support Program on Dementia Care for Home-care Workers", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04537728", "official_title": "My Healthy Brain: Preserving and Promoting Brain Health Through Evidence-based Practices", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aging", "Mild Cognitive Impairment", "Dementia", "Old Age; Dementia", "Cognitive Decline"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06831812", "official_title": "A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of AV-1959R in Healthy Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Alzheimer Disease (AD)", "Alzheimers Disease Prevention"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03555292", "official_title": "Safety and Diagnostic Performance of 11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Parkinson Disease"], "locations": [{"country": "China"}, {"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05352399", "official_title": "Artificial Intelligence + Care Coach Intervention for Persons Living With Dementia and Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Caregiver", "Emergency Department", "Artificial Intelligence", "Care Transition"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02031198", "official_title": "An 18-months Open Label Phase I Follow-up Study on Patients With Alzheimer's Disease Who Have Completed the AADvac1 Phase I Study \"AXON CO 18700\"", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05075187", "official_title": "Epidemiological Study in FRONtoTemporal Dementia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Frontotemporal Dementia"], "locations": [{"country": "Belgium"}, {"country": "Belgium"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03622814", "official_title": "Mealtime Partnerships for People With Dementia in Respite Centers and at Home", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Alzheimer Type", "Weight Loss"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02557464", "official_title": "Identification of Early Semantic Markers of Alzheimer's Disease by Using Eye Tracking in Reading Neutral and Predictable Sentences", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT05543681", "official_title": "A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants With Dementia Due to Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Agitation,Psychomotor", "Care Giving Burden", "NPS", "Aggression"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Colombia"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06745011", "official_title": "Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Polyneuropathy", "Alpha-Synucleinopathy", "Lewy Body Disease", "Parkinson Disease (PD)", "Lewy Body Dementia (LBD)", "Multiple System Atrophy", "Autonomic Failure", "Cardiac Imaging", "Rapid Eye Movement Sleep Behavior Disorder", "REM Sleep Behavior Disorder (iRBD)", "REM Behavior Disorder"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04666077", "official_title": "A Randomized, Blinded, Controlled Trial of Music Therapy Singing Interventions for Patients With MCI and AD", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03479567", "official_title": "Fine and Gross Motor Function and Relationship With Muscle Tone in Older Adults With and Without Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Gait", "Balance", "Muscle Tone", "Fine Motor Function", "Paratonia"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT01055392", "official_title": "Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease: a Double-blind, Placebo-controlled Prevention Study in Elderly Patients With Mild Cognitive Impairment", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02388711", "official_title": "A Randomized Control Trial of the Coordinated-Transitional Care (C-TraC) Intervention for Dementia Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT04055532", "official_title": "Biomarkers in Neurodegenerative Diseases", "overall_status": "WITHDRAWN", "phase": null, "conditions": ["Mild Cognitive Impairment (MCI)", "Alzheimer Disease (AD)", "Dementia With Lewy Bodies (DLB)", "Frontotemporal Lobar Degeneration (FTLD)", "Parkinsons Disease With Dementia (PDD)", "Transient Epileptic Amnesia (TEA)", "Temporal Lobe Epilepsy (TLE)", "Spinocerebellar Ataxias (SCA)", "HIV Associated Neurocognitive Disorder (HAND)", "Amyotrophic Lateral Sclerosis (ALS)", "Primary Lateral Sclerosis (PLS)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03520998", "official_title": "A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Mild to Moderate Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT02671487", "official_title": "Mind-Body Skills Groups for Behavioral and Emotional Problems in War-Traumatized Male Adolescents in Gaza", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Problem Behavior", "Aggression", "Posttraumatic Stress Disorder"], "locations": [{"country": "Palestinian Territories"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT06099587", "official_title": "MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:48+00:00"}
{"nct_id": "NCT03320512", "official_title": "P3 (Prepared, Protected, emPowered): Promoting Pre-exposure Prophylaxis (PrEP) Adherence Through a Social Networking, Gamification, and Adherence Support App", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Sexually Transmitted Diseases", "Safe Sex", "Adherence, Medication"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06452407", "official_title": "Evaluating the Feasibility of elleFA App Implementation", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Endometriosis"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT07169630", "official_title": "PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer s Disease (AD) or Mild Cognitive Impairment (MCI)", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer s Disease", "Mild Cognitive Impairment", "Healthy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT07097675", "official_title": "The Change in Psychoemotional State of Individuals With Dementia Syndrome Applying Art Therapy", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00178165", "official_title": "Coordinating Center for Enhancing Alzheimer Disease and Related Disorder Caregiving", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01126099", "official_title": "Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03316898", "official_title": "A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety, Tolerability, Pharmacokinetics, and Brain Metabolic Response, Using FDG-PET, Following Administration of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) in Participants With Mild to Moderate Alzheimer's Disease", "overall_status": "WITHDRAWN", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01228539", "official_title": "Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["PTSD", "Anger", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03732053", "official_title": "The Effectiveness of Physical Rehabilitation in the Enhancement of Proprioceptive and Cognitive Aspects on Alzheimer Disease Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Type Dementia", "Cognitive Decline", "Postural; Strain"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05371639", "official_title": "Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in the Treatment of Mild to Moderate Vascular Dementia: a Randomized, Placebo Controlled, Double Blind, Parallel Group, Multicenter Trial", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Vascular Dementia", "Cognitive Impairment"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05080777", "official_title": "Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Tauopathies", "Neurocognitive Disorders", "Neurodegenerative Diseases", "Mental Disorders"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03954457", "official_title": "Social Ecology and the Prevention of Suicide and Aggression in African American Youth", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Suicide", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04882735", "official_title": "A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate the Efficacy and Safety of Acoramidis in Subjects with Symptomatic Transthyretin Amyloid Polyneuropathy (ATTRibute-PN Study)", "overall_status": "WITHDRAWN", "phase": "PHASE3", "conditions": ["Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04871698", "official_title": "Improved AD/ADRD Assessment Sensitivities Using a Novel In-Situ Sensor System", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Dementia", "Dementia Alzheimers"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01411163", "official_title": "Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06281314", "official_title": "VESPA 2.0 - Virtual Environment for a Superior Neuropsychiatry Second Generation", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Neurodegenerative Diseases", "Cognitive Decline", "Parkinson Disease Dementia", "Alzheimer Disease", "Multiple Sclerosis"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01189084", "official_title": "An Observational Study to the Patients With Alzheimer's Disease Who Previously Received UB311-Treatment in the V118-AD Trial", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01890343", "official_title": "A Study Evaluating the Imaging Characteristics of Florbetapir 18F (18F-AV-45) in Patients With Frontotemporal Dementia Compared to Patients With Alzheimer's Disease and Normal Controls.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Frontotemporal Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04748263", "official_title": "Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Dementia", "Parkinson Disease(PD)", "Fronto-Temporal Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02910921", "official_title": "Individualized Prediction of Migraine Attacks Using a Mobile Phone App", "overall_status": "COMPLETED", "phase": null, "conditions": ["Migraine Disorders", "Headache Disorders, Primary", "Headache Disorders", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06585384", "official_title": "Safety of a Strategy Combining Etanercept Administration with Repeated Contrast Ultrasound in Patients with Alzheimer's Disease: Phase I Study", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06923358", "official_title": "Virtual Nature as a Health-promoting Intervention for Nursing Home Residents With Dementia - a Randomized Controlled Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Nursing Home Resident", "Virtual Reality", "Quality of Life", "Mental Health"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00777426", "official_title": "HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["HIV Infections"], "locations": [{"country": "Thailand"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03552926", "official_title": "Constitution of a Clinico-radiological Database and a Biobank for Patients With Lacunar Infarcts at Lariboisière Fernand-Widal and Sainte Anne Hospitals", "overall_status": "RECRUITING", "phase": null, "conditions": ["Lacunar Strokes"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06320093", "official_title": "Training Social and Health Care prOfessionals in mUsic-based Therapeutic iNterventions to Support Older People With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Older People"], "locations": [{"country": "Italy"}, {"country": "Portugal"}, {"country": "Romania"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00121004", "official_title": "A Study to Tailor Advance Directives", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Persistent Vegetative State", "Terminally Ill"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01816152", "official_title": "Phase 1 Methodology Issues in a Tailored Light Treatment for Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Sleep Disturbances", "Depression"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02820155", "official_title": "A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating, Single Dose and Multiple Dose Study to Evaluate the Safety and Pharmacokinetics of RGN1016 in Healthy Male Subjects", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Healthy"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04169126", "official_title": "Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01893398", "official_title": "Multistimulation Group Therapy in Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02284906", "official_title": "A Blinded Long-term Extension Study to Evaluate the Safety and Efficacy of Pioglitazone (AD-4833 Sustained Release 0.8 mg Daily) to Slow the Progression of Cognitive Decline in Subjects Who Have Completed the AD-4833/TOMM40_301 Study With Diagnosis of Mild Cognitive Impairment Due to Alzheimer Disease", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Mild Cognitive Impairment Due to Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Switzerland"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00006399", "official_title": "Estrogen Modulation Effects on Cholinergic Function in Normal Post-Menopausal Women and Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05336175", "official_title": "Biomarker Study: Heart Failure Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia [Supplement of: IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia]", "overall_status": "UNKNOWN", "phase": "PHASE1, PHASE2", "conditions": ["Heart Failure NYHA Class II", "Heart Failure NYHA Class III", "Heart Failure NYHA Class IV"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT07029581", "official_title": "A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Lewy Body Dementia Psychosis"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03236792", "official_title": "Phase 1/2 Study Of Ixazomib In Combination With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Immunoglobulin Light Chain AL Amyloidosis", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["AL Amyloidosis"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03019536", "official_title": "Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02172612", "official_title": "Evaluation of a Patient-Centered Medication Therapy Management Intervention to Reduce Inappropriate Anticholinergic Prescribing in the Elderly", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00860275", "official_title": "A Study of the Effect of Concomitant Administration of Ketoconazole or Fluconazole on the Pharmacokinetics of BMS-708163 in Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06216275", "official_title": "Enhancing Calm in Arab Elderly With Dementia: Integrating Snoezelen Methods With Aromatherapy and Personal Items to Reduce Agitation", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Dementia", "Agitation in Dementia, Including Alzheimer's Disease"], "locations": [{"country": "Egypt"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05806177", "official_title": "Safety, Tolerability and Pharmacokinetics of AD16 Tablets After Multiple Administration in Healthy Chinese Adult Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03284112", "official_title": "Old SCHOOL Hip-Hop: A Randomized Controlled Trial to Improve Alzheimer's Disease Knowledge", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00986167", "official_title": "Determining the Efficacy and Tolerance of Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry", "overall_status": "UNKNOWN", "phase": "PHASE4", "conditions": ["Schizophrenia", "Psychosis"], "locations": [{"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06921265", "official_title": "Tailored Neuromodulation Intervention to Enhance Speech and Language Training in Patients With Primary Progressive Aphasia: EEG and MRI Targeted Transcranial Magnetic Stimulation", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Primary Progressive Aphasia(PPA)"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00455234", "official_title": "Rapid Tranquilization of Violent or Agitated People in Psychiatric Emergency Settings- A Pragmatic Randomized Controlled Trial of Intramuscular Olanzepine Vs. Intramuscular Haloperidol + Promethazine.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Psychotic Disorders", "Aggression"], "locations": [{"country": "India"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01815112", "official_title": "Benefit of MRI and 18F-FDG PET Imaging in the Early Diagnosis of Alzheimer-like Dementia", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Vascular Dementia"], "locations": [{"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02968719", "official_title": "Phase 1 Pharmacokinetic (PK) Study to Evaluate Once-weekly Corplex™ Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept® in Healthy Adult Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04715399", "official_title": "University of Pennsylvania Centralized Observational Research Repository on Neurodegenerative Disease (UNICORN)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Frontotemporal Degeneration(FTD)", "Primary Progressive Aphasia(PPA)", "Familial Frontotemporal Lobar Degeneration (fFTLD)", "Amyotrophic Lateral Sclerosis(ALS)", "Lewy Body Disease(LBD)", "Progressive Supranuclear Palsy(PSP)", "Corticobasal Syndrome(CBS)", "Posterior Cortical Atrophy(PCA)", "Alzheimer's Disease(AD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05617014", "official_title": "Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02669433", "official_title": "A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00724607", "official_title": "Validation of Brief Objective Neurobehavioral Detectors of Mild TBI", "overall_status": "COMPLETED", "phase": null, "conditions": ["Brain Concussion", "Posttraumatic Stress Disorder", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02848963", "official_title": "Effect of Ketamine-propofol Mixture on Postoperative Pain and Sedation-agitation", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Agitation", "Postoperative Pain"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05363293", "official_title": "A Multiple-dose, Steady-state, Double-blind, Ascending Dose, Safety, Tolerability, Pharmacokinetic Study of AL001 in Patients With Mild to Moderate Alzheimer's Disease and Healthy Adult Subjects (\"MAD Study\")", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease", "Healthy Non-elderly and Elderly Adults"], "locations": [{"country": "United States"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00058721", "official_title": "SPECT Evaluation of Nicotinic Cholinergic Receptors in Parkinson's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Parkinson Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04672798", "official_title": "The Center for Enhancing Treatment & Utilization for Depression and Emergent Suicidality Phase 2-Study 3-BRITEPath", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depression", "Suicidal Ideation"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT07047963", "official_title": "Neuropsychological Evaluation in Intellectual Disability", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Down Syndrome (Trisomy 21)", "Neuropsychology", "Cognitive Aging", "Alzheimer Disease", "Alzheimer Disease, Early Onset"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06582706", "official_title": "Nicotinic Acid for the Treatment of Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02098499", "official_title": "Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT", "overall_status": "WITHDRAWN", "phase": "PHASE4", "conditions": ["Migraine Headaches", "Nausea", "Restlessness"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02750306", "official_title": "A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Sleep Initiation and Maintenance Disorders", "Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05389644", "official_title": "Circuit-specific Neuromodulation for the Treatment of Apathy in Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease", "Apathy in Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02590744", "official_title": "Effects of Preoperative Using of Eye Patches on Prevention of Preschool Children Emergence Agitation After Cataract Surgery: A Single Center, Prospective, Randomized, Controlled Study.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Agitation", "Child", "Anesthesia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01558193", "official_title": "The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and Aggression", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05516667", "official_title": "Pilot Phase of a Prospective Cohort of Patients with Alzheimer's Disease and Their Families", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT07027072", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment (MCI)", "Mild Dementia", "Alzheimer&#39;s Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03510572", "official_title": "Clinical Evaluation of [18F]PI-2620 Positron Emission Computed Tomography for Imaging Tau Protein in Patients With Tauopathies and Healthy Volunteers: Phase 0 Study", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Healthy Volunteer", "Alzheimer Disease", "Frontotemporal Dementia", "Parkinson Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02246075", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Dementia", "Cognition"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06861231", "official_title": "Combined Intervention Using Transcranial Direct Current Stimulation and Cognitive Training in Alzheimer's Type Dementia Patients", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Prodromal Alzheimer's Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04834037", "official_title": "The Effect of Provision of Information and Supportive Nursing Care on Blood Gas, Vital Signs, Anxiety, Stress and Agitation Levels in COPD Patients Treated With NIV: A Randomised Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Chronic Obstructive Pulmonary Disease"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00570583", "official_title": "Clinical Studies of Mental Illness Not Involving Treatment Development, Efficacy, or Effectiveness Trials Phenotype-genotype Predictors of Cognitive Outcomes in Geriatric Depression", "overall_status": "COMPLETED", "phase": null, "conditions": ["Major Depression", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02450253", "official_title": "Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia, Vascular"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01125631", "official_title": "A Phase 1, Randomized, Placebo-Controlled, Double Blind, Multicenter Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenous Doses Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06151795", "official_title": "A Phase I Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of XTR006 in Healthy Chinese Volunteers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05315895", "official_title": "A Multi-Center Prospective Cohort Study of Dampness Syndrome in China", "overall_status": "RECRUITING", "phase": null, "conditions": ["Chronic Disease", "Cancer", "Dementia Alzheimers", "Metabolic Disease", "Aging", "Alzheimer Disease, Early Onset"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03293537", "official_title": "Skin Conductance and Heart Rate as Biomarkers to Uncover Covert Emotional Reactions in Patients With Dementia Associated Apathy; a Multi-centre Study.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Emotions", "Dementia", "Apathy"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05779839", "official_title": "Fostering Caregiver Connections Via Intentional Technology Pairing for Caregivers of Patients With Alzheimer's Disease and Other Types of Dementia-Phase 2", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Caregiver Stress", "Dementia", "Alzheimer Disease", "Lewy Body Dementia", "Parkinson Disease Dementia", "Frontotemporal Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04863495", "official_title": "A Multi-Center Observational Study of Couples Across the Trajectory of Dementia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Dementia of Alzheimer Type"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01315639", "official_title": "Plasma Abeta Peptides and the Risk of Alzheimer's Disease. Diagnostic Performance and Predictive and Prognostic Values of Measurements of Plasma Amyloid Peptides Concentrations for the Diagnosis of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03537729", "official_title": "A Randomized Controlled Trial of Visual Cues, Signage, and Spaced-Retrieval Education Within Long Term Care Communities to Assist With Wayfinding", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Alzheimer Dementia", "Age-Related Memory Disorders", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02720445", "official_title": "Long-Term Nicotine Treatment of Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02727699", "official_title": "XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia, Alzheimer Type"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02323334", "official_title": "Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3202626", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Volunteers", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03116464", "official_title": "Family Telemental Health Intervention for Veterans With Dementia", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Dementia Family Caregiver Burden and Conflict"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT05627687", "official_title": "Caring Relationships Expression Study (CARES)", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Caregiver Burden", "Anxiety", "Stress"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01825681", "official_title": "Life Enhancing Activities for Family Caregivers (LEAF)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Stress", "Dementia", "Affect"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00388544", "official_title": "A Prescription for Enhancing Resident Quality of Life", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03760809", "official_title": "The Effect of Different Dose of Dexmedetomidine Combined With Hydromorphone in Children With Tonsillectomy and Adenoidectomy", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Agitated; State, Acute Reaction to Stress"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03693209", "official_title": "Evaluation of a Brief Intervention Based on Implementation Intentions to Reduce Anger and Aggression in Adolescence: A Randomised Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression", "Anger"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00920699", "official_title": "A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT00522899", "official_title": "The Effects of Mental Activity and Exercise on Cognitive Function in Older Adults Who Self-Report a Recent Decline in Memory or Thinking", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01148498", "official_title": "Plasma Amyloid Beta Species After a Single Solanezumab Infusion in Nondemented Individuals and Those With Mild Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT07208734", "official_title": "Development and Multicenter Validation of a Personalized Transcranial Alternating Current Stimulation Protocol for Cognitive Impairment in Older Adults", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Alzheimer s Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04866264", "official_title": "Electronic-Nutrition-Optimizer for Personalized Prevention", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Diabetes", "Hypertension", "Frailty", "Dementia", "Cardiovascular Diseases"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02341898", "official_title": "Implementation of a Multicomponent Intervention to Prevent Physical Restraints in Nursing Home Residents: a Cluster-randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03308032", "official_title": "Self-Directed Online Training for Chinese Caregivers", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01561430", "official_title": "Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT02279511", "official_title": "Evaluating the Effectiveness of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in Patients With Moderate Alzheimer's Disease and Severe: Double-blind Dose Finding Clinical Trial.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03378037", "official_title": "The Effects of Acupuncture on the Risk of AD After TBI: A Randomized Controlled Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Brain Injuries, Traumatic"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06595212", "official_title": "Genetics and Environment iNtersection In the Amyotrophic Lateral Sclerosis - FrontoTemporal Dementia Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach", "overall_status": "RECRUITING", "phase": null, "conditions": ["ALS", "FTD"], "locations": [{"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT03855319", "official_title": "SMR/Theta Neurofeedback Training Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment: A Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT06182930", "official_title": "The Effect of Education Given to Caregivers of Alzheimer's Patients Registered With Home Health Services on Their Knowledge and Attitudes Towards Alzheimer's Disease: Randomized Controlled Study", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Education"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT04829500", "official_title": "Montessori Approaches in Person-Centered Care (MAP-VA): An Effectiveness-Implementation Trial in Community Living Centers", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia or a Related Disorder", "Mental Health Diagnoses", "Symptoms of Agitation or Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:49+00:00"}
{"nct_id": "NCT01002300", "official_title": "Investigation of the Effects of Intranasal Oxytocin on Cognition and Emotion Processing in Frontotemporal Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Frontotemporal Dementia", "Pick's Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06135051", "official_title": "Deep Brain Therapy With Low-intensity Ultrasound for Treatment of Cognitive Impairment", "overall_status": "TERMINATED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease", "Dementia", "Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00544453", "official_title": "Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04572477", "official_title": "The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Post-stroke Dementia, Vascular Mild Cognitive Impairment"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04997681", "official_title": "SYNchronizing Exercises, Remedies in Gait and Cognition at Home: Feasibility of a Home-based Double-blind Randomized Controlled Trial to Improve Gait and Cognition in Individuals at Risk for Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03430401", "official_title": "Computer-based Cognitive Rehabilitation Program to Improve Cognition and Delay Deterioration in Functional Performance for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Mild Dementia", "Healthy Older Adults"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06618872", "official_title": "Incremental Diagnostic Value of Tau-PET with [18F]RO948 Vs Amyloid-PET in Patients with", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "Switzerland"}, {"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02262975", "official_title": "A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "Philippines"}, {"country": "Singapore"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Thailand"}, {"country": "Thailand"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06785857", "official_title": "An Intervention Effect Study of a Mobile Medical Supportive Care Program for Family Caregivers with Dementia Combined with Diabetes: a Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Diabetes", "Senile Dementia, Alzheimer Type"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04034875", "official_title": "SOCIALBI, a Rasch Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cerebral Lesion"], "locations": [{"country": "Belgium"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05509153", "official_title": "A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03620981", "official_title": "A Phase 2/3 Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Evaluate the Efficacy and Safety of Brexpiprazole (OPC-34712) in the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Agitation Associated With Dementia of the Alzheimer's Type"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00381381", "official_title": "A Multi-center Study for the Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05826457", "official_title": "North American Prodromal Synucleinopathy Consortium Stage 2", "overall_status": "RECRUITING", "phase": null, "conditions": ["REM Sleep Behavior Disorder", "Parkinson Disease", "Lewy Body Dementia", "Dementia With Lewy Bodies", "Multiple System Atrophy", "REM Sleep Parasomnias"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01112501", "official_title": "SPECT/CT in the Diagnosis of Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Finland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06337201", "official_title": "A Digital Life Story to Support Person-centred Care for Older Adults With Dementia: Healthcare Professionals' Perspectives", "overall_status": "RECRUITING", "phase": null, "conditions": ["Cognitive Impairment", "Dementia"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05586581", "official_title": "PET Imaging of Synaptic Density Combined With Neuroimmunologic Measures to Reveal Mechanisms of HIV Neuropathogenesis During ART", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["HIV Associated Neurocognitive Disorder", "HIV Dementia", "HIV Encephalitis", "Healthy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03761381", "official_title": "Using Optical Coherence Tomography and Noninvasive Retinal Amyloid Imaging to Capture Retinal Changes Associated With Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT07146581", "official_title": "Primary Care Screening and Intervention for Caregiving Assessment and Support for Patients With Dementia: Technology-Based Intervention Usability and Pilot Testing", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Elder Abuse", "Elder Neglect"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03941119", "official_title": "VRx: Randomized Controlled Trial to Evaluate the Impact of Virtual Reality Therapy on Behavioural and Psychological Symptoms and Quality of Life of Individuals With Dementia Admitted to an Acute Care Hospital", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Dementia", "Delirium Superimposed on Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01282619", "official_title": "A Multi-Center, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, Study to Evaluate the Safety and Efficacy of Huperzine A Sustained-Release Tablets in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03382353", "official_title": "Efficacy of Multiple Nonpharmacological Interventions in Individuals With Subjective Memory Complaints", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Lifestyle Risk Reduction"], "locations": [{"country": "Italy"}, {"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06609330", "official_title": "Assessment and Treatment of Chronic Anger and Aggression Following Military-Related Interpersonal and Institutional Betrayal: A Pilot Investigation", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Anger Problems", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05997030", "official_title": "Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04387357", "official_title": "Multimodal Imaging in Alzheimer's Disease and Other Neurodegenerative Diseases", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment", "Dementia", "Disorientation", "Older Adults", "Magnetic Resonance Imaging"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06876857", "official_title": "University of Central Florida CereBank", "overall_status": "RECRUITING", "phase": null, "conditions": ["Biospecimen Donation", "Brain Injury", "Brain Diseases"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06732128", "official_title": "Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease: a Pilot Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Depression"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06833281", "official_title": "An Open-label Extension of SPG302-ALZ-101 Study to Evaluate the Long-term Safety and Efficacy of Daily Oral SPG302 Treatment in Participants With Mild-to-Moderate Alzheimer's Disease (AD)", "overall_status": "ENROLLING_BY_INVITATION", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03113812", "official_title": "A Randomized, Placebo-controlled, Parallel Group, Double-blinded, Single-center Phase-I, Pilot Study to Assess Tolerability and Safety of Repeated Subcutaneous Administration of ABvac40 in Patients With Mild to Moderate Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06467539", "official_title": "Novel Augmentation of DAOIB and Antioxidant for Early Dementia", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05959239", "official_title": "Expanded Access With TB006 Treatment in Adults With Alzheimer's Disease and Related Dementias", "overall_status": "AVAILABLE", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06686511", "official_title": "The Effect of Preoperative Counseling on Emergence Agitation in Patients Candidate for Nasal Surgeries : a Prospective Randomized Controlled Study", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Postoperative Agitation"], "locations": [{"country": "Egypt"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01354444", "official_title": "Pilot Trial of Carvedilol in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03878212", "official_title": "Effects of mHealth on Promoting Self-care Health Management Among Older Adults in the Community: A 3-arm Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Telemedicine"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01476228", "official_title": "EEG Objectification in Neuropsychiatry", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Personality Disorder", "Depression", "Neurodegeneration", "Alzheimer's Disease", "Epilepsy"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04915092", "official_title": "Co-creation of Service Innovation - Evaluation of the Efficacy of an App for Parents to Prevent Childhood Obesity and Promote Healthy Life-styles: CoSIE Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Childhood Obesity"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05628636", "official_title": "A Phase 1, Open-label Study to Evaluate the Tolerability of 21 Days of Treatment With the AC-OLE-01-VA Formulation of Tricaprilin Under Different Dosing Conditions in Healthy Participants", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05926011", "official_title": "Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease: a Pivotal, Sham-controlled, Randomized, Double-blind, Multicentric Investigation (LIGHT4LIFE)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02350634", "official_title": "A High Resolution Autopsy Study Evaluating the Relationship of 18F-AV-1451 PET Imaging and Tau Pathology", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04431401", "official_title": "Repetitive Transcranial Magnetic Stimulation in the Treatment of Primary Progressive Aphasia: A Randomized Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "Repetitive Transcranical Magnetic Stimulation"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04157712", "official_title": "A Phase I, Single Centre, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics in Plasma and Urine of Multiple Ascending Doses of ALZ-801 in Healthy Elderly Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03816228", "official_title": "Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers. (IND 123119, Protocol Z)", "overall_status": "WITHDRAWN", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02131545", "official_title": "A Single Dose Pharmacokinetic Study of Topical and Rectal Quetiapine Compared to Oral Quetiapine in Healthy Adults", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia", "Delirium"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03623672", "official_title": "North American Prodromal Synucleinopathy Consortium", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["REM Sleep Behavior Disorder", "Parkinson Disease", "Lewy Body Disease", "Dementia With Lewy Bodies", "Multiple System Atrophy", "REM Sleep Parasomnias"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT07143331", "official_title": "A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of Single and Multiple Ascending Doses of KS101 in Healthy Volunteers, Including a Pilot Food Effect Evaluation", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1", "conditions": ["Healthy Participants", "Alzheimer Disease", "Chronic Kidney Disease"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05993572", "official_title": "Does Healthy Aging Team-supported Home-care Services Pilot Program Reduce ED Visits? A Prospective before-and After-intervention Study", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Frailty", "Dementia", "Depression", "Malnutrition", "Old Age; Debility", "Drug Use"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03033875", "official_title": "Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02365922", "official_title": "Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2", "overall_status": "COMPLETED", "phase": null, "conditions": ["FTLD", "Progressive Supranuclear Palsy (PSP)", "Frontotemporal Dementia (FTD)", "Corticobasal Degeneration (CBD)", "PPA Syndrome", "Behavioral Variant Frontotemporal Dementia (bvFTD)", "Semantic Variant Primary Progressive Aphasia (svPPA)", "Nonfluent Variant Primary Progressive Aphasia (nfvPPA)", "FTD With Amyotrophic Lateral Sclerosis (FTD/ALS)", "Amyotrophic Lateral Sclerosis (ALS)", "Oligosymptomatic PSP (oPSP)", "Corticobasal Syndrome (CBS)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03269201", "official_title": "Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) EEG Signals in Patients With Movement Disorders", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Parkinson Disease", "Essential Tremor", "Dystonia", "Normal Pressure Hydrocephalus", "Cerebellar Ataxia", "Multiple System Atrophy", "Progressive Supranuclear Palsy", "Corticobasal Degeneration", "Dementia With Lewy Bodies"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01079819", "official_title": "Randomized, Placebo-controlled, Double-blind, Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163 in Healthy Young Male and Elderly Male and Female Chinese Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04823819", "official_title": "Assessment of Effectiveness and Safety of Transcranial Magnetic Stimulation (rTMS) Combined With Transcranial Direct Current Stimulation (tDCS) in Dementia Treatment in Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Poland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02889601", "official_title": "Psycho-behavioral Disorders in Frontotemporal Lobar Degeneration: Validation of a Quantification and Follow-up Scale", "overall_status": "COMPLETED", "phase": null, "conditions": ["Frontotemporal Lobar Degeneration"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04840030", "official_title": "Effectiveness of a Lifestyle Multidomain Intervention to Prevent Cognitive Decline in the Basque Country. GOIZ ZAINDU Gipuzkoa - CITA GO-ON Study", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Dementia", "Cognitive Decline", "Prevention", "Life Style", "Risk Factor, Cardiovascular", "Diet Habit", "Cognitive Intervention", "Behavioral Intervention"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT07069530", "official_title": "Impact of Musical Therapeutic Intervention on Depression in Dementia Patients and Caregiver Burden", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease (AD)", "Depression Chronic", "Caregiver Burden of People With Dementia", "Cognitive Impairments"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03932812", "official_title": "Building a Bridge (Between Clinical and Community Care): Post-diagnosis Support for Persons With Dementia and Their Families", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burden"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02958930", "official_title": "An Open-Label Study to Evaluate the Safety and Efficacy of Transcranial Electromagnetic Treatment (TEMT) for the Treatment of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Alzheimer Disease, Late Onset"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02789800", "official_title": "Patient-Centred Innovations for Persons With Multimorbidity - Quebec", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Hypertension", "Depression", "Anxiety", "Musculoskeletal Pain", "Arthritis", "Rheumatoid Arthritis", "Osteoporosis", "Chronic Obstructive Pulmonary Disease (COPD)", "Asthma", "Chronic Bronchitis", "Cardiovascular Disease", "Heart Failure", "Stroke", "Transient Ischemic Attacks", "Ulcer", "Gastroesophageal Reflux", "Irritable Bowel", "Crohn's Disease", "Ulcerative Colitis", "Diverticulosis", "Chronic Hepatitis", "Diabetes", "Thyroid Disorder", "Cancer", "Kidney Disease", "Urinary Tract Problem", "Dementia", "Alzheimer's Disease", "Hyperlipidemia", "HIV"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00714571", "official_title": "Behavioral and Neuroimaging Changes After Cognitive Rehab in TBI and MCI", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Mild Cognitive Impairment", "Alzheimer's Disease", "Traumatic Brain Injury"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05612711", "official_title": "Single-site, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Dronabinol for the Treatment of Agitation in Outpatient With Dementia", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Dementia Moderate", "Dementia Severe", "Agitation,Psychomotor", "Behavioral Symptoms"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05341271", "official_title": "The Effect of Digital Reminiscence Therapy on People With Mild and Moderate Dementia: A Randomized Controlled Trial.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06295263", "official_title": "Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases", "overall_status": "RECRUITING", "phase": null, "conditions": ["Parkinson Disease", "Alzheimer Disease", "Nervous System Diseases", "Geriatric Diseases"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05104463", "official_title": "A Phase 2a, Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Safety, Tolerability and Effects of CST-2032 and CST-107 on Cognition in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "New Zealand"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03990792", "official_title": "Preventing the Onset of Depression Through a Personalized Intervention Based on ICTs, Risk Prediction Algorithms and Decision Support Systems for Patients and GPs: the e-predictD Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depression"], "locations": [{"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02337907", "official_title": "A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Austria"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04018092", "official_title": "Revitalizing Cognition in Older Adults at Risk for Alzheimer's Disease With Near-Infrared Photobiomodulation", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Cognitive Aging", "Alzheimer Disease, Protection Against"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00762411", "official_title": "Effect of LY450139 a y-Secretase Inhibitor, on the Progression of Alzheimer's Disease as Compared With Placebo", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}, {"country": "Ukraine"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06543134", "official_title": "Evaluation of The Relationship Between Perioperative Hypothermia and Emergence Agitation", "overall_status": "RECRUITING", "phase": null, "conditions": ["Hypothermia; Anesthesia", "Agitation, Emergence", "Postoperative Complications", "Hypothermia Following Anesthesia"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03134963", "official_title": "Cerebral Haemodynamic Changes During Cognitive Testing: a Functional Transcranial Doppler (fTCD) Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease", "Vascular Dementia", "Healthy Controls"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01729598", "official_title": "Safety And Target Engagement Of Clu1 By Valproic Acid In Subjects With Intact Cognition: Proof Of Concept For The Development Of A Prevention Trial For Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02446132", "official_title": "A Phase 3, Multicenter, Long Term, Extension Study of the Safety and Efficacy of AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Agitation in Patients With Dementia of the Alzheimer's Type"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05911932", "official_title": "Investigating Genetic Status in Patients Presenting to Clinic", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia, Frontotemporal", "Alzheimer Dementia (AD)", "Lewy Body Dementia (LBD)"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00053599", "official_title": "A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Slow the Progression of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01202994", "official_title": "Practice Effects and Amyloid Imaging Using 18F-PIB (18F-39-F-6-OH-BTA1) Known as [18FGE067]) or Flutemetamol PET and FDG-PET", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03047694", "official_title": "Contribution of a Semantic Therapy on a Tactile Tablet in the Alzheimer's Disease, Early and Late Onset", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03698695", "official_title": "A Double Blind, Placebo-controlled, Randomized, 15-day Treatment, Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil Administered Orally to Healthy Male Volunteers Including a Scopolamine Challenge", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01552265", "official_title": "Shanghai Cohort Study on Mild Cognitive Impairment for Early Detection of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05288842", "official_title": "TANYCYTES' ROLE IN ALZHEIMER'S DISEASE AND FRONTOTEMPORAL DEMENTIA: ARE THEY THE KEY TO WELL AGING?", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Frontotemporal Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02771886", "official_title": "Evaluation of a Brief \"Surf the Urge\" Intervention", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Substance Use", "Deliberate Self-harm", "Trichotillomania", "Aggression", "Stealing", "Eating Pathology", "Gambling"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00062569", "official_title": "Reminiscence During Bathing Persons With Alzheimer's Disease at Home", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04804241", "official_title": "Proof of Mechanism Study of Senicapoc in Mild or Prodromal Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00297739", "official_title": "Risperidone Augmentation for Treatment-Resistant Aggression in ADHD", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00611312", "official_title": "Effects of Intense Cognitive Training on Standardized Measures of Cognition in Those With Very Mild Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05974527", "official_title": "Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE4", "conditions": ["Agitation", "Schizophrenia", "Schizoaffective Disorder", "Schizophreniform Disorders", "Bipolar Disorder"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06650527", "official_title": "Effect of Cognitive Empathy Training on Dementia Caregivers", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Caregivers of People Living With Dementia", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03421327", "official_title": "Genetic Risk: Whether, When, and How to Tell Adolescents", "overall_status": "COMPLETED", "phase": null, "conditions": ["Huntington Disease", "Hereditary Breast and Ovarian Cancer", "Hereditary Cancer", "Hereditary Non-polyposis Colon Cancer", "Hereditary Non-Polyposis Colorectal Cancer Syndrome"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06757569", "official_title": "Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive Impairment"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01734083", "official_title": "The Effects of Whole Body Vibration Exercise Training on Physical Functioning and Falls in Community-dwelling Elderly With Cognitive Impairments", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02502045", "official_title": "A Study to Examine the Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04212442", "official_title": "Improving Aging in Place for Older Adults in Subsidized Housing", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Physical Disability", "Cognitive Impairment", "Physical Activity"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02204969", "official_title": "Transcranial Magnetic Stimulation (TMS) and Lithium Water for Treatment of Alzheimer Patients", "overall_status": "UNKNOWN", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03924141", "official_title": "Effects of a Brief De-escalation Training Program on Student Nurses' Skills and Confidence Level in Coping With Patient Aggression: a Cluster Randomized Controlled Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["De-escalation Skills"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03938922", "official_title": "A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.", "overall_status": "WITHDRAWN", "phase": "PHASE1", "conditions": ["Parkinson Disease", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06304129", "official_title": "Threshold Values and Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Blood Biomarkers"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02626572", "official_title": "Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms. A 24-week International, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase II Study in Monotherapy Followed by an Optional 28-week Extension Period in Co-administration With Donepezil.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06563895", "official_title": "A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Amyloidosis", "Amyloid Cardiomyopathy", "Transthyretin Amyloidosis", "Cardiomyopathies", "Heart Diseases", "Polyneuropathies"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Malaysia"}, {"country": "Netherlands"}, {"country": "Portugal"}, {"country": "Singapore"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03621839", "official_title": "New Diagnosis or Prognosis Biomarkers for Alzheimer's Disease: Biobank of CSF Collected as Part of Differential Diagnosis of Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Dementia", "Neurodegenerative Diseases"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03114657", "official_title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "China"}, {"country": "China"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Estonia"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Israel"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Peru"}, {"country": "Peru"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "South Africa"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "Turkey (Türkiye)"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03108781", "official_title": "The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "BPSD"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00702780", "official_title": "Multi-center, Randomized, Placebo-controlled, Double-blind Clinical Trial of Escitalopram on the Progression Delaying Effect in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02978742", "official_title": "Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Eating Disorder", "Bulimia Nervosa", "Binge Eating Disorder"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04023994", "official_title": "A Single-Center, Randomized, Adaptive, Investigator/Subject Blind, Single Ascending Dose, Placebo-Controlled Phase I Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimers Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04779866", "official_title": "Feasibility of Self-Administered Hypnosis for Sleep Quality in Caregivers of Individuals With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Poor Quality Sleep", "Caregiver Stress", "Alzheimer's Disease (Incl Subtypes)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06221202", "official_title": "Stories in the Moment: Dance Program for People Living With Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Mild Cognitive Impairment", "Alzheimer Disease", "Lewy Body Disease", "Frontotemporal Dementia", "Vascular Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02439853", "official_title": "Communication Bridge Speech Therapy Research Study: Using Internet-Based Speech Therapy to Improve Quality of Life and Access to Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "Frontotemporal Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00757939", "official_title": "A Two-Part Cross-Sectional and Longitudinal Study to Assess Regional Cerebral Blood Flow by Dynamic Arterial Spin Labeling as an Alzheimer's Disease Biomarker as Compared to FDG-PET in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00675077", "official_title": "Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control, Management and Treatment of HD", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Huntington Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01061827", "official_title": "Validation of the French Version of the Geriatric Mental State: a Structured and Standardized Interview for Diagnosis of Psychiatric Disorders in the Elderly", "overall_status": "COMPLETED", "phase": null, "conditions": ["Validate the French Version of GMS Package"], "locations": [{"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01290861", "official_title": "Cognitive Assessment Battery (CAB)Beta Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00409370", "official_title": "A Randomized Clinical Trial to Compare The Use Of Safety Net Enclosures With Standard Restraints in Agitated Hospitalized Patients", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Delirium", "Agitated Behavior", "Alcohol Withdrawl", "Acute Confusional State", "Acute Psychosis"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04262973", "official_title": "Interprofessional Education and Collaborative Practice Model for Dementia in Acute Care: Development, Implementation and Evaluation", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06556069", "official_title": "Peer Support Enhanced Behavioral Crisis Response Teams in the Emergency Department", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Psychomotor Agitation", "Behavioral Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03834402", "official_title": "Interceptor Project: On Early Diagnosis Of The Prodromal Stage Of Alzheimer Disease. The Progression From Mild Cognitive Impairment (Mci) To Dementia: The Role Of Biomarkers In Early Interception Of Patients Candidate For Prescription Of Future Disease-Modifying Drugs", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT07105501", "official_title": "Hidden Auricular Amyloid Deposits and Aortic Stenosis: Clinical and Prognostic Implications in Aortic Valve Replacement Surgery", "overall_status": "COMPLETED", "phase": null, "conditions": ["Aortic Stenosis", "Amyloid"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01837641", "official_title": "A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03926351", "official_title": "A Randomized, 24 Week Parallel-group Placebo-controlled (Phase 2) Pilot-study of High Dose Omega 3 (DHA) in People at Risk for Dementia", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Dementia", "Inflammation", "Mild Cognitive Impairment", "Cognitive Decline", "SCD", "Cognitive Dysfunction", "Pathologic Processes", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Neurocognitive Disorders", "Mental Disorder", "Cognition Disorders"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00632645", "official_title": "Neuroleptic and Huntington Disease. Comparison of : Olanzapine, la Tetrabenazine and Tiapride. A Multicentric, Randomised, Controlled Study.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Huntington Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04698928", "official_title": "The Effect of Repetitive Transcranial Magnetic Stimulation on the Cognition in People With Parkinson's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Parkinson Disease With Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03724136", "official_title": "Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Alzheimer Disease", "Alzheimer Dementia", "Vascular Dementia", "Lewy Body Disease", "Lewy Body Dementia With Behavioral Disturbance (Disorder)", "Dementia, Mixed", "Parkinson-Dementia Syndrome", "Chronic Traumatic Encephalopathy", "Huntington's Dementia", "Wernicke Korsakoff Syndrome", "Traumatic Brain Injury", "Dementia, Multi-Infarct", "Autism", "Autism Spectrum Disorder", "Autistic Behavior", "Autistic Disorder, Current or Active State", "Cadasil", "LATE Limbic-predominant Age-related TDP-43 Encephalopathy"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United Arab Emirates"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00359944", "official_title": "A Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Assessing the Efficacy and Safety of AC-3933 Tablets Twice Daily in Adults With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT07187141", "official_title": "Phase I Study of the Safety, Tolerability, and Immune Effects of Nasal Protollin in Subjects With Early Symptomatic Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease (AD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05954741", "official_title": "Comparing the Effectiveness of Multidimensional Rehabilitation Programs for Cognitive Impairment in Comorbid Outpatients: a Randomized Controlled Trial", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive Impairment", "Dementia", "Comorbidities and Coexisting Conditions", "Vascular Dementia", "Dementia, Mixed"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06453941", "official_title": "The Validation and Beneficial Effects of Yizhi Baduanjin for Patients With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02606422", "official_title": "Effects of Transcranial Direct Current Stimulation (tDCS) in Spoken and Written Production in Primary Progressive Aphasia (PPA)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "MCI", "FTD"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06899256", "official_title": "The Effect of Horticultural Activities on Physical and Cognitive Status, Mental Well-Being, Social Participation and Quality of Life in Individuals Diagnosed with Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Horticultural Therapy", "Quality of Life", "Occupational Therapy", "ELDERLY PEOPLE"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03328195", "official_title": "A Pilot Study Evaluating the Feasibility, Safety, and Efficacy of the Vielight Neuro RX Gamma Device for the Treatment of Moderate-to-severe Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01339195", "official_title": "Post-stroke Cognitive Impairment and Dementia: Frequency and Anatomical Correlates With the French Version of the National Institute of Neurological Disorders and Stroke (NINDS)-Canadian Stroke Network Battery", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Stroke", "Cognitive Disorders", "Behavioral Disorders"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04462029", "official_title": "A Randomized, Open-label, Single-dose, Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability of BR4002 Comparing to BR4002-1 in Healthy Volunteers", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Dementia Alzheimers"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05450237", "official_title": "Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Multiple Sclerosis", "Epilepsy", "Parkinson Disease", "Dementia", "Stroke"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05590637", "official_title": "A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease", "overall_status": "RECRUITING", "phase": "PHASE4", "conditions": ["Parkinson's Disease Psychosis", "Dementia With Lewy Bodies"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03611439", "official_title": "Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Alzheimer Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04100057", "official_title": "Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Neuropsychiatric Symptoms", "Sleep Disturbance"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03267992", "official_title": "Observational Study of HGE Health Care Solution COPD Co-Pilot AIR™ Application in Subjects Undergoing the PneumRx® Endobronchial Coil Procedure as Part of EU Registry CLN0014", "overall_status": "TERMINATED", "phase": null, "conditions": ["COPD Symptoms After Coil Procedure"], "locations": [{"country": "Switzerland"}, {"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01485302", "official_title": "A Multi-center, Parallel-group, Double-blind, Placebo-controlled Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability and the Pharmacokinetic Properties of SAR228810 Given as IV Infusion or as SC Injection in Patients With Mild to Moderate Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Bulgaria"}, {"country": "France"}, {"country": "France"}, {"country": "Netherlands"}, {"country": "South Africa"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03736057", "official_title": "Pharmacogenic Guidance to Optimize Safety and Efficacy of Psychotropic Drug Use in Treatment of Behavioral and Psychiatric Symptoms in Dementia", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Psychiatric Disorders Mood", "Behavior Disorders"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02778581", "official_title": "Randomized, Double Blind, Placebo Controlled Prospective Study, to Evaluate the Effect of a Vegetal Oil in the Disease's Natural Evolution in Patients Diagnosed With Cognitive Impairment or Mild to Moderate Alzheimer Disease.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Cognitive Impairments", "Alzheimer Disease"], "locations": [{"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06507488", "official_title": "Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia - A Randomized, Double-blind, Placebo-controlled Study", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cerebrovascular Disorders"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02244541", "official_title": "Phase 2a Study of ANAVEX2-73 Adaptive-Trial-Design With Repeated Doses, MTD Finding, Pharmacodynamic and Bioavailability Evaluation in Patients With Mild to Moderate Alzheimer's Disease With a 12-Month Open Label Follow-Up Period", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05749939", "official_title": "Brief Online Acceptance Commitment Therapy for Caregivers: a Fully Longitudinal Mixed Methods RC", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Caregiver Burden", "Behavioral and Psychiatric Symptoms of Dementia", "Depressive Symptoms", "Quality of Life", "Psychological Flexibility", "Sleep Quality", "Positive Aspects of Caregiving"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00637442", "official_title": "Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05921266", "official_title": "Urolithin A Supplementation to Improve Endothelial and Cerebrovascular Function in Middle-aged Adults With Obesity", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Obesity", "Vascular Dementia", "Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04883229", "official_title": "tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Nonfluent Aphasia, Progressive", "Primary Progressive Nonfluent Aphasia", "Primary Progressive Non Fluent Aphasia", "Progressive Supranuclear Palsy", "Corticobasal Degeneration", "Behavioral Variant of Frontotemporal Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00592995", "official_title": "Creatine Safety and Tolerability in Premanifest HD: PRECREST", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04782427", "official_title": "COVID-19 Infections and Mortality in Montreal Long-term Care Facilities During the First Wave: a Retrospective Cohort Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Covid19", "Death", "Infection Viral", "Infections, Respiratory", "Infection, Coronavirus", "Elderly Infection", "Old Age; Dementia", "Epidemic Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05704270", "official_title": "The Efficacy of Computerized Cognitive Training in Patients With Hypertension and Cognitive Impairment, no Dementia: a Randomized Controlled Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Hypertension"], "locations": [{"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04616794", "official_title": "Tailored, Multidomain, and Coach-assisted Interactive Mobile Application for the Adoption and Maintenance of a Healthy Lifestyle in Middle-aged and Older Adults With Modifiable Risk Factors for Dementia: A Proof-of-concept Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Risk Behavior", "Cognitive Decline"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00253227", "official_title": "Galantamine in the Treatment of Alzheimer's Disease: Flexible Dose Range Trial", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03014570", "official_title": "Testing the Implementation of EIT-4-BPSD", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Behavioral and Psychological Symptoms of Dementia (BPSD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02937883", "official_title": "Effects of an Empowerment Intervention for Community-dwelling Persons With Young Onset Dementia and Their Informal Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Empowerment"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00478205", "official_title": "Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06141356", "official_title": "[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01780402", "official_title": "Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02502253", "official_title": "BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Mild Cognitive Impairment", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06378372", "official_title": "Effect of Musical Intervention Based on Piano Learning on Alzheimer's Patients in León (España).", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia of Alzheimer Type", "Dementia", "Dementia, Vascular", "Dementia, Mixed", "Dementia Frontal", "Dementia With Lewy Bodies", "Cognitive Decline", "Neurologic Disorder", "Neurologic Dysfunction", "Neurologic Deficits"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT07058688", "official_title": "A Multicenter, Randomized, Double-masked, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NTRX-07 in Subjects With Mild Cognitive Impairment or Mild to Moderate Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "Czechia"}, {"country": "Czechia"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Poland"}, {"country": "Poland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05697354", "official_title": "Harmonization and Application of Cognitive Rehabilitation Protocols Using New Technologies of Virtual Reality and Telemedicine, in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05082883", "official_title": "Cognitive Screening Made Easy for Primary Care Providers", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Cognitive Decline"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT07158905", "official_title": "A Phase I, Randomized, Double-Blind Study to Evaluate the Safety and Tolerability of AV-1980R in Participants With Preclinical Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Preclinical Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04416529", "official_title": "Tele-Mindfulness for Dementia's Family Caregivers: a Randomized Trial With a Usual Care Control Group", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregivers", "Mindfulness"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02614131", "official_title": "Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Healthy", "Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00034762", "official_title": "Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia", "Alzheimer Disease", "Mental Disorders"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05076331", "official_title": "Health and Aging Brain Study: Health Disparities Tau PET Scan Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01574053", "official_title": "Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort", "overall_status": "RECRUITING", "phase": null, "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Austria"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Chile"}, {"country": "Colombia"}, {"country": "Colombia"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Ireland"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "New Zealand"}, {"country": "New Zealand"}, {"country": "New Zealand"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01687153", "official_title": "Effects of Traumatic Brain Injury and Post Traumatic Stress Disorder on Alzheimer's Disease (AD) in Veterans Using Alzheimer's Disease Neuroimaging Initiative (ADNI)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Traumatic Brain Injury", "Post Traumatic Stress Disorder", "Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05372159", "official_title": "Vanderbilt Memory and Aging Project", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Aging", "Aged, 80 and Over", "Biomarkers", "Brain", "Case-Control Studies", "Cognitive Dysfunction", "Neuropsychological Tests"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06596746", "official_title": "Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Neurodegenerative Diseases", "Parkinson Disease", "Synucleinopathies", "Lewy Body Disease", "Multiple System Atrophy", "Tauopathies", "Alzheimer Disease", "Corticobasal Degeneration", "Supranuclear Palsy, Progressive", "Atypical Parkinsonism", "TDP-43 Proteinopathies", "Amyotrophic Lateral Sclerosis", "Frontotemporal Lobar Degeneration", "Movement Disorders", "Cognitive Impairment", "Dementia", "Iron Overload", "Neurodegeneration With Brain Iron Accumulation (NBIA)"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03435861", "official_title": "Effect of Neflamapimod (VX-745) on Brain Inflammation Using Positron Emission Tomography (PET) Scan in Alzheimer's Disease (AD) Patients", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04769466", "official_title": "Development of a Reminiscence Therapy Online Platform With Machine Learning to Increase Engagement With People Living With Dementia and Their Care Partners", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02365051", "official_title": "Translation of COPE for Publicly-Funded Home Care Clients and Their Families", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05027113", "official_title": "App-Based Mindfulness Meditation for People of Color Who Experience Race-Related Stress: A Randomized Control Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Stress, Psychological", "Anxiety", "Depression", "Rumination", "Emotional Regulation", "Mindfulness", "Self-Compassion", "Emotional Distress"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03890796", "official_title": "Application of Activity Scheduling to Enhance Quality of Life for Older Adults With Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Older Adults With Mild to Moderate Level of Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02119546", "official_title": "Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild CognitIve Impairment", "Alzheimer's Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06565169", "official_title": "Improving Primary Care Clinician's Advance Care Planning Alzheimer's Disease and Related Dementias", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Alzheimer's Disease (Incl Subtypes)", "Aging"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04538066", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04312893", "official_title": "The Effectiveness of Acupuncture for Delirium in Critically Ill Patients: a Double Blind Randomized Control Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Intensive Care Unit Delirium", "Delirium", "Agitation"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00875706", "official_title": "Training and Coaching to Promote High Performance in VA Nursing Home Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03644043", "official_title": "Quantitative EEG for Assessment of Mild Cognitive Impairment Associated With Preclinical Alzheimer's Disease - Evidence for Amyloid Indication Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Dementia Frontal", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05187117", "official_title": "CAPABLE Family Pilot", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Mild", "Mild Cognitive Impairment", "Disability Physical", "Impairment, Cognitive", "Caregiver Burden", "Quality of Life", "Depression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01360450", "official_title": "Efficacy of Clonidine in Reducing Iatrogenic-induced Opioid Dependence in Infants:", "overall_status": "TERMINATED", "phase": "PHASE2, PHASE3", "conditions": ["Neonatal Abstinence Syndrome"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06301750", "official_title": "A Randomly Controlled Study to Explore Oral vs Nasal Enteral Nutrition Feeding in Alzheimer's Patients", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06662578", "official_title": "Exploring Neurocognitive Stimulation in Dementia Through Equine-Assisted Therapy: A RCT Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02817074", "official_title": "MIND Diet Intervention to Prevent Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Decline", "Dementia", "Alzheimer Disease", "Vascular Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02774720", "official_title": "How do we Get People With MCI and Dementia to be Physically Active?", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Dementia"], "locations": [{"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00955422", "official_title": "Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04876911", "official_title": "A Single Case Experimental Design Study to Explore the Use of Simulated Presence Therapy as a Formulation Based Intervention for Patients With Dementia Who Are Presenting in Distress.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Behavioural and Psychiatric Symptoms of Dementia", "Stress, Psychological"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00857415", "official_title": "A Phase III Study of the Correlation Between Florbetapir F 18 (18F-AV-45) PET Imaging and Amyloid Pathology", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT00480818", "official_title": "An Ascending Multiple Dose Study of the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Young and Elderly Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02310620", "official_title": "Computer Games to Prevent Mild Cognitive Impairment and Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Hungary"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02560753", "official_title": "Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02918539", "official_title": "Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Cognition Disorders"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05453539", "official_title": "A Phase 1, Controlled, Open-label, Single Dose, Dose-escalation, Clinical Proof-of-concept Study of MRI Enhanced With ADx-001 (DSPE-DOTA-Gd Liposomal Injection) in Patients With Brain Amyloid Deposits as Demonstrated by Amyloid PET", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01334749", "official_title": "Determinants of Dementia After Stroke", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Ischemic Stroke", "Hemorrhagic Stroke"], "locations": [{"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04377191", "official_title": "Comparison of The Effect of Two Different Virtual Reality Trainings on Gait, Balance and Posture of Individuals With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT03175874", "official_title": "AVP Study: Autophagy and Pathological Aging Human Study in Osteoporosis With or Without Dementia of Alzheimer's Type", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Osteoporosis"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05516147", "official_title": "SAFE at Home: A Service to Provide Social Engagement to Community-Dwelling Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Dementia, Vascular", "Dementia, Mixed"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04045990", "official_title": "Neuromodulation of Language and Memory Networks in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Primary Progressive Aphasia", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT05310890", "official_title": "Long Term Prospective Study of Tai Chi Intervention to Prevent MCI From Conversion to Dementia", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04700826", "official_title": "Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation Using Healthcare Data for Pragmatic Research: A Randomised Controlled Trial", "overall_status": "RECRUITING", "phase": "PHASE4", "conditions": ["Atrial Fibrillation"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT04167813", "official_title": "Trial of Ondansetron as a Parkinson's HAllucinations Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Parkinson's Hallucinations", "Dementia With Lewy Bodies"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT06635876", "official_title": "Piloting an Online Emergency Preparedness Toolkit for Caregivers Preparing for Their Own Health Care Emergency", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Caregiver Burden"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT02752750", "official_title": "Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:50+00:00"}
{"nct_id": "NCT01208675", "official_title": "The Swedish BioFINDER Study: Early Diagnosis of Alzheimer's Disease - a Multidisciplinary Approach", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer's Disease", "Dementia With Lewy Bodies", "Vascular Dementia"], "locations": [{"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05345509", "official_title": "A Phase 1, Randomized, Open-Label, Exploratory, Sequential, Pharmacokinetic Single Ascending Dose Study of IVL3003 Versus Multiple Doses of Aricept (Donepezil) Tablets in Healthy Subjects", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04042532", "official_title": "The Effects and Mechanisms of Theta-burst Stimulation on Cognitive Function in the Patients with Biomarker-defined Young-onset Alzheimer's Disease Dementia", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05242614", "official_title": "The Effects of a Hybrid Face-To-Face and Online Mode of Delivering a Mindfulness-Based Dementia Caregiving Programme for Family Caregivers of Persons With Dementia: A Randomized Controlled Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Caregiver Burden"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03713892", "official_title": "Phase I Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, PK, PD of CKD-504 in Single SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects", "overall_status": "UNKNOWN", "phase": "PHASE1", "conditions": ["Huntington Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02520232", "official_title": "Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition (VIAGECO)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06826612", "official_title": "A Phase 1/2, Randomized, Sequential, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of a One-Time, Bilateral, Intraparenchymal Infusion of SPK-10001 Into the Caudate and Putamen in Participants With Huntington's Disease", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06993207", "official_title": "Validation of a Home-use Instrument for the Quantification of Cognitive Function in a Population at Risk of Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia", "Mild Cognitive Impairment", "Dementia Alzheimers", "Dementia, Mixed", "Subjective Cognitive Decline", "Dementia, Vascular"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00563732", "official_title": "An Open-Label, Nonrandomized Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Lecozotan SR and a Single Oral Dose of Digoxin When Administered Orally to Healthy Adult Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02050464", "official_title": "Virtual Physiological Human (VPH) Dementia Research Enabled by IT - Prospective Cohort Kuopio", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Frontotemporal Dementia", "Dementia, Vascular", "Mild Cognitive Impairment"], "locations": [{"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02363504", "official_title": "Focus on the Locus Coeruleus Network With 7 T MRI: Link to Memory (Dys)Function", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03204604", "official_title": "The Brain Ketone Body Challenge Imaging Study", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04208152", "official_title": "A First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of anle138b in Healthy Male and Female Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Volunteers"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT07091747", "official_title": "Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease (AD)"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06781749", "official_title": "New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Hearing Loss, Bilateral (Causes Other Than Tumors)"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT07033481", "official_title": "A Phase 2a Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Primary Progressive Aphasia (PPA)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Nonfluent Variant Primary Progressive Aphasia (nfvPPA)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01519193", "official_title": "Treatment of Aggressive Behavior and Post-Traumatic Stress Disorder in Former Street Children and Vulnerable Children in Burundi With Narrative Exposure Therapy for Violent Offenders", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Aggressive Behavior", "Post-Traumatic Stress Disorder"], "locations": [{"country": "Burundi"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04869904", "official_title": "Analysis of the Periodontal Microbiota in Elderly Subjects With and Without Alzheimer's Disease: a Case Control Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Periodontitis", "Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04557865", "official_title": "Establishing 18F PMPBB3 (APN 1607) PET Imaging, Genetic and Plasma Biomarkers for Risk Identification, Disease Progression and Prognosis of Tauopathy Related Parkinsonism s Yndromes", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06922071", "official_title": "The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia Risk Factors", "Prevention", "Cognitive Health"], "locations": [{"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04867616", "official_title": "A Patient- and Investigator-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Study Participants With Prodromal to Mild Alzheimer's Disease (AD), Followed by an Open-Label Extension Period", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06868004", "official_title": "Positive Impact of Holistic Nursing on Cognitive Impairment and Psychiatric Symptoms in Patients with Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04421014", "official_title": "Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults >= 55 Years Old. A Double-Blinded Randomized Controlled Clinical Trial.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Metabolic Syndrome", "Normal Cognition"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04939792", "official_title": "Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans", "overall_status": "COMPLETED", "phase": "EARLY_PHASE1", "conditions": ["Vitamin D Deficiency"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04406636", "official_title": "Natural History Study in Prodromal and Manifest Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "Germany"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05020626", "official_title": "Modelling Tau Deposition and Distribution From Diffusion Tensor Imaging With Generative Adversarial Network for Alzheimer's Disease Diagnosis", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer's Disease Diagnosis"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00492115", "official_title": "Cognitive Benefits of Treating Sleep Apnea in Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Parkinson's Disease", "Sleep Disordered Breathing"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00973518", "official_title": "Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction Test: A One-month Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02402426", "official_title": "Brain Health Registry - Online Registry for Brain Research", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Healthy", "Neurodegenerative Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00001917", "official_title": "M2 Receptor Measurements in Aging and in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Healthy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03692182", "official_title": "Antipsychotic Use Within the Program of All-inclusive Care for the Elderly (PACE)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Behavioral and Psychiatric Symptoms of Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03980938", "official_title": "A Double-Blind, Placebo-Controlled Two-Period 10-Week Treatment Within-Subject Crossover Study Of Cognitive Effects Of Neflamapimod in Early-Stage Huntington Disease (HD)", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Huntington Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00086138", "official_title": "Depression in Alzheimer's Disease (DIADS-2)", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer's Disease", "Depression"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04898413", "official_title": "Group-based Acceptance and Commitment Therapy and Group-based Cognitive Behavior Therapy for Family Caregivers of People With Dementia in Japan", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Family Caregivers"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02021682", "official_title": "CNS and Plasma Amyloid-Beta Kinetics in Alzheimers's Disease; A Blood Isotope Labeled Amyloid-beta Test for Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05366023", "official_title": "Elucidating the Necessary Components and Mechanisms of Cognitive Training", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Cognitive Change", "Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00015548", "official_title": "Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05295615", "official_title": "Effects of PEMF Treatment on Patients With Mild to Moderate Alzheimer's Disease in a Controlled Pilot Study", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04623125", "official_title": "Spaced Retrieval as Treatment for Aphasia: Does Adaptive Spacing Enhance Picture Naming Performance?", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aphasia, Acquired", "Aphasia Primary Progressive"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06298474", "official_title": "The BRAIN App (Phase 2 SBIR): Building Relationships Using Artificial Intelligence and Nostalgia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Vascular Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05788848", "official_title": "Virtual Reality Cognitive Therapy for Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05368350", "official_title": "Treating Primary Progressive Aphasia and Apraxia of Speech With High Definition Transcranial Direct Current Stimulation (HDtDCS-PPA/PAOS)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "Apraxia of Speech"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03824197", "official_title": "Extra-virgin Olive Oil Prevents Mild Cognitive Impairment Conversion to Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Cerebral Amyloid Angiopathy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02137460", "official_title": "Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06008782", "official_title": "HEARS-SLP: Providing Speech Language Pathologist-Delivered Hearing Health Care to Individuals With Cognitive Impairment", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Hearing Loss", "Dementia", "Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00240760", "official_title": "Efficacy and Safety of Memantine Hydrochloride, a Low Affinity Antagonist to N-Methyl-D-Aspartate (NMDA) Type Receptors, in the Prevention of Cognitive Decline and Disease Progression in Down's Syndrome", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Down's Syndrome", "Dementia", "Learning Disabilities"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05446584", "official_title": "Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment", "Amnestic Mild Cognitive Disorder", "Amnestic Mild Cognitive Impairment", "Mild Traumatic Brain Injury", "Concussion, Brain"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06143826", "official_title": "Progressive Muscle Relaxation Exercise on Care Burden, Depression, Anxiety and Stress Levels in Dementia Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burden", "Dementia"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01773915", "official_title": "New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease, Late Onset"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01887535", "official_title": "A Double-Blind, Placebo-Controlled, Randomized, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02233517", "official_title": "Group Cognitive Behavioral Therapy for Anger and Aggression in Veterans With PTSD", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression", "Anger", "Posttraumatic Stress Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06898931", "official_title": "A Study of Language Intervention Training for Cognitive Protection in High-risk Cardio-Cerebrovascular Elderly Population", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Vascular Cognitive Impairment No Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00375557", "official_title": "An Open Label, Randomized, Flexible Dose, 6-week Clinical Trial of the Safety and Efficacy of Divalproex ER vs Quetiapine in the Treatment of Behavioral Symptoms in the Elderly With Moderate to Severe Alzheimer's Dementia", "overall_status": "WITHDRAWN", "phase": "PHASE4", "conditions": ["Alzheimer's Disease", "Dementia", "Behavioral Symptoms"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00966966", "official_title": "An Open-Label, Nonrandomized Study To Evaluate The Potential Pharmacokinetic Interaction Between SAM-531 and Gemfibrozil, A Cytochrome P-450 2C8 Inhibitor, When Coadministered Orally To Healthy Young Adult Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02212353", "official_title": "Care Delivery in Acute Hospital Settings: an Observational Study. WP1 P3", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Hip Fractures"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03446001", "official_title": "Randomized, Double-Blind, Placebo-Controlled, Three-Arm, 12-Month, Safety and Efficacy Study of TRx0237 Monotherapy in Subjects With Alzheimer's Disease Followed by a 12-Month Open-Label Treatment", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01403519", "official_title": "Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00887601", "official_title": "A 4-Period, Placebo-Controlled, Crossover Study to Evaluate the Utility and Feasibility of BOLD fMRI and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (Donepezil and MK3134)", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03848312", "official_title": "Cognitive Training to Reduce Incidence of Cognitive Impairment in Older Adults", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Age-related Cognitive Decline", "Alzheimer's Disease and Related Dementias"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00948766", "official_title": "A 24 Week, Prospective, Randomized, Parallel-group, Double-blind, Multi-center Study (ENA713DUS44) Comparing the Effects of Rivastigmine Patch 15 cm^2 vs. Rivastigmine Patch 5 cm^2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION) and a 24-week Open-label Extension to Study ENA713DUS44", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06817902", "official_title": "A Preliminary Sham-Controlled Theta Burst Stimulation (TBS) Study in Early-Stage Alzheimer's Disease (AD)", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01068353", "official_title": "A Phase 2, Double-blind, Placebo-controlled Study of the Safety and Tolerability of Etanercept in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05635695", "official_title": "Assessment of Cultural Pathways in the City Developed on a Smartphone Application on Physical Abilities, Well-being and Sustainable Health Knowledge", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Sedentary Behavior"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06075329", "official_title": "Dementia Caregivers and Contemplative Practice: A Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Loneliness"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04566770", "official_title": "A Randomized, Double-blind, Placebo -Controlled Phase IIb Clinical Trial to Evaluate the Safety and Immunogenicity of Ad5-nCoV in Person 6 Years of Age and Older and Those Who Have Previously Been Vaccinated With Ad5-EBOV", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["COVID-19"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03430869", "official_title": "Exploring and Subtyping the Pathophysiology of Neurodegeneration in Late-life Depression: Implications for Treatment and Prognosis in the Future", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Major Depressive Disorder"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06928454", "official_title": "INFORMED: Brain Health Project for Korean American Dementia Caregivers", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Caregiving Stress"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05534139", "official_title": "Clinicopathological MRI and CSF Correlates of Iron Accumulation, Neurodegeneration and Neuroinflammation in Huntington's Disease.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04283994", "official_title": "Using the Electronic Health Record to Identify and Promote Goals-of-Care Communication for Older Patients With Serious Illness", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Chronic Disease", "Neoplasm Metastasis", "Lung Neoplasms", "Pulmonary Disease, Chronic Obstructive", "Heart Failure, Congestive", "Liver Cirrhosis", "Kidney Failure, Chronic", "Lung Diseases, Interstitial", "Peripheral Vascular Disease", "Diabetes With End Organ Injury"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01819545", "official_title": "Shanghai Mental Health Center", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05558839", "official_title": "The Effect of Exercise and Cognitive Training on the Physical Fitness, Fall, and Cognition Among Community-dwelling Older Adults With Dementia.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Exercise", "Fall", "Cognitive Training"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT07204977", "official_title": "Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)", "overall_status": "RECRUITING", "phase": "PHASE1", "conditions": ["Amyotrophic Lateral Sclerosis", "Motor Neuron Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00428389", "official_title": "A Prospective, 5-Week, Open-Label, Randomized, Multi-Center, Parallel-Group Study With a 20-Week, Open-Label Extension Evaluating the Tolerability and Safety of Switching From Donepezil to an Initial Dose of 5 cm2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00001260", "official_title": "Brain Procurement for the Human Brain Collection Core", "overall_status": "TERMINATED", "phase": null, "conditions": ["Bipolar Disorder", "Depression", "Anxiety Disorders", "Schizophrenia", "Tourette's Syndrome", "Brain Diseases"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01038583", "official_title": "Aspirin in Reducing Events in the Elderly", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Functional Disability", "Dementia", "Heart Disease", "Stroke", "Cancer", "Bleeding", "Depression"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03221894", "official_title": "A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06040502", "official_title": "Reducing Inappropriate Medication Use for BPSD and Improving Health Outcomes for PLWD", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03647137", "official_title": "Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD", "overall_status": "COMPLETED", "phase": null, "conditions": ["Parkinson's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04865172", "official_title": "ECOCAPTURE@HOME: Program for the Assessment of Behavioural Markers of Apathy Under Real-life Conditions Aimed At Patients with Neurodegenerative Dementias and Their Caregivers", "overall_status": "RECRUITING", "phase": null, "conditions": ["Frontotemporal Dementia, Behavioral Variant", "Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02299154", "official_title": "Study of Memory Problems Perceptions With the French Adaptation of the Illness Perception Questionnaire Memory, Among Patients Who Come for the First Time at a Memory Center Until Diagnosis Disclosure Post-visit", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Memory Disorders", "Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01253122", "official_title": "Comparative Bioavailability of TRx0037 and TRx0014 in Healthy Elderly Volunteers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03778151", "official_title": "Repetitive TMS of the Precuneus: a Randomized Double-blinded Placebo-controlled Trial in Alzheimer's Disease Patients.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}, {"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00039702", "official_title": "SPECT Imaging of Alpha4beta2 Nicotinic Acetylcholine Receptors Using [123I]5-I-A-85380 in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06941506", "official_title": "The Integration of SPOZ Technology to Support and Enhance the Vitality Acupunch Exercise Program for Improving the Cognitive Behavioral Impairment and Sensory Perceptual Impairment of Older Adults With Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cognitive and Behavioral Impairment", "Sensory and Perceptual Impairment"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00242593", "official_title": "The Effects of Rosiglitazone on Cognition in Patients With MCI", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02676843", "official_title": "Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Frontotemporal Lobar Degeneration (FTLD)", "Frontotemporal Dementia (FTD)", "Tauopathies"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03602391", "official_title": "The Senior Companion Program Plus (SCP Plus): A Psychoeducational Intervention for African American Dementia Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Family", "Alzheimer Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03325699", "official_title": "Support Monitoring and Reminder Technology for Mild Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Dementia", "Cognitive Impairment, Mild"], "locations": [{"country": "Belgium"}, {"country": "Czechia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT01312363", "official_title": "A Six-month, Open Labeled, Multi-centered, Observational Study for the Tolerability of Exelon Patch (Rivastigmine) for Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00200538", "official_title": "Double-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) Patients", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04040348", "official_title": "A Phase I, Prospective, Open-label Trial to Evaluate the Safety, Tolerability and Exploratory Outcomes of Multiple Allogeneic Human Mesenchymal Stem Cells (HMSC) Infusions in Patients With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00287248", "official_title": "Evaluation of [123I] IMPY and SPECT as a Marker of Beta-amyloid Protein Deposition in the Brain of Healthy Subjects and Patients With Alzheimer Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04241068", "official_title": "Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (Aducanumab) in Subjects With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Switzerland"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04817891", "official_title": "Cholinergic Functions and Modulation of the Cingulo-opercular Alertness Network in LBD", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Lewy Body Disease", "Lewy Body Variant of Alzheimer Disease", "Lewy Body Dementia With Behavioral Disturbance"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT03846232", "official_title": "T1rho: Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT04101084", "official_title": "Rocking Chair Therapy: A Non Pharmacological Intervention in Elderly With Dementia, Its Effects in Agitation, Pharmacological Restraint Use, and Pain", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT07177352", "official_title": "Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimers Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT06413849", "official_title": "Telephone-coached \"Graphic Narrative\" Bibliotherapy for Informal Caregivers of People With Dementia", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia Caregiver", "Depressive Symptoms", "Caregiving Appraisal"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT00241293", "official_title": "Influence of Age on Hemispheric Lateralization of Language : a Longitudinal Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Aging", "Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT05773443", "official_title": "A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial to Demonstrate Clinical Efficacy on Cognitive, Neuropsychiatric and Functional Outcomes of Ambroxol in New and Early Patients With Prodromal and Mild Dementia With Lewybodies (ANeED) - Joint Effort 21: eHealth and a PPI-program in Dementia With Lewybodies (DLB)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia, Lewy Body"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:51+00:00"}
{"nct_id": "NCT02187276", "official_title": "The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer Disease and Mixed Dementia: a Naturalistic Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease, Late Onset"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02983032", "official_title": "Brief Behavioural Treatment for Insomnia (BBTI) in Family Carers of People With Dementia: a Feasibility Study", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04270604", "official_title": "Biological Sample Collection for Research and Biobanking", "overall_status": "TERMINATED", "phase": null, "conditions": ["Parkinson Disease", "Diabetes Mellitus, Type 1", "Macular Degeneration", "ALS", "Cancer", "Alzheimer Disease", "Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01855152", "official_title": "An Optimized Person Centred Intervention to Improve Quality of Life for People With Dementia Living in Care Homes. A Cluster Randomized Controlled Trial.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01371214", "official_title": "Maintaining Independence in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03861884", "official_title": "Cognition and NeuroImaging in neuroDegenerative Disorders (CogNID)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia (Diagnosis)"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00198055", "official_title": "An Open-Label Study of Aripiprazole in Children and Adolescents With Autistic Disorder", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Asperger's Disorder", "Pervasive Developmental Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02846415", "official_title": "Play Intervention for Dementia for Promoting Cognitive Function", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03560245", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02248116", "official_title": "An Open-label Multicentre, Follow-up Trial to Assess the Long-term Safety and Tolerability of Oral Administration of Talsaclidine 24 mg Tid in Patients With Mild to Moderate Dementia of the Alzheimer Type", "overall_status": "TERMINATED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02029547", "official_title": "Evaluation of Computer-Based Training to Educate Japanese Physicians in the Methods of Interpreting Florbetapir (18F) PET Scans", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT07006155", "official_title": "Intra-individual Comparison of PET Scans on the Biograph Vision 600 With the New Biograph Vision.X PET/CT", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Cancer", "Alzheimer Disease"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03860857", "official_title": "The BEACoN Study- Biomarker Exploration in Aging, Cognition and Neurodegeneration", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer Disease", "Cognitive Impairment", "Cognitive Decline"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04122001", "official_title": "Transcranial Direct Current Stimulation in Typical and Atypical Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease, Early Onset", "Atypical Alzheimer's Disease", "Logopenic Progressive Aphasia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04632628", "official_title": "Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Insomnia Chronic", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02041728", "official_title": "The Detection of Early Dementia With the Digital Game Memory", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02769000", "official_title": "Phase IIa Trial of Low Dose Radiation THerapy to Reduce Cerebral Amyloidosis in Early Alzheimer's Dementia", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05330871", "official_title": "A Single Center, Open-label, Parallel Controlled, Randomized Phase II Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV-IM, Ad5-nCoV-IH or Inactivated COVID-19 Vaccine in Population 6 to 17 Years of Age", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["COVID-19"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03628404", "official_title": "Defining the Genetic Etiology of Alzheimer's Disease in the Faroe Islands", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "Faroe Islands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00708552", "official_title": "Study AZ3110865, a Study Comparing SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Estonia"}, {"country": "Estonia"}, {"country": "Estonia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06859658", "official_title": "Développement et Validation d'un Biomarqueur en IRM Fonctionnelle de la Dysfonction Des Petits Vaisseaux cérébraux Dans la Maladie de CADASIL", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["CADASIL"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00105638", "official_title": "A Telehealth Education Program for Caregivers of Veterans With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01254448", "official_title": "Two-Part, Sequential Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TC-5619-238 in Elderly Subjects With and Without Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06384378", "official_title": "Central and Peripheral Immune Cross-talk in Alzheimer's Disease and Their Modulation by a Novel Immunotherapy", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03943264", "official_title": "Phase 1b Open-Label, Dose-Identification Study of XPro1595 in Patients With Alzheimer's Disease and Biomarkers of Inflammation.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06372587", "official_title": "Leveraging Genetically Encoded engiNeered protEins foR Next-Generation alzheImer'S Therapeutics", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05531526", "official_title": "A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 Over 52 Weeks in Participants With Early Alzheimer's Disease (Polaris-AD)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06093126", "official_title": "Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial", "overall_status": "RECRUITING", "phase": "PHASE4", "conditions": ["Insomnia", "Dementia", "Frontotemporal Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00416078", "official_title": "Caregiver Psychoeducation and Support: Improving Outcomes in AD/ADRD", "overall_status": "COMPLETED", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03291093", "official_title": "Identification of Plaque Vulnerability Wit PET/MRI: a Feasibility Study of 18F-Flutemetamol in Atherosclerosis", "overall_status": "UNKNOWN", "phase": "PHASE2, PHASE3", "conditions": ["Atherosclerosis"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01117948", "official_title": "A Multicentre Double-blind, Placebo-controlled, Randomised, Parallel-group Study to Evaluate the Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer´s Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01120002", "official_title": "Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00624026", "official_title": "Prospective, Single-arm, Multicenter, Open-label Study to Investigate the Efficacy and Tolerability of the Once Daily (OD) Memantine Treatment", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04049643", "official_title": "Impact of Hearing Aid Intervention on Individuals With Cognitive Disorders", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Presbycusis, Bilateral", "Alzheimer Disease 2 Due to Apoe4 Isoform", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05558215", "official_title": "Remote Online Administration of Otago Exercise Program for Individuals With Dementia and Their Care Partners: A Feasibility Study", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02054208", "official_title": "A Double-blind, Single-center, Phase 1/2a Clinical Trial to Evaluate the Safety and Exploratory Efficacy of Intraventricular Administrations of NEUROSTEM® Versus Placebo Via an Ommaya Reservoir in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05697380", "official_title": "Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia 3.0 Pilot", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aphasia", "Primary Progressive Aphasia", "Dementia", "Communication", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00462917", "official_title": "Risk Evaluation and Education for Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06880510", "official_title": "The Locus Coeruleus, Norepinephrine and Cognitive Aging", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02205710", "official_title": "Adaptive Cognitive Training in Healthy Older Adults", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Mild to Moderate Dementia", "Alzheimer's Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00165815", "official_title": "The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia With Parkinson's Disease"], "locations": [{"country": "Germany"}, {"country": "Germany"}, {"country": "Ireland"}, {"country": "Ireland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04418024", "official_title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Polyneuropathy (ATTRibute-PN Trial)", "overall_status": "WITHDRAWN", "phase": "PHASE3", "conditions": ["Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02844478", "official_title": "Effect of Stress-Busting Program on Caregivers' Quality of Life, Stress/Immunity Bio-markers, and Cellular Aging", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Stress, Psychological", "Telomere Shortening", "Stress, Physiological"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01324518", "official_title": "Safety and Efficacy of ORM-12741 on Cognitive and Behavioral Symptoms in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Finland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00556660", "official_title": "Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04335110", "official_title": "Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology: Living and Learning With Advancing AD", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Caregiver Burnout", "Family Members"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05322317", "official_title": "Testing Critical Components for a Trial of Advance Care Planning in Primary Care for Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Advance Care Planning"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03626324", "official_title": "Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Urinary Retention", "Neurogenic Bladder"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02247180", "official_title": "Cognitive Rehabilitation in Alzheimer's Disease (AD)", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01702480", "official_title": "Effects of Medium-Chain Triglycerides on Cognitive Function in Older Subjects With Age-Related Cognitive Decline", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04148391", "official_title": "A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment", "Mild Dementia", "Parkinson Disease", "Lewy Body Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06278818", "official_title": "Neural and Clinical Correlates of Rehabilitation in Neurodegenerative Conditions", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT07152418", "official_title": "A Study on the Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research", "overall_status": "NOT_YET_RECRUITING", "phase": null, "conditions": ["Alzheimer Disease (AD)", "Alzheimer Dementia", "Mild Cognitive Impairment (MCI)"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06613971", "official_title": "Dynamic Light Scattering Ocular Measurement in the Detection of Dementia", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia", "Dementia Alzheimer Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05828992", "official_title": "Benchmarking Integrated Care for People Living With Huntington's Disease in England (Integrate-HD Study)", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04194411", "official_title": "Association of Plasma Biomarkers for Neurological Injury and Postoperative Delirium After Cardiac Surgery", "overall_status": "COMPLETED", "phase": null, "conditions": ["Postoperative Delirium"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04741932", "official_title": "Interprofessional Dementia Care: Redistribution of Tasks Between Physicians and Qualified Nurses in Primary Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Nurse's Role", "Nurse Physician Relations"], "locations": [{"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06475898", "official_title": "Longitudinal Endpoint Assessment of Disease Burden in HD", "overall_status": "RECRUITING", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00219804", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Huntington's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04277104", "official_title": "Improving Slow Wave Sleep by Auditory Stimulation to Enhance Memory Consolidation and New Learning in Healthy Older Adults and Older Individuals at Risk for Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Healthy", "Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05256121", "official_title": "HAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06972004", "official_title": "Preventing Loss of Independence Through Exercise in Community Living Centers: An Effectiveness-Implementation Trial", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Cognitive Dysfunction"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01796314", "official_title": "Impact of a Therapeutic Educational Programme for Alzheimer's Disease Patients and Their Caregiver in Community Dwelling, on the AD Patient's Quality of Life", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00703430", "official_title": "The Effect of Memantine on Aggression and Agitation and Its Impact on Caregiver Burden of Patients With Alzheimer's Disease: A 12-week Open-label Study", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03691428", "official_title": "A Daily Self-Regulation Intervention for Persons With Early Stage Alzheimer's Disease and Related Dementias and Their Spouses", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia Caregiving"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01255163", "official_title": "A Pilot Study of Exendin-4 in Alzheimer s Disease", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02674516", "official_title": "The Effect of Repeated Transcranial Direct Current Stimulation of the Prefrontal Cortex on Antisocial and Aggressive Behavior", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Antisocial Behavior", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01434563", "official_title": "The CNS HAND Study: The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort", "overall_status": "COMPLETED", "phase": null, "conditions": ["HIV-1-Associated Cognitive Motor Complex"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06885567", "official_title": "A Multicenter, Randomized, Double-blind, Parallel Design, Placebo-controlled, Phase 2 Clinical Trial and Open-Label Extension Study to Evaluate the Safety and Efficacy for BEY2153 in Patients with Early Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Alzheimer&#39; Disease"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01572311", "official_title": "Study of Community Based Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults Without Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Impairment"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00735800", "official_title": "Psychosocial Telephone Intervention for Dementia Caregivers", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03656107", "official_title": "The Effects of Brain Training on Brain Blood Flow: The Cognition and Flow Study", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Mild Cognitive Impairment", "Aging", "Cognitive Impairment"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01599975", "official_title": "Phase III, Placebo-Controlled, Double-Blind Crossover Study of Slow-Release Methylphenidate (Concerta ™) for Treatment of HIV Associated Neurocognitive Disorder", "overall_status": "UNKNOWN", "phase": "PHASE3", "conditions": ["HIV Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03360019", "official_title": "Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support: Phase II", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia, Vascular", "Alzheimer Dementia", "Lewy Body Dementia With Behavioral Disturbance"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02860065", "official_title": "Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02327182", "official_title": "A Long-Term Safety Study of MT-4666 in Patients With Mild to Moderate Alzheimer's Disease (AD)", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00675623", "official_title": "A Global Phase 3, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Oral Dimebon in Patients With Mild-to-Moderate Alzheimer's Disease (CONNECTION)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02362880", "official_title": "Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease: 18F-Florbetaben Positron Emission Tomography Study", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03944603", "official_title": "Investigating the Contribution of Peripheral Versus Central Nervous System Dysfunction to Cognitive Aging", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Healthy Older Adults Ages 60-89"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01747213", "official_title": "Phase I, Double-Blind, Placebo-Controlled, Ascending, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Bisnorcymserine (BNC), a Highly Selective Inhibitor of Butyrylcholinesterase, in Healthy Adult Volunteers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Volunteers"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01661660", "official_title": "Ecological Assessment of Autonomy and Apathy in Alzheimer Patients at Mild and Moderate Stages, as Welle as in Healthy Control Particpants", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Predemential Alzheimer Patient", "Demential Alzheimer Patient", "Witness"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04245579", "official_title": "Cognitive Training in Elders Without Dementia Using UMAM Method. Genetic, Brain Volume and Cognitive Reserve Predictors: A Randomized Controlled Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Age-Related Memory Disorders"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04844060", "official_title": "Analysis of Clinical Data and Diagnosis in Any Person Requiring an Assay of Alzheimer Biomarkers in Cerebrospinal Fluid", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "Dementia With Lewy Bodies", "Frontotemporal Dementia", "Parkinson's Disease Dementia", "Multiple System Atrophy"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02630446", "official_title": "Effectiveness and Cost-effectiveness of an In-home Respite Care Program to Support Informal Caregivers of People With Dementia: a Comparative Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04350060", "official_title": "Memory Care of the Future: Improving the Quality of Dementia Care Through Innovative Redesign of the Memory Care Environment", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00409279", "official_title": "An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02099123", "official_title": "A Study of STAtins for Reducing Events in the Elderly (STAREE)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE4", "conditions": ["Independent Living", "Disability Free Survival", "Elderly", "Healthy"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01937923", "official_title": "A Pre-Cellular Therapy Observational Study in Early Huntington's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Huntington Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05313659", "official_title": "Intramuscular Ketamine Effect on Postnasal Surgery Agitation: a Double Blinded Randomized Controlled Trial.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Agitation, Emergence"], "locations": [{"country": "Jordan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05686980", "official_title": "An Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-552 in Healthy Adult Japanese and Han Chinese Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Volunteers"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03418688", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of COR388 in Older Healthy Volunteers and Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01998490", "official_title": "Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia: Impact on Factors Related to the Risk of Falls, on Evidence Based Practice and on the Relatives' Burden", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04149860", "official_title": "Interventional, Randomized, Double-blind, Placebo-controlled, Single-ascending-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AF87908 in Healthy Subjects and Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03994159", "official_title": "Impact of an Emotional Robot on Quality of Working Life of Caregivers in a Geriatric Unit Specialized in Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Burnout, Professional", "Stress", "Anxiety"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01092546", "official_title": "A Principal, Prospective, Open-label Biopsy Study to Validate Detection of Cerebral Cortical Amyloid With Flutemetamol (18F) Injection in Normal Pressure Hydrocephalus (NPH) Subjects.", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Normal Pressure Hydrocephalus"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01322373", "official_title": "Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test: A Follow-up Study", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00392483", "official_title": "The Use and Diffusion of an E-learning Programme in Diagnostic Evaluation of Dementia Among General Practitioners in Denmark", "overall_status": "COMPLETED", "phase": null, "conditions": ["Education", "Dementia"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04748666", "official_title": "Problem Solving Training (PST) for English- and Spanish-speaking Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Frontotemporal Degeneration (FTD)", "Lewy Body Dementia (LBD)", "Vascular Contributions to Cognitive Impairment and Dementia (VCID)", "Mixed Etiology Dementias (MED)", "Mild Cognitive Impairment (MCI)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03430973", "official_title": "Driving Simulation Experiments of Aggressive Driving and Road Rage", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01085266", "official_title": "HORIZON-Plus: An Open-Label Extension of the HORIZON Protocol (DIM20) Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Huntington Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03817931", "official_title": "Higher Neural and Cognitive Changes Following Anticholinergic Versus Beta 3 Agonist Versus Placebo Treatments in Female Patients With Overactive Bladder: a Multicenter Randomized Controlled Pilot Trial", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Overactive Bladder", "Dementia", "Lower Urinary Tract Symptoms", "Incontinence, Urge"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04992195", "official_title": "Impact of COVID-19 Vaccines on Cerebrovascular Health - a Population-based Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Stroke", "Stroke, Acute", "Stroke, Ischemic", "Dementia", "Brain Ischemia", "Alzheimer Disease", "Brain Diseases", "Major Adverse Cardiovascular Event", "Arterial Thromboembolism", "Venous Thromboembolism"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02686554", "official_title": "Elucidating the Proteostatis Network to Control Alzheimer's Disease - Identification of Proteostasis-related Biomarkers in Alzheimer´s Dementia", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05827094", "official_title": "Pilot Evaluation of a Mobile Intervention to Support Mediterranean Diet (MedD) for Persons With Mild Alzheimer Disease and Alzheimer Disease Related Dementia's (AD/ADRD) and Frailty", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Frailty"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05783102", "official_title": "Knowledge and Interpersonal Skills to Develop Exemplary Relationships (Pilot 2)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Caregiver Burden", "Relation, Family", "Elder Abuse"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03877783", "official_title": "Diet, Physical Exercise and Metabolic Control (DEMAND) Intervention to Reduce the Incidence of Major Neurocognitive Disorders Among Individuals With Type 2 Diabetes Combined With Mild Neurocognitive Impairment - a Pilot Study", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Type 2 Diabetes Mellitus", "Mild Cognitive Impairment"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00510094", "official_title": "Determining the Efficacy of a Relational Aggression Intervention for Urban African American Girls", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02221622", "official_title": "Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase 1", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05260151", "official_title": "Cross-sectional Validation and Longitudinal Study of Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases and Normal Controls", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Progressive Supranuclear Palsy", "Frontotemporal Dementia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT07167966", "official_title": "Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2", "conditions": ["Preclinical Alzheimer's Disease", "Prodromal Alzheimer's Disease", "Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01412151", "official_title": "Creatine Safety & Tolerability in Huntington's Disease (CREST-X): A Single-Center, Open-Label, Long-Term Safety & Tolerability Extension Study of Creatine in Subjects With HD", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington's Disease (HD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04423666", "official_title": "Findings of a Health-coached Technology Based Walking Program in Unpaid Caregivers of Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06563453", "official_title": "Implication of Cognitive Reserve in Non-pharmacological Intervention Outcomes", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Aging", "Mild Cognitive Impairment", "Dementia With Lewy Bodies"], "locations": [{"country": "Czechia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03378245", "official_title": "Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations and Healthcare Costs in Appalachia KY Skilled Nursing Facilities", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia Alzheimers", "Disruptive Behavior"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06149702", "official_title": "A Feasibility Randomised Controlled Trial of a Digital Program to Prevent Falls and Improve Well-being in People Living With Dementia in the Community.", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04445831", "official_title": "A Phase Ib/IIa Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses, Regimens and Combinations of Tau Targeted Vaccines in Subjects With Early Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer's Disease", "Cognitive Impairment", "Tauopathies", "Mild Cognitive Impairment", "Dementia", "Brain Diseases", "Central Nervous System Diseases"], "locations": [{"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01428453", "official_title": "A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) on Biomarkers Related to the Pathogenesis and Progression of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Norway"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05204745", "official_title": "Gait and Balance Impairment, Dementia and Wide Brain Ventricles in the Ages 65-84 Years", "overall_status": "COMPLETED", "phase": null, "conditions": ["Idiopathic Normal Pressure Hydrocephalus (INPH)", "Brain Diseases", "Central Nervous System Diseases", "Dementia", "Gait Disorders, Neurologic", "Hydrocephalus, Normal Pressure"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02351453", "official_title": "Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03888222", "official_title": "A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies (DLB)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00277602", "official_title": "A Phase III Multicenter, Double-Blind, Parallel-Group, Placebo Controlled Study to Measure the Effect of Riluzole 50 mg b.i.d. Over a Period of Three Years on the Progression of Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Huntington Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT07163377", "official_title": "Effect of Art Therapy on Cognitive and Hand Functions of Alzheimer's Patients", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05428475", "official_title": "Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital", "overall_status": "UNKNOWN", "phase": "PHASE3", "conditions": ["Dementia", "Cognitive Impairment", "Dementia With Lewy Bodies"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05992467", "official_title": "WECARE: A mHealth Intervention to Enhance Caregiving Mastery Among Chinese American Dementia Caregivers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burden", "Caregiver Stress Syndrome"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01190800", "official_title": "Decision Capacity Assessment in Persons With Alzheimer's Disease: Approach by Capacity to Appoint a Proxy, to Consent to Treatment and to Vote", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Capacity to Consent to Treatment", "Capacity to Vote", "Capacity to Design a Proxy"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06049732", "official_title": "Psychometric Evaluation of the Electronic Pain Assessment Tool PainChek® Adult in Nursing Homes in the United States", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia", "Pain"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01409564", "official_title": "Cilostazol Augmentation Study In Dementia (CASID): A Randomized, Placebo-controlled Pilot Study to Compare the Efficacy Between Donepezil Monotherapy and Cilostazol Augmentation Therapy in Alzheimer's Disease Patients With Subcortical White Matter Hyperintensities", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer's Dementia"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06365645", "official_title": "Examining the Feasibility and Acceptability of a Novel App-based Cognitive Behavioral Therapy Intervention for Preventing Postpartum Depression", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Postpartum Depression", "Postpartum Anxiety", "Stress"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03891277", "official_title": "Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA,FAVORITE", "overall_status": "UNKNOWN", "phase": "PHASE2", "conditions": ["Vascular Cognitive Impairment", "Dementia, Vascular", "Iron-deficiency", "Cerebral Infarction", "TIA"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05761665", "official_title": "Comparison of Kinesiophobia, Balance, Falling and Walking Speeds of the Cognitively Frail Elderly With Alzheimer's Dementia With the Physically Fragile Elderly.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Frail Elderly Syndrome"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00000177", "official_title": "Estrogen Hormone Protocol", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00183092", "official_title": "Novel Therapeutics For Prion Diseases: A Randomized, Double-blinded, Placebo-controlled Study of the Efficacy of Quinacrine in the Treatment of Sporadic Creutzfeldt-Jakob Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Creutzfeldt-Jakob Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02439099", "official_title": "Retinoic Acid Homeostasis in Neuropsychiatric Diseases", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Major Depression", "Alzheimer's Disease", "Alcoholism", "Schizophrenia"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03522129", "official_title": "A Pilot Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02801877", "official_title": "Artificial Intelligence in a Mobile (AIM) Intervention for Depression", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Depression", "Anxiety"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03147222", "official_title": "Hip Fracture Caregiver Intervention - Function Focused Care: Fracture Care at Home", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Fractures, Bone", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02252653", "official_title": "DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis", "overall_status": "COMPLETED", "phase": null, "conditions": ["Familial Amyloidotic Cardiomyopathy (FAC)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Brazil"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05519137", "official_title": "Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00585572", "official_title": "University of Wisconsin-Madison: Wisconsin Brain Donor Program (WBDP)", "overall_status": "ENROLLING_BY_INVITATION", "phase": null, "conditions": ["Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02118701", "official_title": "SHARED DECISION MAKING ON A 'LIFE-AND-CARE PLAN' IN LONG-TERM CARE FACILITIES", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02128828", "official_title": "H020: Single-Arm Open Label, Pilot Study of CCR5/CCR2 Inhibitor Cenicriviroc (CVC) for HIV Associated Neurocognitive Disorder (HAND)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["AIDS Dementia Complex", "HIV-1-Associated Cognitive Motor Complex", "Human Immunodeficiency Virus"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00315900", "official_title": "Depakote ER vs. Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Agitation", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00975481", "official_title": "A Randomized, Double-Blind, Placebo- And Active-Controlled Single-Dose, Crossover Study To Evaluate The Abuse Potential Of Single Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease", "Huntington's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01029132", "official_title": "Characteristics of Treatment Responders to Galantamine Administration in the Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02194036", "official_title": "The Effect of Learning Oriented Physiotherapy on Health-Related Functioning and Quality of Life in Patients With Various Anxiety Disorders", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Agitation", "Anxiety", "Dizziness", "Pain", "Numbness", "Depression", "Fatigue", "Sleep Disturbances"], "locations": [{"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05613699", "official_title": "Implementation and Evaluation of Physical Exercise Services for Young Adults With Cancer", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Fatigue", "Cancer", "Physical Activity", "Exercise"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04403165", "official_title": "Locus-coeruleus Function in Normal Elderly and AD Risk", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03420807", "official_title": "Evaluation of Beta-amyloid Plaques of the Retina Using Metabolic Hyperspectral Retinal Camera (MHRC) in Alzheimer's Patients - Toronto Study Arm", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00106899", "official_title": "Alzheimer's Disease Neuroimaging Initiative", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06705192", "official_title": "Open-label Multiple Dosing Study in Asymptomatic GRN-frontotemporal Dementia Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Dementia", "Frontotemporal Dementia", "Asymptomatic Condition"], "locations": [{"country": "Netherlands"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01695889", "official_title": "A Case-control Study of Exposure to General Anesthesia and a Diagnosis of Alzheimer´s Disease Later in Life.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer´s Disease", "General Anesthesia"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05484960", "official_title": "Multicenter Collection of Uniform Data on Patients With Cognitive Impairment in the Philippines: the Philippine Neurological Association One Database -Dementia (PNA1DB-Dementia)", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Cognitive Impairment", "Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Philippines"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06898424", "official_title": "Effects of Concurrent Plant-Based Ketogenic Diet and Intermittent Fasting (Ketoflex 12/3) on the Clinical Progression of Early-to-Mid Stage Alzheimer's Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Type Dementia", "Alzheimer&#39;s Disease (AD)"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03539380", "official_title": "TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease: Intermediate-Size Patient Population", "overall_status": "AVAILABLE", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02397980", "official_title": "A Multicenter, Randomized Trial to Assess Efficacy of Therapeutic Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease", "Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05255068", "official_title": "Optimizing Mealtime Care (OPTIMAL): Development and Pilot Testing of a Person-Centered Mealtime Care Intervention for Nursing Home Residents With Alzheimer's Disease and Related Dementias (ADRD)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease and Related Dementias"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03556280", "official_title": "Multi-Center Study of Sensory Stimulation to Improve Brain Function (Overture Study)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "Cognitive Impairment", "Mild Cognitive Impairment", "Dementia Alzheimers", "Dementia, Mild", "Dementia, Alzheimer Type", "Dementia of Alzheimer Type", "Dementia", "Cognitive Impairment, Mild", "Cognitive Decline"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00608946", "official_title": "Treatment With Copper in Patients With Mild Alzheimer´s Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer´s Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04823143", "official_title": "Natural History of Disease Progression in Individuals With a Confirmed Diagnosis of Disease Caused by Mutation of the Valosin Containing Protein (VCP) Gene", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["IBMPFD"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04820335", "official_title": "Promoting Independence With Compensatory Cognitive Rehabilitation: A Pilot Clinical Trial for Early-Stage Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00822224", "official_title": "Use of MEOPA for Elderly With Dementia.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00005123", "official_title": "Honolulu Heart Program", "overall_status": "COMPLETED", "phase": null, "conditions": ["Cardiovascular Diseases", "Coronary Disease", "Cerebrovascular Accident", "Heart Diseases", "Heart Failure, Congestive", "Myocardial Infarction", "Asthma", "Emphysema", "Lung Diseases, Obstructive", "Aortic Aneurysm, Abdominal", "Bronchitis", "Dementia", "Hypertension", "Chronic Obstructive Pulmonary Disease", "Heart Failure"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06453746", "official_title": "Effectiveness of Dementia Prevention in Elderly Patients With Mild Cognitive Impairment at Nhân dân Gia Định Hospital, Hồ Chí Minh City", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Dementia Prevention"], "locations": [{"country": "Vietnam"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00884507", "official_title": "A Dose-ranging, Randomized, Double-blind , Placebo-controlled Study of the Effect of RO5313534, Used as add-on Therapy to Donepezil, on Cognitive Function in Patients With Mild to Moderate Symptoms of Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Romania"}, {"country": "Romania"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03746392", "official_title": "Using the Electronic Health Record to Identify and Promote Goals-of-Care Communication", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Malignant Neoplasm", "Leukemia, Lymphocytic, Chronic, B-Cell", "Lung Disease Chronic", "Congestive Heart Failure", "Liver Failures, Chronic", "Renal Insufficiency, Chronic", "Dementia", "Diabetes Complications", "Peripheral Vascular Disease", "Frail Elderly"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05654584", "official_title": "Evaluation of the Relationship Between Weight Loss and Aggression After Laparoscopic Sleeve Gastrectomy Surgery", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Obesity", "Obesity, Morbid", "Aggression"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03838185", "official_title": "A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 in Healthy Young Volunteers and Healthy Elderly Volunteers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05318976", "official_title": "A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Dementia", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Tauopathies", "Neurodegenerative Diseases", "Neurocognitive Disorders", "Mental Disorders", "Mild Cognitive Impairment"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02489097", "official_title": "Evaluating the Incidence and Association Between Nitrous Oxide and Postoperative Cognitive Disorders in Anaesthesia", "overall_status": "TERMINATED", "phase": "PHASE4", "conditions": ["Anesthesia", "Delirium, Dementia, Amnestic, Cognitive Disorders"], "locations": [{"country": "China"}, {"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06152120", "official_title": "Preparing Surrogates of Dementia Patients for In-the-moment Decision Making Through a Structured Advance Care Planning Intervention: A Mixed-methods Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02997982", "official_title": "Feasibility and Effects on Markers in Spinal Fluid in Persons With Early Alzheimer's Disease When Treated With Valaciclovir - Open Fas II Pilot Study (VALZ-Pilot)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment", "Herpes Simplex"], "locations": [{"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02624778", "official_title": "A Single- and Multiple-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Intravenous Doses of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00018278", "official_title": "Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01438060", "official_title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia, Alzheimer Type"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00001362", "official_title": "Structural and Functional Imaging of Neurologically Impaired Patients and Normal Volunteers With 1.5 and 3.0 Tesla MRI", "overall_status": "COMPLETED", "phase": null, "conditions": ["Amnesia", "Dementia", "Healthy", "Nervous System Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01624389", "official_title": "Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06474013", "official_title": "Initial Safety and Efficacy of Repetitive BBB (Blood Brain Barrier) Disruption Using High Intensity Focused Ultrasound 'ExAblate 4000 Type 2.1' in Patients With Alzheimer's Disease: Single-center, Open, Prospective, Single-arm, Feasibility, Investigator-initiated Trial)", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03597360", "official_title": "Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia (LDIR-CT-AD) Trial: A Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia Alzheimers"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT07145723", "official_title": "Supporting Care Partners' Well-Being With AI Chatbots: A Feasibility and Acceptability Study", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Caregivers"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01479855", "official_title": "Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimers Disease"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02061878", "official_title": "A Randomized Controlled Study to Evaluate the Effect of Bexarotene - an RXR Agonist - on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01565343", "official_title": "Test-retest Reproducibility of 18F-AV-45 for Brain Imaging of Amyloid in Healthy Volunteers and Alzheimer's Disease Patients", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04381468", "official_title": "SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD): A Multi-center, Randomized, Double-Blind, Placebo-Controlled Safety and Biomarker Study of Pepinemab Anti-SEMA4D Antibody in Early-AD", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05215782", "official_title": "Evaluation of Optina Retina Scans to Detect the Likeley Cerebral Amyloid Status (CAS) as Determined by Prospective PET Imaging", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02191267", "official_title": "Tau Imaging of Chronic Traumatic Encephalopathy", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Chronic Traumatic Encephalopathy"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00322036", "official_title": "Phase 3 Multinational, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment With MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects With Mild Dementia of the Alzheimer's Type", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Switzerland"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05078944", "official_title": "Randomized, Blinded, Sham-Controlled Trial of Acupuncture on the Progression of Mild Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease 1"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT07033494", "official_title": "A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants With Early Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Early Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02736695", "official_title": "Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and FTD", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "Behavioral Variant of Frontotemporal Dementia", "Frontotemporal Dementia, Behavioral Variant"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04552795", "official_title": "Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease (ART-AD)", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06098612", "official_title": "PET Imaging Evaluation of [11C]SY08", "overall_status": "RECRUITING", "phase": "EARLY_PHASE1", "conditions": ["Parkinson's Disease", "Multiple System Atrophy", "Dementia With Lewy Bodies", "Healthy Controls"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT03569722", "official_title": "EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)", "overall_status": "TERMINATED", "phase": null, "conditions": ["Dementia", "Telemedicine", "Cognitive Dysfunction"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04514328", "official_title": "Highlighting the Benefits of Therapeutic Gardens in Alzheimer's Disease by 18F-FDG Cerebral PET /CT", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT01168245", "official_title": "Effects of a Combined TMS Stimulation and Cognitive Training in Alzheimer Patients: a Single-center, Randomized, Double-blind, Placebo-controlled Study", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease", "Mild to Moderate"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT04850781", "official_title": "Home-delivered Meals for Persons With Dementia: Which Model Delays Nursing Home Placement?", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02529436", "official_title": "Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT05579236", "official_title": "An Observational Longitudinal Cohort Study to Investigate Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease", "Dementia"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02760602", "official_title": "A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Puerto Rico"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT00477828", "official_title": "Cognitive Benefits of Treating Apnea in Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Sleep Apnea"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT02185053", "official_title": "A Phase II, Single-Blind, Placebo-Controlled, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of CPC-201 in Patients With Alzheimer's Disease Type Dementia", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:52+00:00"}
{"nct_id": "NCT06626412", "official_title": "Longitudinal Imaging of Striatal Synaptic Density and Volume in People With Premanifest Huntington's Disease.", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Huntington Disease"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04263519", "official_title": "A Pilot Open Labeled Study of Tacrolimus to Assess it's Effects on Bio-markers of Mild Cognitive Impairment and Alzheimer's Disease", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03095066", "official_title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury (TBI).", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Neurobehavioral Disinhibition"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05352529", "official_title": "Utilizing Assistive Technology to Reduce Caregiver Burden and Enhance Quality of Life in Individuals Living With Alzheimer's Disease and Related Dementias", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Caregiver Burden", "Quality of Life", "Activities of Daily Living"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05821153", "official_title": "Phase I Trial Using Interleukin-2 (IL-2) to Expand Regulatory T Cells in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06629207", "official_title": "Artificial Intelligence on Molecular Imaging to Predict the Risks of Parkinson's Disease for Patients With Rapid Eye Movement Sleep Behavior Disorder", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Parkinson Disease", "REM Sleep Behavior Disorder", "Dementia, Lewy Body"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00455000", "official_title": "A Phase I, Randomized, Placebo Controlled, Double Blind Dose Escalation Study Of The Safety, Tolerability, Pharmacokinetics,Pharmacodynamics, And Immunogenicity Of A Single Intravenous Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02953964", "official_title": "Perceptual and Semantic Memory Encoding Strategies for People With Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Mild Dementia"], "locations": [{"country": "Australia"}, {"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00291421", "official_title": "International Outcomes Survey In Dementia (IOSID)", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Dementia", "Nervous System Diseases", "Mental Disorders", "Brain Diseases"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06722352", "official_title": "Preparing Assisted Living Staff to Provider Palliative Care to Residents With Dementia: Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease", "End of Life", "Caregiver Burden", "Caregiver Burnout", "Patient Participation", "Self Efficacy"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06557863", "official_title": "Reducing Burden in Care Partners of Community-Dwelling Persons With Dementia and Oropharyngeal Dysphagia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burden", "Alzheimer Disease", "Dementia", "Oropharyngeal Dysphagia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04981587", "official_title": "Effects of Strength Exercise on Fall Risk in Elderly With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia; Alzheimer's Type (Etiology)", "Fall Risk", "Elderly", "Resistance Training"], "locations": [{"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03475316", "official_title": "Social Dancing Intervention for Older Adults at High Risk of Alzheimer's Disease and Other Dementias: A Pilot Study.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Cognitive Decline", "Cognitive Impairment", "Dementia, Alzheimer Type"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03412604", "official_title": "Effect of Modulating Gamma Oscillations by Transcranial Alternating Current Stimulation on Brain Structure and Function in Humans", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02245568", "official_title": "An Open-Label, Extension Study of the Effects of LMTM in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease", "Behavioral Variant Frontotemporal Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Malaysia"}, {"country": "Malaysia"}, {"country": "Malaysia"}, {"country": "Netherlands"}, {"country": "Romania"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Singapore"}, {"country": "Singapore"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03937297", "official_title": "A Culturally Appropriate Multimodal Non-pharmacological Intervention for Chinese People With Mild-to-Moderate Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Hong Kong"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02467413", "official_title": "A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia", "overall_status": "WITHDRAWN", "phase": "PHASE2", "conditions": ["Alzheimer's Disease", "Vascular Dementia"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06027320", "official_title": "Risk Education Technology As Individualized Neuroprotection", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia", "Healthy Participants", "Brain Health"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02629640", "official_title": "Enhanced CJD Surveillance in the Older Population", "overall_status": "COMPLETED", "phase": null, "conditions": ["Prion Disease", "Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02199782", "official_title": "Pilot Study of Cognitive Assessment in Welsh Speakers", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Cognitive Impairment - e.g. Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05406648", "official_title": "The Effect of Black Mulberry (Morus Nigra) Consumption on Cognitive Functions and Antioxidant Capacity in Individuals Diagnosed With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease, Early Onset"], "locations": [{"country": "Turkey (Türkiye)"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06735950", "official_title": "The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRD", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Apathy in Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01712074", "official_title": "A Randomized, 18-week, Placebo-controlled, Double-blind, Parallel Group Study Of The Safety And Efficacy Of Pf-05212377 (Sam-760) In Subjects With Mild-to-moderate Alzheimer's Disease With Existing Neuropsychiatric Symptoms On A Stable Daily Dose Of Donepezil", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02370524", "official_title": "Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease (AD)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04250376", "official_title": "The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Mild Dementia", "Parkinson Disease", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03491150", "official_title": "A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Finland"}, {"country": "France"}, {"country": "Germany"}, {"country": "Hong Kong"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Lithuania"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Poland"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Turkey (Türkiye)"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00675090", "official_title": "A Single Blind, Placebo-controlled, Randomised Study in Mild to Moderate Alzheimer's Disease Patients to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK239512, a Selective Histamine H3 Receptor Antagonist", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Australia"}, {"country": "Australia"}, {"country": "Czechia"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00276510", "official_title": "Efficacy and Tolerance of EGb 761® 120mg Two Times a Day on Dementia of Alzheimer Type's Onset in Patients Suffering From Memory Complaints. A Randomised, Double-blind, Multicentre, Parallel Groups, Placebo Controlled Phase IIIb/IV Study in Elderly Over 70", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Memory Disorders, Age-Related", "Retention Disorders, Cognitive"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01377948", "official_title": "Phase 1 Study of Anger Control Therapy Augmented With RAGE-Control (Regulate and Gain Emotional-Control)Delivered on an Inpatient Psychiatric Unit", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Anger", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02530255", "official_title": "Evaluation of an Oral Telomerase Activator on Retinal Amyloid", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05166278", "official_title": "The Effectiveness of Verbal and Non-verbal De-escalation Techniques on Reduction of Aggressive Behaviour and Coercion", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression", "Physical Restraint", "Education"], "locations": [{"country": "Slovenia"}, {"country": "Slovenia"}, {"country": "Slovenia"}, {"country": "Slovenia"}, {"country": "Slovenia"}, {"country": "Slovenia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03489278", "official_title": "Clinical Procedures to Support Research in ALS (CAPTURE-ALS)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis", "ALS-Frontotemporal Dementia", "Primary Lateral Sclerosis", "Progressive Muscular Atrophy"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06508268", "official_title": "Language, Speech and Motor Function in Mild Cognitive Impairment Due to AD and Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer's Disease", "MCI Due to AD", "Dementia Alzheimers"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04639050", "official_title": "A Phase Ib/IIa, Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Patients With Prodromal or Mild to Moderate Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimers Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04875416", "official_title": "Phenotype, Genotype and Biomarkers 2", "overall_status": "RECRUITING", "phase": null, "conditions": ["Amyotrophic Lateral Sclerosis", "Hereditary Spastic Paraplegia", "Primary Lateral Sclerosis", "Progressive Muscular Atrophy", "Frontotemporal Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "South Africa"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT07094516", "official_title": "A Randomized, Placebo-controlled, Parallel Group, 72-week Study to Evaluate the Efficacy and Safety of VHB937 in Participants With Early Alzheimer's Disease Followed by an Extension", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01194128", "official_title": "Intervention to Facilitate Family Caregiver Adaptation to Nursing Home Transition", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Dementia", "Stroke", "Heart Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06544044", "official_title": "Efficacy of Brief Mindfulness Based Self-Compassion Intervention for Management of Anger Among Adolescents", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression"], "locations": [{"country": "Pakistan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02236832", "official_title": "Organisation du Cortex préfrontal ventrolatéral Pour l'Analogie: Approche Bimodale Chez le Sujet Sain et Chez le Patient Ayant un Syndrome Frontal.", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Frontotemporal Dementia", "Progressive Supranuclear Palsy", "Healthy Subjects"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05565833", "official_title": "Internet-based Insomnia Intervention to Prevent Cognitive Decline in Older Adults With Mild Cognitive Impairment (SHUTi MIND)", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Insomnia", "Cognitive Dysfunction", "Mild Cognitive Impairment", "Sleep Initiation and Maintenance Disorders", "Sleep Disorders, Intrinsic", "Dyssomnias", "Sleep Wake Disorders", "Nervous System Diseases", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06191952", "official_title": "Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Subjective Cognitive Decline", "Alzheimer Dementia"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06442852", "official_title": "Study on the Relationship Between Peripheral Blood miRNA and Risk and Severity of Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease", "MicroRNAs"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05860647", "official_title": "A Single Arm Study of Resting State Functional Magnetic Resonance Imaging (Rs-fMRI)-Guided Theta Burst Stimulation (TBS) in Primary Progressive Aphasia (PPA)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03969732", "official_title": "Multimodal Biomarkers for Diagnosis and Prognosis in Cerebral Amyloid Angiopathy", "overall_status": "UNKNOWN", "phase": "PHASE3", "conditions": ["Cerebral Amyloid Angiopathy", "Intracranial Hemorrhages", "Alzheimer Disease"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04515433", "official_title": "Interventional Cross-over Study to Evaluate the Efficacy on Cognitive Performance of Alternating Current Brain Stimulation (tACS) in Patients Suffering From Neurodegenerative Diseases", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00782067", "official_title": "A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Leukemia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Austria"}, {"country": "Belgium"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Netherlands"}, {"country": "Norway"}, {"country": "Poland"}, {"country": "Turkey (Türkiye)"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02519036", "official_title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 443139 in Patients With Early Manifest Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "Canada"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06718764", "official_title": "Evaluating the Feasibility of Utilizing a Novel Brain Activity Monitor in the Neurosciences Intensive Care Unit", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Delirium", "Sedation", "Agitation"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02667314", "official_title": "Jigsaw Puzzles As Cognitive Enrichment", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Impairment"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01264614", "official_title": "Neuropsychological and Neuroimaging Effects of Strengthening Exercise for Early Dementia and Normative Older Adults", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Decline", "Dementia", "Alzheimer's Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01865604", "official_title": "Impact of tDCS on Cerebral Autoregulation", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cerebral Microangiopathy", "CADASIL", "Migraine With Aura", "ICA Stenosis"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03387267", "official_title": "A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Stroke", "Parkinson Disease", "Multiple Sclerosis", "Oropharyngeal Dysphagia", "Alzheimer Disease", "Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Finland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05631236", "official_title": "Promoting Cognitive Resilience and Reducing Frailty in Older Veterans With Bright Light Therapy", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Veteran Aged 65 and Older"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03485898", "official_title": "Patient Outcomes After an Hospitalization in the Specialized Cognitive-behavioral Unit (UCC) of Toulon", "overall_status": "TERMINATED", "phase": null, "conditions": ["Behavior Disorders"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02258152", "official_title": "SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Parkinson's Disease Dementia (PDD)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03442322", "official_title": "Optimizing Care for Patients With Dementia: A Comparison of Two Non-pharmacological Treatment Approaches", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02767609", "official_title": "Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Traumatic Brain Injury", "Multiple Sclerosis", "Alzheimer's Disease", "Tumor"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02586909", "official_title": "A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Serbia"}, {"country": "Singapore"}, {"country": "Singapore"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Taiwan"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05034107", "official_title": "Effects of Diffused Ylang-Ylang (Cananga Odorata) Essential Oil Amongst Older Persons With Dementia: A Pre-Post Quasi-Experimental Study Protocol", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Behavioral and Psychiatric Symptoms of Dementia"], "locations": [{"country": "Malaysia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05622734", "official_title": "VOCALE LBD+ Leveraging Social Technologies and Problem-Solving Skills to Enhance Mastery Among Caregivers of Persons With Lewy Body Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burden", "Lewy Body Disease", "Stress", "Skill, Coping"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06770309", "official_title": "A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease (AD)", "Sarcopenia", "Asthenia"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01650454", "official_title": "Sleep, Cognition and Memory Disorder", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Sleep Architecture", "Sleep Disorders", "Cognitive Impairment"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05356702", "official_title": "Low-cost Detection of Dementia Using Electronic Health Records Data: Validation and Testing of the eRADAR Algorithm in a Pragmatic, Patient-centered Trial.", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00479219", "official_title": "A Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSI-953 in Blood and Cerebrospinal Fluid, When Administered Orally to Healthy Young Subjects and Patients With Alzheimer Disease", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05068830", "official_title": "Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease: The ExPlas Study", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02914366", "official_title": "Ambroxol as a Novel Disease Modifying Treatment for Parkinson's Disease Dementia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Parkinson's Disease Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03035851", "official_title": "Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias: Harnessing Translational Physiology", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06217237", "official_title": "Phase II Neuroimaging Network: Optimization and Harmonization of Advanced MRI Sequences and Their Application in the Study of Dementia and Intellectual Disability in Pediatric Age", "overall_status": "COMPLETED", "phase": null, "conditions": ["Dementia Frontal", "Dementia Alzheimers", "Lewy Body Variant of Alzheimer Disease", "Neuro-Degenerative Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05007730", "official_title": "Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Dementia", "Nutrition Poor"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04207502", "official_title": "Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Health Aging", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Sleep Disturbance", "Cognitive Change", "Aging"], "locations": [{"country": "Taiwan"}, {"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00593372", "official_title": "Treatment of Language and Memory in Patients With Alzheimer's Disease: A Comparison Between Drug Therapy and Drug Therapy Plus Behavioral Intervention", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06501495", "official_title": "Slow Waves During Sleep and Wakefulness: a Common Denominator for Cognitive and Attentional Disorders in Normal and Pathological Aging (Exploratory Study)", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Aging", "Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01300728", "official_title": "A Randomized Double-Blinded Placebo-Controlled Exploratory Study of Intravenous Immunoglobulin (NewGam 10%) in Amnestic Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01879267", "official_title": "Exercise Effects in Huntington's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Huntington's Disease"], "locations": [{"country": "Switzerland"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00391794", "official_title": "Efficacy of Early Stage Alzheimer's Support Groups", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Memory Loss", "Alzheimer's Disease", "Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04120766", "official_title": "Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging: SMArT-HS", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04747431", "official_title": "A Phase 1b Open-Label, Multicenter, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacodynamic Effects of a Single Dose of PBFT02 Delivered Into the ICM of Adults With FTD and Mutations in the GRN or C9ORF72 Genes", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Frontotemporal Dementia", "FTD", "FTD-GRN", "Dementia Frontotemporal", "C9orf72"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "Brazil"}, {"country": "Brazil"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01681602", "official_title": "Preserving Quality of Life, Physical Health and Functional Ability in Alzheimer's Disease: The Effect of Physical Exercise", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05501119", "official_title": "Palliative Care Telehealth Delivered Program of SUPPORT-D Intervention for Persons With Alzheimer's Disease and Caregivers Phase 2", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00414622", "official_title": "A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06385951", "official_title": "An Immersive Virtual Reality Spatial Navigation Task as Potential Biomarker for the Early Detection of Alzheimer's Disease.", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Alzheimer Disease", "Healthy Aging"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00914095", "official_title": "Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentric Trial", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Parkinson's Disease", "Gait Disorders, Neurologic", "Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT04200612", "official_title": "The Therapeutic Effects of Equine-Assisted Psychotherapy on Lowering Aggression Levels Through an Increase of Emotion Regulation", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression", "Stress", "Psychopathy", "Empathy"], "locations": [{"country": "Singapore"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00886951", "official_title": "Evaluation of [123I] MNI-388 and 123-I MNI-390 and SPECT as Markers of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03514095", "official_title": "Cognitive Stimulation in the Elderly: Individual Intervention on Cognitive Frailty", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Neurocognitive Disorders", "Dementia"], "locations": [{"country": "Portugal"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00369577", "official_title": "A Multi-center, Randomized, Double-blind, Placebo-controlled, Single Dose Efficacy and Safety Study of StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Schizophrenia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06514066", "official_title": "Cannabidiol's Role in Dementia Management: Evaluating Cognitive, Quality of Life, and Well-being Outcomes in Malaysia", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2, PHASE3", "conditions": ["Dementia, Vascular", "Dementia, Mixed"], "locations": [{"country": "Malaysia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01574456", "official_title": "Blood-brain Barrier Permeability in Alzheimer's Disease", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01760005", "official_title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2, PHASE3", "conditions": ["Alzheimers Disease", "Dementia", "Alzheimers Disease, Familial"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Brazil"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Colombia"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Ireland"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Netherlands"}, {"country": "Puerto Rico"}, {"country": "Spain"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05545657", "official_title": "A Cross-sectional and Longitudinal Study to Investigate the Relationship and Central Mechanism Between Diabetes and Cognitive Impairment Based on Simultaneous EEG-fMRI Approach and Peripheral Neuropathology Biomarkers Assay", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Type 2 Diabetes", "Alzheimer Disease", "Cognitive Impairment"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT00548145", "official_title": "The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Alzheimer Disease", "Hypercholesterolemia"], "locations": [{"country": "Japan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05831371", "official_title": "Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Late Onset Epilepsy", "Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05291234", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-916 in Subjects With Early Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer's Disease (AD)"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02990663", "official_title": "The Effect of Antihypertensive Medication Timing on Morbidity and Mortality: The \"BedMed\" RCT", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Hypertension"], "locations": [{"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT03557593", "official_title": "Optimizing Prescribing of Antipsychotics in Long-Term Care (OPAL): A Randomized Trial to Reduce Inappropriate Antipsychotic Prescribing in Long-Term Care", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02215616", "official_title": "A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Laquinimod (0.5, 1.0 and 1.5 mg/Day) as Treatment in Patients With Huntington's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Huntington's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Czechia"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Netherlands"}, {"country": "Portugal"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT06043700", "official_title": "A Community-Based Screening Program to Identify, Using Blood-Based Biomarkers, Individuals With or Without Alzheimer's Disease Symptoms Who Are at High Risk for Brain Amyloid Pathology", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01549834", "official_title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT02453763", "official_title": "In Vivo Imaging of Therapeutic Electric Current Flow", "overall_status": "COMPLETED", "phase": null, "conditions": ["Parkinson Disease", "Epilepsy", "Alzheimer's Disease", "Stroke", "Autism", "Depression", "Schizophrenia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT05887063", "official_title": "Investigating the Feasibility, Acceptability, and Impact of an Online UK Dementia Awareness Course for Informal Caregivers: A Mixed Methods Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Caregiver Burden"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:53+00:00"}
{"nct_id": "NCT01354314", "official_title": "Pilot Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder (HAND)", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["HIV Associated Neurocognitive Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02946710", "official_title": "P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03959124", "official_title": "The Effect of Deep Brain Stimulation on Memory Network and Neurological Function of Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Dementia, Alzheimer Type", "Deep Brain Stimulation"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01642420", "official_title": "Quantitative Electroencephalography, Cerebrospinal Fluid Biomarkers, Linear CT Analyses and Timed Up and GO Dual Task as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimers Disease", "Mild Cognitive Impairment"], "locations": [{"country": "Denmark"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT07101380", "official_title": "A Multicenter, Prospective, Investigator-initiated, Feasibility Randomized Controlled Study to Evaluate the Applicability and Safety of the Multi-Domain Personalized Physical Activity Prescription Software 'SuperBrain BOOM' for Patients With Mild Cognitive Impairment", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment (MCI)"], "locations": [{"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05801380", "official_title": "Monitoring Drug Efficacy Through Multi-omics Research Initiative in Alzheimer's Disease", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "Philippines"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01892579", "official_title": "Reducing Agitation in People With Dementia: the Customized Activity Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02406027", "official_title": "A Randomized, Two-Period, Double-Blind Placebo-Controlled and Open-Label, Multicenter Extension Study to Determine the Long-Term Safety and Tolerability of JNJ-54861911 in Subjects in the Early Alzheimer's Disease Spectrum", "overall_status": "TERMINATED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Belgium"}, {"country": "Belgium"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Netherlands"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05683860", "official_title": "A Multicenter, Open-label Extension (OLE) Study to Evaluate the Safety, Pharmacodynamics, and Clinical Effects of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)", "overall_status": "TERMINATED", "phase": "PHASE1, PHASE2", "conditions": ["ALS", "FTD"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01292382", "official_title": "Effects of rTMS on the Cognition of Elderly With Cognitive Impairment no Dementia ( CIND )", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Mild Cognitive Impairment"], "locations": [{"country": "Brazil"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05929924", "official_title": "Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects With Alzheimer's Disease Family History", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04063124", "official_title": "Pilot Study to Investigate the Safety and Feasibility of Senolytic Therapy to Modulate Progression of Alzheimer's Disease (SToMP-AD)", "overall_status": "COMPLETED", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06767124", "official_title": "Simultaneous PET/MR Imaging of Brain Glucose and Oxygen Metabolism to Assess Energy Deficits Related to Alzheimer's Disease and the Response to Intervention", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease and Related Dementias (ADRD)"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05525780", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 Intramuscular Depot and Aricept® Oral Tablets (Pfizer Canada Inc.) in Healthy Male Volunteers", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03300180", "official_title": "Caregiver Outcomes of Alzheimer's Disease Screening", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05315960", "official_title": "SOcial coNNEction in Long-Term Care Home Residents", "overall_status": "RECRUITING", "phase": null, "conditions": ["Dementia"], "locations": [{"country": "Canada"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04579120", "official_title": "Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04627662", "official_title": "Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Alzheimer Disease", "Caregiver Burnout", "Family Members"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00494962", "official_title": "An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between Two 5-mg Tablets and a New 10-mg Tablet Formulation of Lecozotan SR in Healthy Subjects.", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05336123", "official_title": "The Peace of Mind and Body Project: Treatment Development of Yoga for Anger Management in Incarcerated Adults", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Anger", "Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05402423", "official_title": "An Integrated Intervention of Computerized Cognitive Training and Physical Exercise in Virtual Reality for People With Alzheimer's Disease: the JDome Study Protocol", "overall_status": "WITHDRAWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05235113", "official_title": "Tele-exergame: Remotely-supervised Exercise Platform for Improving Cognition and Motor Function Using Telemedicine", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Mild Cognitive Impairment", "Dementia", "Cognitive Impairment", "Memory Loss"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06888713", "official_title": "Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults with Cognitive Deficits: a Large-scale Action Design Research Study", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04388982", "official_title": "Open-Label, Single-Center, Phase I/Ⅱ Clinical Trial to Evaluate the Safety and the Efficacy of Exosomes Derived From Allogenic Adipose Mesenchymal Stem Cells in Patients With Mild to Moderate Dementia Due to Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "PHASE1, PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06217146", "official_title": "A Two-part Study, Part I an Open-label; and Part II a Randomized Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MediCane's Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia Including Probable Alzheimer's Disease (AD)", "overall_status": "TERMINATED", "phase": "NA", "conditions": ["Agitation,Psychomotor", "Disruptive Behavior", "Dementia", "Alzheimer Disease"], "locations": [{"country": "Israel"}, {"country": "Israel"}, {"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03906123", "official_title": "The Efficacy of DL-3-n-butylphthalide (DL-NBP) on the Cognitive Function and Vascular Regulation in Patients With Mild Vascular Dementia (VaD) Caused by Subcortical Ischemic Vascular Disease (SIVD)", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Subcortical Vascular Dementia", "Cerebral Small Vessel Diseases"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06611878", "official_title": "Memory for Music: Effects of Individual Intensive Musical Training Based on Singing in Non-musicians With Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Argentina"}, {"country": "Austria"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06439355", "official_title": "Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Idiopathic Parkinson's Disease and Lewy Body Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02501876", "official_title": "Type 2 Diabetes Mellitus as Accelerator for the Progression to Alzheimer's Disease in Patients With Mild Cognitive Impairment", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer´s Disease", "Diabetes Mellitus Type 2"], "locations": [{"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00786318", "official_title": "Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department", "overall_status": "WITHDRAWN", "phase": "PHASE4", "conditions": ["Psychosis", "Agitation", "Delirium"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00468897", "official_title": "An Open-Label, Randomized, Two-Period Crossover Study to Demonstrate the Bioequivalence of a Tablet Formulation of Rosiglitazone XR (BRL-049653) 8mg Manufactured at Two Different Sites in Healthy Volunteers in Fasting Conditions", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Germany"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05606991", "official_title": "The Impact of 2 Weeks CPAP Withdrawal on Brain Waste Clearance in Adults With Severe Obstructive Sleep Apnoea - A Randomised Controlled Crossover Trial", "overall_status": "ENROLLING_BY_INVITATION", "phase": "NA", "conditions": ["Obstructive Sleep Apnea", "Dementia", "Cognitive Impairment"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03430648", "official_title": "Is Tau Protein Linked to Mobility Function?", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer Disease", "Physical Activity"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02908815", "official_title": "Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Australia"}, {"country": "Canada"}, {"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04588285", "official_title": "A Clinical Trial to Demonstrate Clinical Efficacy on Cognitive, Neuropsychiatric and Functional Outcomes of Ambroxol in New and Early Patients With Prodromal and Mild Dementia With Lewybodies", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Dementia With Lewy Bodies"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05077826", "official_title": "Modern Energetic Methods of Response Improvement (MEMORI)", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease", "Mild Cognitive Impairment"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04576793", "official_title": "Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01713816", "official_title": "Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress", "overall_status": "COMPLETED", "phase": null, "conditions": ["Oxidative Stress", "Alzheimer's Disease", "Aging"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT07120347", "official_title": "Remote Sensing for ADRD-Specific Activities Identification in Older Adults", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Alzheimer Disease and Related Dementias (ADRD)", "Mild Cognitive Impairment (MCI)"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04247347", "official_title": "Tailored Health Self-Management Interventions for Highly Distressed Caregivers: Family Members of Persons With Dementia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Stress", "Carer Stress Syndrome", "Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00056225", "official_title": "High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03118947", "official_title": "A 52-Week Open-Label Extension Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Agitation and Aggression in Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "France"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01366027", "official_title": "PRISM Registry: Pseudobulbar Affect Registry Series", "overall_status": "COMPLETED", "phase": null, "conditions": ["Alzheimer's Disease", "Amyotrophic Lateral Sclerosis (ALS)", "Multiple Sclerosis (MS)", "Parkinson's Disease", "Stroke", "Traumatic Brain Injury"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05711342", "official_title": "The Added Value of an Internet-based Intervention for Treatment of Aggression in Forensic Psychiatric Outpatients: A Multicentre, Randomized Controlled Trial", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Aggression", "Psychosocial Problem", "Forensic Psychiatry", "Internet-based Intervention"], "locations": [{"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00431470", "official_title": "Is the Classroom Education Program Intervention Effective in Increasing Positive Self Esteem, Enhancing Leadership Behaviors, While Decreasing the Prevalence of Bullying Behaviors in Fifth Grade Elementary Students?", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01076855", "official_title": "Guidance Programme for Elderly With Cognitive Disorders", "overall_status": "COMPLETED", "phase": null, "conditions": ["Mild Dementia"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05292248", "official_title": "Confidently Navigating Financial Decisions and Enhancing Financial Wellbeing in Dementia Caregiving", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Caregiver Burden", "Financial Stress", "Dementia", "Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04852055", "official_title": "Effect of an Advance Care Planning Intervention on Documentation of Advance Directives and Goals of Care in Assisted Living Centers", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00041678", "official_title": "Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01340885", "official_title": "Cognitive Dysfunction in PD: Pathophysiology and Potential Treatments, a Pilot Study", "overall_status": "COMPLETED", "phase": "PHASE4", "conditions": ["Parkinson's Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01081743", "official_title": "Evaluation de la Mise en Place d'un Auxiliaire d'évaluation Dans la Prise en Charge de la Maladie d'Alzheimer et Des Maladies apparentées en France", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease or Associated Disorder", "Mild to Moderately Severe Dementia"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00348140", "official_title": "A 54 Week, Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Acetylcholinesterase Inhibitors on Cognition and Overall Clinical Response in APOE4-stratified Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Belgium"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Hong Kong"}, {"country": "Hong Kong"}, {"country": "Malaysia"}, {"country": "Malaysia"}, {"country": "Malaysia"}, {"country": "Malaysia"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Philippines"}, {"country": "Philippines"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Singapore"}, {"country": "Singapore"}, {"country": "Singapore"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovenia"}, {"country": "Slovenia"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05508789", "official_title": "Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease", "overall_status": "RECRUITING", "phase": "PHASE3", "conditions": ["Alzheimer Disease", "Dementia", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Tauopathies", "Neurodegenerative Diseases", "Neurocognitive Disorders", "Mental Disorders"], "locations": [{"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Argentina"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "Australia"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04522960", "official_title": "Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Belgium"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06665074", "official_title": "Inflammatory Challenge in Human Aggression.", "overall_status": "NOT_YET_RECRUITING", "phase": "PHASE2", "conditions": ["Intermittent Explosive Disorder"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05349318", "official_title": "Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease: A Prospective, Randomized, Double Blind Study", "overall_status": "RECRUITING", "phase": "NA", "conditions": ["Prodromal Alzheimer's Disease", "Cerebral Vascular Disorder", "Mild Cognitive Impairment", "Vascular Cognitive Impairment"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05317910", "official_title": "Evaluation of Effect of Music Therapy on Anxiety of Carers of Alzheimer's Disease Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04182282", "official_title": "Online Training & Certification for Competency in Dementia Friendly Hospital Care", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Knowledge, Attitudes, Practice", "Burnout, Caregiver", "Job Satisfaction"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00224497", "official_title": "A Phase IIa/b Double-blind, Randomised, Placebo-controlled, Linear Trend Design Dose-ranging Study to Investigate the Effects of 24 Weeks of Monotherapy With SB-742457 on Cognition in Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Bulgaria"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Chile"}, {"country": "Croatia"}, {"country": "Croatia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "New Zealand"}, {"country": "New Zealand"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "Slovakia"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Africa"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02788513", "official_title": "A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy and Safety of Orally Administered BI 425809 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease.", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Austria"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "Finland"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Greece"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Hungary"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT07064382", "official_title": "VR-based Multi-dimensional Intervention on Cognitive Function and Well-beings", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia", "Sleepiness", "Mental Health", "Alzheimer Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01434940", "official_title": "Early Oculomotor Markers in Alzheimer's Disease: Test of Predictive Value in the Differential Diagnosis Depression/Alzheimer", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Alzheimer Disease", "Depression"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03945968", "official_title": "The Role of Concomitant Diseases in Postoperative Complications Risk Stratification - a Prospective Observational Multi-center Cohort Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Coronary Heart Disease", "Anemia", "Bronchial Asthma", "Stroke", "Epilepsy", "Parkinson's Disease", "Heart Rhythm Disorders", "Alzheimer's Disease", "Neuromuscular Diseases", "Diabetes", "Chronic Heart Failure", "Chronic Obstructive Pulmonary Disease", "Chronic Kidney Diseases"], "locations": [{"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04130360", "official_title": "A Randomized Controlled Trial of an Online Problem-solving Intervention to Reduce Aggression Among Youth", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Aggression"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04408625", "official_title": "A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN)", "overall_status": "RECRUITING", "phase": "PHASE1, PHASE2", "conditions": ["Frontotemporal Dementia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Australia"}, {"country": "Belgium"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01701089", "official_title": "An Open-Label, Parallel Group Study to Assess the Inhibition of Brain MAO-B by RO4602522 After Repeated Dosing in Patients With Alzheimer's Disease and in Healthy Control Subjects", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Healthy Volunteer, Alzheimer's Disease"], "locations": [{"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01330160", "official_title": "Characterization of Clinical, Biological, Morphological and Pharmacological Factors Influencing Occurrence of Dementia or Cognitive Disorders After Stroke", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Cerebrovascular Disorders", "Dementia"], "locations": [{"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01123408", "official_title": "Clozapine and Olanzapine in the Treatment of Violence in Schizophrenic Patients", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Schizophrenia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04046991", "official_title": "Treating Primary Progressive Aphasia (PPA) and Elucidating Neurodegeneration in the Language Network Using Transcranial Direct Current Stimulation (tDCS)", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "PHASE2", "conditions": ["Primary Progressive Aphasia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04881617", "official_title": "Establishing Evidence-based Treatment for Speech and Language in Primary Progressive Aphasia", "overall_status": "ACTIVE_NOT_RECRUITING", "phase": "NA", "conditions": ["Primary Progressive Aphasia", "Semantic Dementia", "Semantic Memory Disorder", "Logopenic Progressive Aphasia", "Nonfluent Aphasia, Progressive", "Aphasia", "Aphasia, Progressive"], "locations": [{"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01194713", "official_title": "Losing Sleep Over Alzheimer's Disease? Effects of Sleep Deprivation on Cerebrospinal Fluid Amyloid-beta Dynamics", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Netherlands"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03789760", "official_title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel, and Multi-centre Study to Evaluate the Clinical Efficacy and Safety of SaiLuoTong (SLT) in the Treatment of Vascular Dementia", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Vascular Dementia"], "locations": [{"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04187391", "official_title": "The Effects of a Multimodal Approach for the Treatment of Primary Progressive Aphasia", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Primary Progressive Aphasia"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02051335", "official_title": "A Randomized, Double-Blind, Placebo Controlled, 4-Period, Cross-Over Study to Evaluate the Effects of Single Oral Administrations of Roflumilast in Combination With Donepezil on Reversing Scopolamine (Hyoscine) Induced Deficits in Psychomotor and Cognitive Function in Healthy Adults", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Memory Impairment", "Alzheimer's Disease"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06156917", "official_title": "Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.", "overall_status": "COMPLETED", "phase": null, "conditions": ["Parkinson Disease"], "locations": [{"country": "Italy"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04286139", "official_title": "Self-management and HeAlth Promotion in Early-stage Dementia With E-learning for Carers - SHAPE: A Multicentre, Randomised, Controlled Trial", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "Australia"}, {"country": "Norway"}, {"country": "Norway"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03901261", "official_title": "Cohort Study of Adult Patients With Down Syndrome at Risk of Developing Alzheimer's Disease", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Down Syndrome", "Alzheimer Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06772194", "official_title": "Taiwan Post-Stroke Disability Study (T-PODS): A Survey of Multiple Post-Stroke Disability Domains Among Stroke Patients in Taiwan", "overall_status": "RECRUITING", "phase": null, "conditions": ["Stroke", "Dementia", "Epilepsy", "Depression"], "locations": [{"country": "Taiwan"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04850053", "official_title": "Detection of Alzheimer's Disease (AD)-Related Seeds as Biomarkers for Accurate Diagnosis of AD（AD-seeds-detector）", "overall_status": "RECRUITING", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00630851", "official_title": "A Six-month, Multicenter, Double-blind, Parallel, Placebo-controlled Study of the Effect on Global/Behavioural/ADL Functions and Tolerability of Aricept in Patients Wtih Severe Alzheimer's Disease Living in an Assisted Care Facility", "overall_status": "COMPLETED", "phase": "PHASE3", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}, {"country": "Sweden"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04074837", "official_title": "Phase1a, Randomized Placebo-controlled, Single and Multiple Dose, Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNI-362 in Healthy Aged Volunteers 50 to 72 Years of Age", "overall_status": "COMPLETED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05385445", "official_title": "The Use of Electronic Medical Records to Change Clinician Behaviour and Increase Adherence to the Choosing Wisely Recommendations", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Viral Infection", "Vitamin D Deficiency"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03378453", "official_title": "Narcolepsy Protect Against Alzheimer's Disease? Protective Role of Low Rates of Orexin on the Occurrence of Intracerebral Amyloid Deposits Characteristic of the Alzheimer's Disease: A Pilot Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Narcolepsy", "Amyloid Pathology"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06611202", "official_title": "Enhancing Mobility and Mental Health in Dementia Patients: A Multidisciplinary Six-Minute Walking Group Pilot Study", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03429686", "official_title": "The Use of Digital Technology in Reminiscence Work With People With Dementia in Jordanian Care Homes: A Feasibility Study", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06836141", "official_title": "Silent Brain Infarcts in Spontaneous Intracerebral Hemorrhage as a Prognostic Biomarker for Vascular Contributions to Cognitive Impairment and Dementia (VCID)", "overall_status": "RECRUITING", "phase": null, "conditions": ["Primary Intracerebral Hemorrhage"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04851496", "official_title": "A Study to Evaluate the Ability of Speech- and Language-based Digital Biomarkers to Detect and Characterise Prodromal and Preclinical Alzheimer's Disease in a Clinical Setting - PAST Extension Study.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer Disease", "Preclinical Alzheimer's Disease", "Prodromal Alzheimer's Disease", "Alzheimer's Disease (Incl Subtypes)", "Mild Cognitive Impairment"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02783573", "official_title": "A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia", "overall_status": "TERMINATED", "phase": "PHASE3", "conditions": ["Alzheimer's Disease"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "Canada"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "China"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Czechia"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "Denmark"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "France"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Germany"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Italy"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Japan"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Mexico"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Netherlands"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Poland"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Portugal"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "Russia"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "South Korea"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Spain"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "Taiwan"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01217541", "official_title": "Collaboration Between Department of Old Age Psychiatry and Nursing Homes", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia", "Alzheimer's Disease", "Behavioral Symptoms", "Agitation"], "locations": [{"country": "Norway"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04065854", "official_title": "Promoting Activity, Independence and Stability in Early Dementia and Mild Cognitive Impairment", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Dementia", "Mild Cognitive Impairment"], "locations": [{"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}, {"country": "United Kingdom"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT05969054", "official_title": "A Clinical Study Exploring Lacosamide and Levetiracetam in Improving Cognitive in Patients With Alzheimer's Disease and Epilepsy", "overall_status": "RECRUITING", "phase": "PHASE4", "conditions": ["Alzheimer Disease 3", "Epilepsy"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01459783", "official_title": "Comparative Effectiveness of Dementia Care Strategies in Underserved Communities", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Dementia"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02836054", "official_title": "Study of Degenerescence CSF Hallmarks in Older Bipolar Patients", "overall_status": "UNKNOWN", "phase": "NA", "conditions": ["Bipolar Disorder", "Alzheimer's Disease"], "locations": [{"country": "France"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT01696019", "official_title": "A Pilot Randomized Intervention Study of Physical Exercise and Social Engagement in Chinese Elders", "overall_status": "COMPLETED", "phase": "NA", "conditions": ["Cognitive Impairment", "Dementia", "Mild Cognitive Impairment", "Alzheimer Disease"], "locations": [{"country": "China"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT00325728", "official_title": "A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of 8 Week Treatment of Rozerem 8 mg (QHS) in Sleep Disturbed, Mild to Moderately Severe Alzheimer's Disease Subjects", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Chronic Insomnia"], "locations": [{"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}, {"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT02051244", "official_title": "Pilot Study That Investigates the Potential of Using OCT (Optical Coherence Tomography) Measurements of the Thickness of the Retinal Nerve Fiber Layer as a Biomarker for the Early Detection of Alzheimer's Disease.", "overall_status": "UNKNOWN", "phase": null, "conditions": ["Alzheimer's Disease"], "locations": [{"country": "Israel"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03613844", "official_title": "The Delivery of Essential Fatty Acids to the Brain", "overall_status": "COMPLETED", "phase": "PHASE2", "conditions": ["Brain DHA Delivery and Alzheimer's Disease Risk"], "locations": [{"country": "United States"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT06856681", "official_title": "A Study of the Clinical Effect of the Implementation of a Blood Biomarker Into Memory Clinics in the Department of Veterans Affairs and Other Closed System Healthcare Memory and Dementia Sites in the United States", "overall_status": "NOT_YET_RECRUITING", "phase": "NA", "conditions": ["Alzheimers Disease"], "locations": [], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT03020381", "official_title": "Gait as Predictor of Cognitive Decline, Dementia, and Risk of Falls in MCI. A Cohort Study", "overall_status": "RECRUITING", "phase": null, "conditions": ["Gait Apraxia", "Mild Cognitive Impairment", "Subjective Cognitive Impairment", "Cerebral Atrophy", "Alzheimer Disease", "Dementia"], "locations": [{"country": "Canada"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
{"nct_id": "NCT04759365", "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Oral ASN51 in Healthy Young Adult and Elderly Subjects and Elderly Subjects With Alzheimer's Disease", "overall_status": "TERMINATED", "phase": "PHASE1", "conditions": ["Alzheimer Disease"], "locations": [{"country": "Australia"}], "last_changed_date": null, "ingestion_ts": "2025-10-06T15:08:54+00:00"}
